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Chapter I. GENERAL INTRODUCTION 
 
A large variety of structurally complex compounds has been isolated from plants. This 
complexity does not allow a simple organisation of an overview of plant-derived chemicals. 
For a clear presentation of this general introduction, the chapter is divided into four parts. 
 
The first part is devoted to a survey of important plant-derived drugs and agrochemicals.  
 
In the second part will be given a brief presentation of the Rubiaceae plant family and some 
of its biologically active compounds. Besides, a special emphasis will be made on the genus 
Pentas (from which are the plants under investigation in the present study), wich will includes 
an overview of the traditional medicine usages (in Africa) of its species, together with a 
presentation of the results of phytochemical investigations already made on Pentas longiflora 
Oliver and Pentas zanzibarica (Klotsch) Vatke. 
 
In the third part, the purpose and the goal of the present research work will be presented, 
whereas the fourth part will be devoted to the materials and methods used. 
 
I.1. Nature: An Invaluable Source of Useful Chemical Agents 
 
Nature has been a source of medicinal treatments for thousands of years. Nowadays, the 
search for new chemotherapeutic agents has been expanded to the whole biodiversity: plants, 
microorganisms, as well as marine organisms. 
 
From 1960 to 1982, more than 180,000 microbial-derived, some 16,000 marine organism-
derived, and more than 114,000 plant-derived extracts were screened for antitumor activity, 
and a number of clinically effective drugs were developed. Microorganisms are a profilic 
source of structurally diverse bioactive metabolites, and have yielded some of the most 
important products of the drug industry, including penicillins, aminoglycosides, tetracyclines, 
cephalosporines, and other classes of antibiotics that have revolutionized modern medicine 
(1a). The most prominent of the marine-derived chemotherapeutic agents is bryostatin 1, 
isolated from the bryozoan Bugula neritina (2), and which is in phase II clinical trials (USA) 
as anticancer agent (1a). 
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Of the newly approved drugs reported between 1983 and 1994, drugs of natural origin 
predominated (78%) in the area of antibacterials, while 61% of the 31 anticancer drugs 
approved in the same period were either natural products, nature-derived products or 
compounds modeled on natural product parents or “leads”. In addition, 50% of the best 
selling pharmaceuticals in 1991 were either natural products or their derivatives (3). 
 
Plant-based systems continue to play an essential role in the primary health care of 80% of the 
world’s population (4). An increasing number of chemotherapeutic agents are discovered as a 
result of chemical studies directed towards the isolation of the active substances from plants 
used in traditional medicine (1a). Tropical forest plant species have served as a source of 
medicines for people of the tropics for millennia. Many medical practitioners are well aware 
of the number of modern therapeutic agents that have been derived from tropical forest 
species. In fact, over one-hundred and twenty pharmaceutical products currently in use are 
plant-derived, and some 75% of these were discovered by examining the use of these plants in 
traditional medicine. Of these, a large portion has come from tropical forest species (1b). 
Given the arising of new diseases, particularly in the area of infectious diseases, and the 
occurrence of a variety of drug resistance such as in the AIDS and tropical malaria treatments, 
it is expected that this interest in nature, and rather in the plant kingdom, as a source of 
potential drug agents will continue to grow. 
 
It has to be also noted that plants, as living organisms, possess biological self-defense 
mechanisms which served as the basis for the discovery of a number of agrochemicals such as 
insecticides, fungicides, and herbicides. 
 
I.1.1. Survey of Plant-derived Drugs 
 
An increasing number of modern drugs have been isolated and purified from plant extracts. 
Well-known examples of plant-derived medicinal agents include the antimalarial drug 
quinine, isolated from the bark of Cinchona officinalis, the analgesics codeine and morphine 
from Papaver somniferum, the cardiac glycoside digitoxin from Digitalis purpurea, the 
antihypertensive reserpine 1 from Rauwolfia serpentina (5), and the anticancer drugs 
vinblastine 2 and vincristine 3, isolated from the Madagascar periwinkle, Catharanthus 
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roseus (6), to name a few. Of the established plant-derived anticancer drugs, vinblastine 2 and 
vincristine 3 are still produced by their direct isolation from the plant material (1a). 
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I.1.1.1. Infectious Diseases Area 
 
The occurrence of new bacterial and viral pathogens and the increasing clinical importance of 
drug-resistant variants of well-known pathogens have given additional urgency to 
antiinfectious diseases research in the last decades. Many effective antibacterial, 
antimicrobial, antiviral or antifungal agents have been isolated from various plant species. 
(+)-Calanolide A 4 (phase I clinical trials) is a reverse-transcriptase inhibitor discovered from 
the Malaysian rainforest tree Calophyllum lanigerum (Clusiaceae) by the U. S. National 
Cancer Institute (7,8). In vitro studies of this compound demonstrated its effectiveness against 
the Human Immunodeficiency Virus Type 1 (HIV-1), including strains resistant to AZT and 
other non-nucleoside reverse-transcriptase inhibitors (9,10). It also exhibited synergistic anti-
HIV activity in combination with nucleoside reverse-transcriptase inhibitors, including AZT, 
ddI, and ddC (11,12). 
 
In an effort aiming at the discovery of more potent anti-HIV pyranocoumarins of the (+)-
calanolide A (4) type from plants of the genus Calophyllum, 31 species have been analyzed 
and their anti-HIV activity tested (13). In addition to isomers of (+)-calanolide A (4), more 
than 10 other pyranocoumarins were isolated, among which soulattrolide 5 (from C. 
teysmannii), which was found to be also a potent inhibitor of HIV-1 reverse transcriptase 
(IC50  
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of 0.34 µM) (13,14). Two isomers of this last compound, inophyllum B (6) and inophyllum P 
(7) were isolated from C. inophyllum, and inhibited HIV reverse transcriptase with IC50 
values of 38 and 130 nM, respectively (15). 
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R2
R1
Inophyllum B   6    R1 = H         R2 = OH
Inophyllum P   7    R1 = OH      R2 = H
 
 
Another class of anti-HIV natural products, the atropisomeric naphthylisoquinoline alkaloids 
dimers, michellamines A, B, and C, were isolated from Ancistrocladus korupensis 
(Ancistrocladaceae), an extremely rare tropical rainforest plant of Cameroon (16). The most 
potent and abundant member of the series, michellamine B (8), inhibited the enzymatic 
activities of reverse transcriptases from both HIV-1 and HIV-2. Enzymatic assays showed 
michellamine B (8) to inhibit drug-sensitive and drug-resistant HIV-1 and HIV-2 reverse 
transcriptases, including the AZT-resistant strain G910-6 (16,17). 
 
From the root bark of Schumanniophyton magnificum was isolated the chromone secondary 
amine, schumannificine 9, which displayed activity against HIV, whereas potent anti-Herpes 
simplex (anti-HSV) activity was also observed for a number of its derivatives (18,19). 
Pancratistatin 10 is an Amaryllidaceae isoquinoline alkaloid isolated from the bulbs of the 
Hawaian Pancratium littorale Jacq. (20), and which exhibited consistent in vitro activity 
against flaviviruses (Japanese encephalitis, yellow fever, and dengue viruses) and the 
bunyaviruses (Punta Toro and Rift Valley fever virus) (21). 
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In the early 1970's, the antimalarial artemisinin 11 was isolated (22-23) from Artemisia annua 
L. (Asteraceae plant family), a plant used in traditional Chinese medicine for the treatment of 
febrile diseases. The drug is effective in treating chloroquine-resistant malaria and other 
severe cases without major toxicity. Its synthetic and fat-soluble analogue, artemether, which 
is a methyl ether of the corresponding lactol, is as effective as quinine in the treatment of 
severe malaria. The in vitro concentration at which artemisinin can inhibit 50% of the growth 
of Plasmodium falciparum ranges from 3 to 30 µg/L, while artemether is approximately twice 
as active. Artemisinin 11 and its derivatives have found their way into clinical use in many 
areas where malaria is endemic (8,24). 
 
Artemisinin (qinhaosu)  11
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Various tropical species from the Malpighiaceae plant family, which are used regularly by 
tropical tribe groups in South America, contain ß-carboline alkaloids (25-27). In an in vitro 
test against epimastigotes of Trypanosoma cruzi (Costa Rica strain), one of these alkaloids,  
harmine 12, was effective in reducing growth for more than 90% at a concentration of 50 
µg/mL, and showed significant activity at 5 µg/mL as anti-leishmanial compound (28). 
I.1.1.2. Neurological Diseases Area 
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Natural products research afforded some interesting compounds which are effective 
medicines for neurological diseases. Galanthamine 13, a natural product originally isolated 
from Caucasian snowdrop Galanthus woronowi (29a), and the common snowdrop Galanthus 
nivalis (29b) in the 1950s, is a long-acting, centrally active competitive cholinesterase 
inhibitor. It has also been found in several South African Amaryllidaceae (29c). Galanthus 
species have been used for hundreds of years in traditional medicine to treat painful 
neurological conditions such as facial neuralgia, with such treatment being essentially topical 
(8). Galanthamine 13 has been used extensively as a curare reversal agent in anaesthetic 
practice in Eastern bloc countries (30). In the 1990s, preliminary clinical trials have claimed 
that Galanthamine 13 has some beneficial effects in restoring cholinergic transmission in 
patients with Alzheimer’s disease (31a-c). Phase II clinical trials carried out in patients with 
senile dementia of Alzheimer’s type have shown a statistically significant improvement in 
cognitive performance (32). 
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Another example of a plant derived candidate for the treatment of Alzheimer’s disease is 
huperzine A 14. For several centuries, elderly people in some parts of mainland China have 
brewed Huperzia serata (Lycopodiaceae) for improvement of their memory. In the early 
1980's, huperzine A 14 was isolated from this traditional medicinal plant (33a-c) as a potent, 
reversible, and selective inhibitor of acetylcholinesterase (34). In a prospective, multicenter, 
double-blind trial with 103 patients, huperzine A 14 induced improvement in memory 
cognition and behaviour in about 58% of patients with Alzheimer’s disease (35). Because of 
the fact that the compound is produced at very low levels in nature, its total synthesis has 
been developed (36a-b). 
 
I.1.1.3. Cardiovascular and Metabolic Diseases Area 
 
General Introduction                                                      Nature: An Invaluable Source of Useful Chemical Agents 
 9
Recently, research efforts have been focussed on the discovery of oral antihyperglycemic 
agents for the treatment of Type II diabetes primarily from the screening of medicinal plants 
in animal models. 
 
A number of orally active natural products were shown to reduce blood glucose in these in 
vivo models (37). An example of an active cardiovascular and metabolic plant-derived 
compound is forskolin (colforsin) 15, which is a labdane-type diterpene isolated from the 
Indian Coleus forskohlii (Lamiaceae) (38a-b). The compound was first found to have blood 
pressure lowering and cardioactive properties (8,39). Due to its powerful and direct action on 
adenylate cyclase, therapeutic benefit in various diseases, such as congestive heart failure, 
hypertension, and asthma, has been expected. However, because of its low water solubility 
(0.0026%), the usage of forskolin 15 as a drug has been limited. To overcome this problem, 
semisynthetic efforts generated a water-soluble forskolin derivative, colforsin daproate 
(NHK-477) 16 which exhibited reversible effects on the respiratory, circulatory, and 
autonomic nervous systems. Its preliminary clinical trials demonstrated beneficial 
hemodynamic effects in heart failure patients. The compound was then brought into phase II 
trials in Japan for treatment of asthma and phase III clinical trials for treatment of cardiac 
insufficiency (8,40). 
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I.1.1.4. Immunological, Inflammatory, and Related Diseases Area 
 
Interesting compounds with effective activity against immunological and inflammatory 
diseases have been isolated from some Chinese medicinal plants. Triptolide 17 is a major 
active component isolated from Tripterygium wilfordii (Celastraceae), a plant traditionally 
used in China for the treatment of rheumatoid arthritis. A variety of formulations of the plant 
extract were developed in mainland China and were shown to be effective in the treatment of 
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patients with inflammatory and autoimmune diseases. The compound was demonstrated to 
significantly inhibit arthritis in animal models. The immunosuppressive effect is mediated by 
inhibition of IL-2 signal transduction (8). 
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Ginkgo biloba (Ginkgoaceae) is a Chinese tree which has been used therapeutically for 
thousands of years. Ginkgolides, a class of unique diterpene cage-like compounds, are among 
the natural products isolated from the leaves. In the late 1980's, it was demonstrated that the 
ginkgolides were highly active as selective platelet-activating factor (PAF) receptor 
antagonists. One of them, ginkgolide B (BN-52021) 18, has been advanced to phase III 
clinical trials for the treatment of septic shock in patients with severe sepsis caused by Gram-
negative bacterial infections. Good results were also found in inflammatory and autoimmune 
disorders (41a-b). 
 
Another plant-derived drug of immunological activity is gomisin A (19), a lignan derivative 
isolated from the dry fruits of Schisandra chinensis, a plant used in Chinese traditional 
medicine for the treatment of liver intoxication. Gomisin A (19) was found to protect against 
hepatocarcinogenesis and liver damage in various animal models. Its mechanism of action 
includes induction of hepatic metabolizing enzyme systems, increase in the proliferation of 
the endoplasmic reticulum of liver cells, and antioxidant activity (42). 
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I.1.1.5. Oncological Diseases Area 
 
Plants have a long history of use in the treatment of cancer (43), although many of the claims 
for the efficacy of such treatment should be viewed with some skepticism because cancer, as a 
specific disease entity, is likely to be poorly defined in terms of folklore and traditional 
medicine (1a). 
 
Of the plant-derived anticancer drugs in clinical use, the best known are the so-called Vinca 
alkaloids, vinblastine 2 and vincristine 3, isolated from the Madagascar periwinkle, 
Catharanthus roseus (6) in the early 1960's. In the 1970's, combretastatin A-4 (20) was 
isolated from Combretum caffrum (Combretaceae), an African willow tree that has a history 
of being used by the Zulu for various purposes. The compound 20 has proved to be a 
powerful inhibitor of tubulin assembly and a variety of human cancer cell lines (44). 
 
The toxicity of European yew trees has been known for thousands of years (45) and the use of 
various parts of some of the species (e.g., Taxus brevifolia, T. canadensis, T. baccata) by 
several native American tribes for the treatment of some non cancerous conditions has been 
reported (43). However, it was only in the 1960's, that laboratory tests demonstrated that the 
extracts of the Western Pacific Yew, Taxus brevifolia (Taxaceae), could kill cancer cells (46). 
The active compound, the diterpenoid paclitaxel (Taxol®) 21, was initially isolated from a 
species collected in USA, Washington State (47). In test systems using human tumor cell 
lines, paclitaxel 21 showed distinct activity against several types of cancer, while phase I 
clinical studies have shown that this compound has significant clinical benefit for the 
treatment of ovarian and breast cancer (46). As paclitaxel 21 occurs in low yield in the bark of 
the Western Pacific yew, its production as a clinical drug is problematic. A related 
diterpenoid, baccatin III, and other key precursors (the baccatins) occur in higher yields in the 
needles (which represent a renewable source for the tree) of several species of Taxus. 
Semisynthetic modification of baccatin III readily led to the paclitaxel analogue docetaxel 
(Taxotere) 22, which proved to be a serious rival of paclitaxel 21 (45,48). 
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I.1.2. Agrochemicals of Plant Origin 
 
I.1.2.1. General Overview 
 
Enhancement of health quality by fighting against endemic and novel diseases is certainly one 
of the major challenges for the whole world today. However, pest management is also an 
important and vital component in actual production of food, which is needed in increasing 
quantities to meet the demands of the world’s burgeoning population. 
 
The main important strategy of this management is the use of chemicals to control insect (but 
also bacteria, fungi and viruses) pests, which not only attack plants and plant products at 
various stages of production, but also destroy structures and transmit human and livestock 
diseases. There are approximately one million insect species in the world, representing ∼ 70% 
of all species in the animal kingdom. Of these, around 10,000 have been recognized as 
harmful. It has been estimated that 14% of crop losses worldwide are caused by insect pests. 
Thus, control of harmful insects is a must for mankind (49). 
 
But there is an enormous scope for the discovery of safer, more potent, and environmentally 
non-polluting insecticides. Because biologically derived chemicals are perceived by 
consumers as having less environmental toxicity and lower mammalian toxicity, chemical 
companies currently tend to have a greater desire to discover and develop natural product-
based plant pesticides (50). At present, the commercial success is below the results expected. 
Of the various strategies used for developing new biologically active compounds for specific 
applications, probing nature’s bounty of so-called secondary metabolites has proved quite 
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effective in the past, and promises to remain so in the future. These secondary metabolites are 
now thought to mediate plant defense mechanisms by producing chemical barriers against 
animal and microbial predators. Plants must also compete with other plants (allelopathic 
interactions), often of the same species, for sunlight, water and nutrients. This chemical 
warfare between plants and their pathogens consistently provides new natural product leads 
(49,50). 
 
Plant-derived substances have been used as botanical pesticides since ancient times, as 
attested by the so-called “Persian dust” or “Persian insect powder” (Pyrethrum) (51). 
However, from early Roman times to the mid-20th century, only pyrethrins, rotenone, 
nicotine, sabadilla and quassin were widely used as insect repellents and toxicants in the 
Western hemisphere (52). 
 
Over 2000 plant species belonging to some sixty families (Table 1.1) are now known to 
possess insecticidal properties. Of these, the following families have provided plants of 
commercial value, both present and past: Asteraceae (Compositae), Flacourtiaceae, Fabaceae 
(Leguminosae), Liliaceae and Solanaceae (49). 
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Table 1.1. Plant Families with Insecticidal Species (49) 
 
N° Family N° Family N° Family N° Family 
1. Acanthaceae 17. Asteraceae  
      (Compositeae) 
33. Lauraceae 49. Ranunculaceae 
2. Agavaceae 18. Convolvulaceae 34. Fabaceae  
      (Legumunosae) 
50. Rosaceae 
3. Annonaceae 19. Cucurbutaceae 35. Liliaceae 51. Rubiaceae 
4. Apocyanaceae 20. Dioscoreaceae 36. Loganiceae 52. Rutaceae 
5. Araceae 21. Ebenaceae 37. Lycopodiaceae 53. Sapindaceae 
6. Aristolochiaceae 22. Ericaceae 38. Magnoliaceae 54. Sapotaceae 
7. Asclepidiaceae 23. Euphorbiaceae 39. Malvaceae 55. Simaroubaceae 
8. Balanitaceae 24. Flacourtiaceae 40. Meliaceae 56. Solanaceae 
9. Berberidaceae 25. Guttiferae 41. Menispermaceae 57. Stemonaceae 
10. Boraginaceae 26. Helleboraceae 42.Myristicaceae 58. Taxaceae 
11. Brassicaceae 27. Hippocastanaceae 43. Myrtaceae 59. Theaceae 
12. Burseraceae 28. Hypericaceae 44. Papaveraceae 60. Apiaceae  
      (Umbelliferaceae) 
13. Capparaceae 29. Illiciaceae 45. Piperaceae 61. Verbenaceae 
14. Capparidaceae 30. Juglandaceae 46. Poaceae  
15. Celastraceae 31. Lamiaceae 47. Polygonaceae  
16. Chenopodiaceae 32. Lamiaceae 48. Polypodiaceae  
 
I.1.2.2. Few Examples of Plant-derived Insecticides 
 
Currently and commercially, the most important insecticidal plant widely used is pyrethrum 
(53), which consists of the fried flower-heads of any of the two species of the genus 
Chrysanthemum (Family: Asteraceae) now revised to the genus Tanacetum (54): the Persian 
insect flower (red flower), T. coccineum Willd and the Dalmatian insect flower (white flower) 
T. cinerariaefolium Vis. Of the two species, T. cinerariaefolium, a native to former 
Yugoslavia, is commercially the most important and is cultivated on a large scale in Kenya, 
Tanzania, Ecuador, Brazil, Russia, Japan and India. 
 
The insecticidal principles of pyrethrum have been fully characterized (53,55) and consist of 
six esters, namely pyrethrins 23a-f belonging to the two series I, II. Esters of series I are 
derivatives of (+)-trans-chrysanthemic acid and have excellent insect killing properties, while 
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series II, derived from pyrethric acid, has high knock-down activity. Products based on 
pyrethrum are essentially used for indoor applications. 
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                             R1               R2
Pyrethrin  I         CH3          CH=CH2    a
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Cinerin     I         CH3             CH3         c
Pyrethrin II     CO2CH3      CH=CH2    d
Jasmolin  II     CO2CH3      CH2CH3    e
Cinerin    II     CO2CH3         CH3         f          
 
Pyrethrins are quite photolabile and their half-life in open environment is such that their use 
on agricultural crops is excluded essentially on economic grounds. On the other hand, they 
have a high safety margin for mammals (LD50 for pyrethrin I 23a: 260-400 mg/kg, rat, oral), 
chiefly because of their rapid metabolic disposal. Thus, there has been a distinct need to 
develop pyrethrin analogues, which would be photostable, safe and environmentally non-
persistent (49,51). Intense efforts aiming at the latter goal led, in between the late 1940's and 
the lates 1960's, to the synthesis of several very effective household insecticides, namely the 
so-called pyrethroids (56a-c), opening a major area of industrial and academic research. The 
development of pyrethroids has been one of the major success stories in the use of natural 
products as a source of leads for novel compounds possessing useful insecticidal activity. 
Their synthesis strategies lie in the modulation of the natural pyrethrins, both in the 
carboxylic acid as well as in the alcohol moieties. 
 
The neem tree or margosa, Azadirachta indica, A. Juss (Meliaceae) is widespread in many 
Asian and African countries. Centuries before synthethic insecticides became available, 
farmers in India protected crops with natural repellents found in neem fruits and leaves (57). 
The active principles or “bitters” have been identified as limonoids, a group of 
stereochemically homogenous tetranortriterpenoids. The most potent and chemically the most 
important of them is azadirachtin 24, although some 64 triterpinoids have been reported from 
the seeds, wood, bark, leaves, and fruit of the neem tree (58a-b). Neem derivatives have 
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diverse behaviour and physiological effects ranging from repellency to feeding deterrence, 
growth disruption, sterilizing effects, mating disruption, oviposition inhibition, etc. (59a-b). 
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Two other phytoinsecticides (60), sabadilla (61,62) and ryania (61,63) may be mentioned. 
Sabadilla is the dried powdered barley-like ripe seeds of the South and Central American 
plant Schoenocaulony officinale Gray (Liliaceae), also known as Sabadilla officinalis Brant, 
and Veratrum sabadilla Retz (61b), which the local people had been using for a long time to 
control insect-infestation. The major insecticidal components of Sabadilla are veratridine 25, 
the 3-veratronyl [3-(3,4-dimethoxybenzoyl)], and cevadine 26, the 3-angenoyl [3-(Z)-2-
methylbut-2-enoyl] derivative of veracevine 27. These alkaloids are highly poisonous (e. g. 
LD50 for veratridine 25: 1.35 mg/kg, mouse, intraperitoneal) (49,59b). Veratridine 25 is one 
of several alkaloids identified as neurotoxins that affect sodium ion channels in excitable 
membranes (62). An extensive study on the effect of varying the nature of the acyl group, 
attached to the 3-position (sixty-five 3-acyl derivatives tested) of veracevine 27, on 
insecticidal activity and toxicity to mice has been reported. Of all the derivatives, the 
naturally occurring veratridine 25 and cevadine 26 were near optimal in potency (62). 
 
Ryania consists of the powdered roots and stems of the South American plant Ryania 
speciosa Vahl (Flacourtiaceae) and has been used as a contact and stomach poison to insects 
(49,59b). The active principle is the diterpene ryanodine 28 which is present in the roots with 
a yield of 0.1-0.25%. It is less photolabile than pyrethrum and its mammalian toxicity is also 
low (LD50: 750 mg/kg, rat, oral) (49). Dehydroryanodine 29 was also isolated from Ryania. 
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The two compounds were found essentially equipotent and accounted for almost all of the 
biological activity of Ryania insecticide (61c). 
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The sesquiterpene polyol ester angulatin A (30) is claimed to be strongly antifeedant (and 
insecticidal) against a variety of insects (64). Angulatin A (30) and close antifeedant 
analogues (65) are derived from the root bark of Celastrus angulatus Max. (Celastraceae), 
which is used, in China, to protect plants from insects (59b). 
 
From the seeds of Croton tiglium L.(Euphorbiaceae) was isolated the tigliane diterpene ester 
31 which showed both growth inhibitory and insecticidal activities in diet against newly 
hatched larvae of Pectinophora gossypiella (100% kill at 20 ppm) (66). It also gave 100% kill 
of Culex pipiens larvae at 0.6 ppm but was ineffective against Oncopeltus fasciatus and 
Tribolium confusum. Esters of this type are also well-known for their vesicant and tumor-
promoting properties (61b,66). 
 
Several quassinoid drugs have been used for a long time for their tonic and insecticidal 
properties (27). A series of antileukemic and cytotoxic quassinoids, isolated from Simaba 
multiflora Juss. and Soulamea soulameoides (Gray) Nooteboom (Simaroubaceae), were 
evaluated in diets for their growth-inhibitory and insecticidal activities against the tobacco 
budworm Heliothis virescens and for their antifeedant activity against H. virescens and the 
fall armyworm Spodoptera frugiperda (67). The most effective quassinoid was 6α-
senecioyloxychaparrinone 32 which was equivalent to azadirachtin 24 as a growth inhibitor of 
newly hatched H. virescens but was, at an LD50 of 7 ppm, 2.5-3.5 times less toxic (59b). 
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I.2. Rubiaceous Plants in African Traditional Medicine 
 
The Rubiaceae plant family is one of the six largest angiosperm families (Table 1.2) in terms 
of number of genera and species. Its essentially tropical and its species are mainly woody. 
Less than 20% of the genera are herbaceous and twenty nine of the thirty eight currently 
accepted tribes are predominantly woody (68). In East Africa, there are 100 genera and about 
600 species (69). 
 
Various natural products occur in rubiaceous plants. Extensive phytochemical investigation 
has been realized regarding the natural occurrence of iridoids (70), anthraquinones (71), and 
indole alkaloids (72) in the plant family. 
 
Table 1.2. The six largest angiosperm families, with their number of 
genera and species (68) 
 
 genera Species 
Asteraceae 1 317 21 000 
Orchidaceae 795 17 500 
Fabaceae 657 16 400 
Rubiaceae 637 10 700 
Poaceae 737 7 950 
Euphorbiaceae 326 7 750 
 
I.2.1. Biologically Active Species 
 
Several rubiaceous plant species are widely used in African traditional medicines. Rubia 
cordifolia is widespread in tropical and southern Africa. In the Cape Province (South Africa), 
a decoction of the leaf and root of the plant is used as a remedy for pleurisy and other 
inflammatory conditions of the chest. The southern Sotho use a decoction of the root to 
relieve colic, sore throat and chest complaints, and to wash the teeth (73). The dried roots and 
rhizomes of the plant are listed officially as a herbal medicine in the Chinese Pharmacopeia 
for the treatment of arthritis, dismenorrhea, hematorrhea and hemostasis, as a tonic, and for 
wound healing (74). In India, it has also been used for menstrual pain, rheumatism, and 
urinary disorders (75). 
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Several quinones (76,77) and anthracenes (78) have been isolated from the plant. In addition, 
the complex molecule RA-VII 33 is a typical representative of antitumor bicyclic 
hexapeptides (RAs series) (79) isolated from the dried roots of Rubia cordifolia. (80). 
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Morinda lucida Benth is a commonly used medicinal plant in Africa. Its stem bark decoction 
is used for the treatment of asthma and bronchitis, whereas an infusion of the leaf is used as 
antiseptic (81). In Central Africa, the decoction of leaves is used as diuretic, and the decoction 
of the roots as purgative. In West Africa, the roots are used as remedy for fever and malaria, 
and the leaf as an astringent and as an application to ulcers (73,82). Bark extracts of the plant 
showed strong but short-lasting hypotensive effects, along with sedative effect (83). However, 
the alcoholic stem wood extract exhibited a remarkably strong hypertensive effect (84). The 
plant also inhibited significantly, in a dose-dependent manner, the growth of the malarial 
parasite Plasmodium falciparum, in vitro (85). The antimalarial (86,87) and the 
antileishmanial (87) activities of the stem bark and the roots of M. lucida have been related to 
their anthraquinone 34-36 contents. The most potent anthraquinones were found to be the 2-
carboxyaldehyde substituted ones (87).  
 
Another widely used medicinal plant is Pentanisia prunelloides Walp. In Southern Africa, the 
plant has been used for a long time for the treatment of rheumatism, fever, venereal diseases, 
and as anthelminthic in infants. It is also used for relieving pain in the chest (73). In the Zulu 
traditional medicine (South Africa), it is believed that the plant is effective in relieving 
inflammation, bacterial and viral infections and also stimulating uterine contraction.  
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aqueous, the ethanolic, and ethyl acetate extracts of leaves and roots showed cyclooxygenase-
1 inhibition in an anti-inflammatory assay, together with inhibition of viral replication of 
Influenza A virus (88). A crude decoction of the plant also exhibited direct stomach muscle 
activity on rat uterus and ileum preparation (89). 
 
I.2.2. Studies on Plant Species of the Genus Pentas 
 
The genus Pentas comprises about 40 species, widely distributed throughout tropical Africa 
from West Africa and Somali Republic to Angola and Natal (South Africa), also in tropical 
Arabia, Madagascar and Comoro Islands (69,90). 
 
Many species of this genus are widely used by local people as medicinal plants. In Kenya, a 
decoction of the roots of Pentas bussei is taken as a remedy for gonorrhoea, syphilis and 
dysentery. Roots of Pentas decora are used as a cure for pimples (the roots are normally 
pounded, mixed with some ghee and rubbed on the pimples). Pentas hindsioides is used as a 
remedy for scabies (pounded roots and leaves are soaked in warm water for bathing), while 
Pentas micrantha is used as a cough remedy (fresh roots chewed or boiled or pounded and 
soaked in water and the infusion drunk). The juice of the pounded leaves of Pentas 
zanzibarica, mixed with a little water, is drunk as a drastic purgative, whereas a decoction of 
the roots is taken as a remedy for gonorrhoea and syphilis or given to children as a tonic (91). 
 
Roots of Pentas longiflora are used as a cure both for tapeworm, itchy rashes and pimples; a 
decoction of the roots is mixed with milk and taken as a cure for malaria. In Rwanda, the 
powder of the roots of this plant mixed with butter is used as an ointment to treat skin 
diseases, e.g. scabies and pityriasis versicolor (91,92a). A decoction of the roots of Pentas 
purpurea, mixed with sugar cane, is used by Tanzanian women to initiate the menstruation, 
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whereas the juice of the plant is taken as a remedy for headache, fever and rheumatic pains. 
The plant is reported in Kenya to be toxic to sheep. The juice of the leaves of another Pentas 
sp., mixed with a small amount of water, is taken as a drastic purgative in East Africa (73). 
 
I.2.2.1. Phytochemical Investigation of Pentas longiflora Oliver. 
 
Pentas longiflora Oliver has been the first species from the genus Pentas to be investigated. 
Two major constituents, mollugin 38 and pentalongin 39 have been isolated from the root 
bark of a plant sample collected in Burundi (93). Mollugin 38 was already isolated from two 
other rubiaceous plant species, Galium molluga (94) and Rubia cordifolia (95). 
 
An alcoholic root extract of P. longiflora (in Rwanda) is used as an ointment to cure Pityrias 
versicolor and the bioassay guided-fractionation led to the isolation of pentalongin 39 as 
active principle (92). Pentalongin 39 also exhibited an antifungal activity against 
Pityrosporum ovale, an algicidal activity against freshwater green algae Chemydomonas 
sphagmophilla var. dysosmos and Chlorella vulgaris, and marine algae Phaeodactylum 
tricornutum and Porphyridium purpureum. The compound also showed antibacterial activity 
against freshwater blue-green bacterium Anabaena cylindrica (96). A pentalongin 
hydroquinone diglycoside, harounoside 37 (97), has been isolated from Mitracarpus scaber 
Zucc (Rubiaceae), a plant used in African traditional medicine (Niger) for antifungal and 
antiparasital activity (98). 
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Pentalongin 39 has been synthesised by a photochemical [2+2] addition of 2-chloro-1,4-
naphthoquinone and acrolein dimethyl acetal and subsequent treatment of the resulting 1-
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dimethoxymethyl-1,2-dihydrocyclobuta[b]naphthalene-3,8-dione with p-toluenesulfonic acid 
(99). The total synthesis of the compound was also successfully performed by various 
strategies (100). The photochemical reactions of pentalongin 39 under sunlight conditions (in 
various organic solvents) met with difficulties in duplication in several hands. Therefore, 
efforts have been performed to elaborate suitable syntheses. 
 
A detailed phytochemical study of P. longiflora, which was aiming at the identification of 
minor constituents and new physiologically active compounds, led to the isolation of several 
compounds belonging to different chemical families (Figure 1.1): naphthoquinones, 
anthraquinones, coumarins, and steroids (96). 
 
In addition to mollugin 38 and pentalongin 39, six other known naphthoquinones were 
isolated from the plant (96): psychorubrin 40 (100,101), 3-hydroxymollugin 41 (76a), trans-
3,4-dihydroxy-3,4-dihydromollugin 42 (76a), 3-methoxymollugin 43 (76a), and the 
prenylated naphthoquinones, methyl 2,3-epoxy-3-prenyl-1,4-naphthoquinone-2-carboxylate 
44 (76a,102) and methyl 3-prenyl-1,4-naphthoquinone-2-carboxylate 45 (103). The plant also 
yielded three novel naphthoquinones, the dimeric derivative of pentalongin 39, i.e. (3α,3′α,4β
,4′β)-3,3′- dimethoxy-cis-[4,4′-bis-(3,4,5,10-tetrahydro-1H-naphtho[2,3-c]pyran)]-5,5′,10,10′-
tetraone 46 (104), the tetracyclic isagarin 47 (105,106), and cis-3,4-dihydroxy-3,4-
dihydromollugin 48 (104). Isagarin 47 has been successfully synthesised (106) as shown in 
Scheme 1.1. 
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Figure 1.1. Natural Products Isolated from the Roots of Pentas longiflora 
 
Three anthraquinones were isolated from the plants during the same study (96), the known 
tectoquinone 49 (102) and 2-methoxy-3-methyl-9,10-anthraquinone 50 (107), together with 
the new 3-hydroxy-1-methyl-9,10-anthraquinone 51. However, literature studies (108,109) 
revealed a possible erroneous substituent positioning for the latter anthraquinone, and 
therefore its structure elucidation needs to be reinvestigated. 
 
The coumarin scopoletin 52 (110), the two steroids ß-stigmasterol (111) and ß-sitosterol 
(111), together with stearic acid were also isolated from Pentas longiflora (96). 
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Scheme 1.1: Synthesis of Isagarin 47 (ref. 106) 
 
I.2.2.2. Phytochemical Investigation of Pentas zanzibarica (Klotsch) Vatke 
 
The methanol extract of stems of P. zanzibarica (from Congo) has been studied (112) and 
yielded the anthraquinones rubiadin 53, damnacanthal 35 and rubiadin-1-methyl ether 36, 
together with the anthraquinone glycosides rubiadin-3-O-β-primeveroside 54, rubiadin-1-
methyl ether 3-O-β-primeveroside 55, lucidin-3-O-β-primeveroside 56 and damnacanthol-3-
O-β-primeveroside 57. 
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Figure 1.2. Anthraquinones and Anthraquinone Glycosides Isolated from the Stems 
of Pentas zanzibarica 
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I.3. Purpose and Goal of the Present Research 
 
The motivations of the present study lie in some important facts which can briefly be  
described as follow: 
 
The phytochemistry of the important Pentas species is only scarcely investigated. From the 
about 40 known species, only P. longiflora (96) and P. zanzibarica (112) have been studied. 
 
These species display a broad range of uses in traditional medicine, particularly in Africa 
(73,91,92). These medicinal uses constitute an important indication of the presence of various 
constituents responsible of the biological effects. 
 
The two Pentas species already investigated revealed a predominant presence of quinones, 
compounds known to have a broad spectrum of biological activities. Particular quinone 
derivatives, which contain a pyran unit in their structures, were isolated from P. longiflora 
(93,96) 
 
One of the latter compounds was pentalongin 39, which has served as a "lead" compound for 
the synthesis of new compounds having antibiotic activity (100). 
 
Based on the above considerations, the present research was undertaken to achieve the double 
purpose of 1) investigation of unstudied Pentas species and 2) search for novel naturally 
occurring compounds which may be used as "lead" for the synthesis of more potentially 
active compounds. Three Pentas species have been chosen for the study: P. bussei K. Krause, 
P. lanceolata (Forsk.) Deflers and P. parvifolia Hiern. 
 
In addition, in order to confirm their structural assignment, the synthesis of two new natural 
products isolated from P. longiflora (96), i.e. cis-3,4-dihydroxy-3,4-dihydromollugin 48 and 
3-hydroxy-1-methylanthraquinone 51, will be performed. 
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I.4. Materials and Methods 
 
I.4.1. Plant Materials 
 
The roots of Pentas bussei K. Krause were collected at Shimba Hills, Coast Province (Kenya) 
at an altitude of 1-450 m on May 15, 1999. The roots of Pentas lanceolata (Forsk.) Deflers 
were collected at Chiromo (Nairobi, Kenya) at an altitude of 1520-3000 m on May 5, 1999. 
The two plants were identified by S. G. Mathenge (Botany Department, University of 
Nairobi, P. O. Box 30197, Nairobi, Kenya). The roots of Pentas parvifolia Hiern were 
collected in the Carnivore plains (Nairobi, Kenya) at an altitude of 650-2400 m on April 25, 
1999. The plant was identified by F. P. Mudida (TRAMEDA, P. O. Box 66514, Nairobi, 
Kenya). The voucher herbarium specimen of the three plants (LVP-PB, LVP-PL and LVP-
PP) were deposited at the herbarium of the Department of Botany, Faculty of Sciences, Ghent 
University. The roots were dried in a ventilated oven at 40 °C during 5 days and powdered 
mechanically. 
 
I.4.2. Instrumentation 
 
Medium Pressure Liquid Chromatography (MPLC) was executed with a Büchi system 
consisting of a 688 chromatography pump (maximum pressure: 40 bars), a 687 gradient 
former, borosilicate glass columns (various sizes), and a 684 fraction collector (Büchi, 
Switzerland), together with a SEDEX 55 evaporative light scattering detector (LSD) 
(S.E.D.E.R.E, France). Silica gel 60 (0.015-0.040 mm for column chromatography; Merck) 
was used as normal phase, whereas LiChroprep RP-18 ( LiChroprep RP-18 for liquid 
chromatography, 40-63 µm particle size; Merck) was used as reversed phase column material. 
Preparative Centrifugal Partition Chromatography (CPC) was carried out on a CCC-1000 
High Speed Countercurrent Chromatograph (Pharma-Tech Research Corp., Baltimore, 
Maryland, USA) equipped with SSI 300 pump, a Pharmacia LKB Uvicord S II detector (254 
and 280 nm) and a Retriever II fraction Collector. 
 
Analytical High Pressure Liquid Chromatography (HPLC) was executed on a Kontron 
instrument equipped with a single 422 pump (maximum pressure: 350 bars), and a 430 UV 
detector (Kontron, Germany). Preparative HPLC was carried out on a Kontron instrument 
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equipped with two 422 pumps (maximum pressure: 200 bars), a 430 UV detector (Kontron, 
Germany), and a Retriever II fraction collector. 
 
Silica gel plates 60 F254+366, 20 x 20 cm (Merck) were used for analytical TLC, whereas 
preparative TLC was performed on Silica gel PLC plates 60 F254+366, 20 x 20 cm, 2 mm 
(Merck). Analytical reversed phase (RP-18 F254) plates, 20 x 20 cm (Merck), were also used 
for TLC monitoring of highly polar fractions. 
 
Büchi Rotavapor R-124 systems, connected to diaphragm vacuum pumps, type MZ 2C, were 
used for evaporation of the solvents. For powdering the plant material, a Retsch GmbH, type 
SK1, 1100 watt, 2840 u/min, DR 80B/2Q, was used. Solvents for large scale extraction and 
chromatographic purification were from Merck (Germany) or Rathburn Chemicals Ltd 
(Welkerburn, Scotland). Extraction was executed by sonication with a 8210E-DTH ultrasonic 
bath (Branson Ultrasonic Corporation, CT 06813, USA). 
 
NMR spectra were recorded on a JEOL-JNM-EX 270 MHz FT NMR spectrometer (270 MHz 
for 1H NMR, 67.5 MHz for 13C NMR) (JEOL, Japan). The HMBC NMR data were obtained 
with a Bruker Avance DRX-500 spectrometer (500 MHz for 1H NMR, 125 MHz for 13C 
NMR) or a JEOL-DELTA-ECP400 NMR spectrometer (JEOL, Japan). Deuterated NMR 
solvents were obtained from Aldrich or Acros. 
 
Direct inlet mass spectroscopy (for the EI-MS) was carried out on a Varian MAT 112 mass 
spectrometer (70 eV). ESIMS was performed using the LC-MS technique with mass spectra 
recorded on a Waters ZMD spectrometer coupled to an LC system using a Waters Alliance 
2690 separation module with 996 PDA detector, a Waters Xterra MS C18 (50 x 4.6 mm, i.d., 
2.5 µm) column with a gradient of 10 mM HCOONH4 (0.1% HCOOH)/CH3CN (0.1% 
HCOOH) from 85:15 to 100:0 (%) for 5 min, and a flow rate of 1.2 mL min-1, maximum 
pressure: 300 bars. Another system alternately used for ESIMS was composed of an Agilent 
1100 Series HPLC system coupled with an Agilent LC-MS mass detector (VL type). The 
HPLC was executed on a Phenomenex Luna C18(2) (250 x 4.6 mm, i. d., 5µm) column and 
elution performed under a gradient mode with 0.5% (w/v) NH4OAc (in H2O, w/v)/CH3CN, 
stepwise: 100% of 0.5% NH4OAc (in H2O) for 2 min, a gradient of 0.5% NH4OAc (in H2O, 
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w/v)/CH3CN from 100:0 to 0:100 (%) for 15 min, and 100% of CH3CN for 5 min; flow rate, 
1.5 mL min-1; maximum pressure 300 bars. 
 
The IR spectra were obtained using a Perkin-Elmer Spectrum OneTM instrument using 
SpectrumTM software and the UV spectra was recorded on a Varian Cary 50 probe 
spectrophotometer. The optical rotation was obtained on an AA-10 automatic polarimeter (l = 
1 dm). The melting point measurement was carried out with a Büchi melting point apparatus.  
 
I.4.3. Partial Hydrolysis of Anthraquinone Glycosides on TLC 
 
Anthraquinone glycosides were applied on silica gel TLC plates (HPTLC plates, 10 x 10 cm, 
silica gel 60 F254) and left in a HCl atmosphere at room temperature for 3 hours. HCl vapours 
were eliminated under hood ventilation (30 minutes), and authentic sugars were applied to the 
plates. The TLC plates were then developed with CHCl3/MeOH/H2O (8:5:1) and spots 
detected by spraying with aniline/diphenylamine/H3PO4/MeOH (1:1:5:48), followed by 
heating in an oven at 110 °C for 30 minutes. 
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Chapter II. STUDY OF THE ROOTS OF PENTAS BUSSEI 
 
II.1. Introduction 
 
Pentas bussei K. Krause is a woody herb or shrub, about 0.5-4 m high, sometimes scrambling, 
leaves ovate, base cuneate, apex acute or acuminate, 3.5-15 by 1.5-5 cm, stems with sparse to 
dense white or brown hairs above, usually drying ferruginous or yellowish, white-velvety 
beneath. Flowers red, in axillary and terminal many-flowered cymes; corolla tube 7-20 mm, 
lobes 3-10 mm long. Fruiting inflorescences with individual branches; fruit oblong, 3-6 mm 
long. The plant was collected in Kenya where it is mainly located in coastal bushland, forest 
margins and thickets (69,113).  
 
 
Figure 2.1. Pentas bussei K. Krause 
 
In this area, where it is called "Mdobe" or "Mudobe" in a local dialect ("Digo"), a decoction 
of the roots of the plant is taken as a remedy against gonorrhoea, syphilis and dysentery (91). 
In a screening of antitumor cyclic hexapeptides in some rubiaceous plant, aerial parts and 
roots of P. bussei revealed no presence of these compounds (114). No other phytochemical 
study of this species is reported in the literature. 
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II.2. Experimental 
 
II.2.1. Extraction and Purification 
 
II.2.1.1. Extraction 
 
The ground dried roots of the plant (613.80 g) were extracted exhaustively (x 3) with n-
hexane, dichloromethane (CH2Cl2), ethyl acetate (EtOAc) and methanol (MeOH), 
respectively. A volume of 0.75 litres of each solvent was used for each extraction. The 
solvent was removed and the sample dried before the extraction with a new solvent started. 
Extraction was executed under sonication at room temperature. The extracts were filtered and 
concentrated by evaporation under reduced pressure on a rotavapor at 40 °C to afford a dark 
green n-hexane residue (7.52 g, 1.23 % yield), a dark CH2Cl2 residue (16.65 g, 2.71 %  yield), 
a dark EtOAc residue (1.74 g, 0.28 % yield), and a dark brown MeOH residue (31.27 g, 5.09 
% yield). 
 
II.2.1.2. Study of the n-Hexane Extract of the Roots of Pentas bussei 
 
The n-hexane extract (7,52 g, 1.23 % yield) was chromatoghraphed over a silica gel column 
in a MPLC system (Büchi) with elution using a n-hexane/CH2Cl2/MeOH gradient (Table 2.1).  
 
Table 2.1. Programme for separation of the n-hexane extract of the roots 
of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane/CH2Cl2 90:10 90:10 ---- 5 
n-Hexane/CH2Cl2 70:30 70:30 ---- 10 
n-Hexane/CH2Cl2 60:40 0:100 10% 200 
CH2Cl2/MeOH 95:5 80:20 5% 220 
CH2Cl2/MeOH 70:30 70:30 ---- 50 
MeOH (clean up) 100 100 ---- 50 
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The MPLC conditions were: column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample 
adsorbed on 53.4 g of silica gel and packed in a 230 x 36 mm i.d. sample column; flow rate 
75 ml/min at a back pressure < 40 bar; detection, LSD, 42 °C, 2 bar N2 flow; collection, 65 
seconds per fraction. A total of 26 different fractions (Table 2.2) were obtained after 
monitoring by TLC. 
 
Table 2.2. MPLC fractionation of the n-hexane extract of the roots of P. bussei 
Fraction Eluate number Weight (mg) 
1:1 1-11 91.9 
1:2 12-21 33.3 
1:3 22-38 65.8 
1:4 39-75 74.5 
1:5 76-84 46.5 
1:6 85-92 87.7 
1:7 93-101 132.3 
1:8 102-105 79.5 
1:9 106-127 894.2 
1:10 128-133 181.7 
1:11 134-143 174.4 
1:12 144-192 286.6 
1:13 193-224 165.4 
1:14 225-264 101.3 
1:15 265-283 128.1 
1:16 284-299 208.1 
1:17 300-311 89.5 
1:18 312-323 91.5 
1:19 324-333 27.7 
1:20 334-361 832.5 
1:21 362-375 745.4 
1:22 376-383 85.6 
1:23 384-413 339.1 
1:24 414-448 1234.3 
1:25 449-475 748.6 
1:26 476-494 458.2 
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II.2.1.2.1. Isolation of Methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)-
3H-benzo[f]chromene-9-carboxylate 58 
 
Fractions 1:8 to 1:11 (1.33 g, 0.23 % yield) were combined together and rechromatographed 
over a normal phase MPLC (Table 2.3) to afford, after monitoring by TLC, 9 fractions (Table 
2.4). MPLC conditions were: column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample 
adsorbed on 8.94 g of silica gel and packed in a 230 x 26 mm i.d. sample column; flow rate 
70 ml/min at a back pressure < 40 bar; detection, LSD; collection 48 seconds per fraction. 
 
Table 2.3. Programme for separation of fractions 1:8-1:11 of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane/EtOAc 100:0 100:0 ---- 50 
n-Hexane/EtOAc 98:2 98:2 ---- 50 
n-Hexane/EtOAc 95:5 95:5 ---- 50 
EtOAc/MeOH (clean up) 90:10 90:10 ---- 50 
 
Table 2.4. MPLC fractionation of fractions 1:8-1:11 of P. bussei 
Fraction Eluate number Weight (mg) 
2:1 1-6 38.5 
2:2 7-46 27.2 
2:3 47-85 485.6 
2:4 86-98 95.0 
2:5 99-127 311.8 
2:6 128-158 247.6 
2:7 159-191 30.8 
2:8 192-215 22.9 
2:9 216-250 35.6 
 
Fractions 2:3 to 2:6 (1.14 g, 0.19 % yield) were combined together and submitted to MPLC 
using n-hexane/EtOAc (98:2) in isocratic mode to yield 3 fractions (Table 2.5). The MPLC 
conditions were: column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 
7.66 g of silica gel and packed in a 230 x 26 mm i.d. sample column; flow rate 60 ml/min at a 
back pressure < 40 bar; detection, LSD; elution for 75 min; collection 45 seconds per fraction. 
Table 2.5. MPLC fractionation of fractions 2:3-2:6 of P. bussei 
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Fraction Eluate number Weight (mg) 
3:1 1-19 251.4 
3:2 20-34 127.5 
3:3 35-60 680.1 
 
Fraction 3:3 (680.1 mg, 0.11 % yield) was purified by preparative TLC with n-
hexane/acetone (9:1) as eluent. A band with a Rf 0.32 was colored in yellow and blue under 
UV light at 254 and 365 nm, respectively. The band was scraped off and the compound 
removed from the adsorbent by extraction with acetone. Further purification by preparative 
HPLC on a RP18 column yielded a pure product (350.6 mg, 0.057 % yield). The analytical 
HPLC conditions were: column, a Kromasil C18, 5µm, 10 x 0.4 cm i.d., Teknokroma 
(Barcelona); elution, gradient mode with H2O/CH3CN (30:70 to 0:100); flow rate, 1 ml/min; 
detection, UV 254 nm. The preparative HPLC conditions were: column, a Kromasil C18, 5 
µm, 25 x 2 cm i.d., Teknokroma (Barcelona); elution, isocratic mode with H2O/CH3CN 
(12.5:87.5); flow rate, 15 ml/min corresponding to a back pressure ≈ 176 bar; detection, UV 
254 nm; collection 36 seconds per fraction. The sample was dissolved in 15 ml of 
H2O/CH3CN (5:95) and filtered through 0.45 µm filter (Acrodisc 13 CR PTFE, 13 mm, 
Gelman) prior to injection. A sample volume of 3 ml was injected. The running time (elution) 
was 45 min and 5 injections were executed for all the samples. The eluates from 17.2-20.0 
min were mixed together and dried under reduced pressure to afford the new compound 58 as 
a yellow solid. 
 
Based on the analysis of the spectral and physical data, the compound was identified as 
methyl-5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]chromene-
9-carboxylate 58. 
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Methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]chro-
mene-9-carboxylate 58: Yellow solid (from hexane); mp 89.9-92.1 °C; [α]21D +34.8° (c 0.05, 
CHCl3); UV (CHCl3) λmax (log ε) 252.0 (4.63), 255.0 (4.57), 272.0 (4.62), 283.0 (4.62), 328.0 
(4.28) nm; IR νmax (KBr) 3455 (OH), 2960, 2919, 2848, 1727, 1632, 1593, 1455, 1359, 1273 
cm-1; 1H NMR (CDCl3, 270 MHz) δ (ppm) 12.26 (1H, s, OH-10), 8.02 (1H, d, J = 10.4 Hz, H-
1), 7.60 (1H, s, H-6), 6.92 (1H, s, H-8), 6.05 (1H, s, OH-5), 5.66 (1H, d, J = 10.4 Hz, H-2), 
5.04-5.14 (1H, br t, J = 7.1 Hz, H-3’), 3.97 (3H, s, COOCH3-9), 3.91 (3H, s, OCH3-7), 2.08-
2.22 (2H, m, H2-2’), 1.76-1.86 (2H, m, H2-1’), 1.66 (3H, s, H3-6’), 1.57 (3H, s, H3-5’), 1.47 
(3H, s, H3-7’); 13C NMR (CDCl3, 67.5 MHz) δ (ppm) 171.98 (COOCH3-9), 157.60 (C-10), 
147.30 (C-5), 146.96 (C-7), 140.97 (C-4a), 131.96 (C-4’), 127.81 (C-2), 127.18 (C-8), 123.82 
(C-3’), 123.31 (C-1), 117.35 (C-10b), 115.98 (C-10a), 105.33 (C-6), 103.53 (C-9), 99.59 (C-
8), 78.95 (C-3), 55.78 (OCH3-7), 52.15 (COOCH3-9), 40.33 (C-1’), 25.61 (C-7’), 25.56 (C-
6’), 22.78 (C-2’), 17.62 (C-5’); ESIMS m/z 399 [M+H]+ (73), 367 (100), 355 (12), 315 (74), 
283 (13),  279 (19), 257 (12); HREIMS m/z 399.1735 (calcd for C23H26O6 + H, 399.1808). 
 
II.2.1.2.2. Isolation of Methyl 5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-1a,2,3,3a,10c,10d-
hexahydro-1H-4-oxacyclobuta[3,4]indeno[5,6-a]naphthalene-9-carboxylate 59 
 
Fraction 3:2 (127.5 mg, 0.021 % yield) was purified by preparative TLC with n-hexane/ 
acetone (9:1) as eluent. A blue (under UV light at 254 and 365 nm) band with a Rf 0.41 was 
scraped off and the compound removed from the adsorbent by extraction with acetone. 
Further purification by HPLC on a RP18 column yielded a pure product (22.4 mg, 0.0036 % 
yield). The analytical HPLC conditions were: column, a Kromasil C18, 5µm, 10 x 0.4 cm i.d., 
Teknokroma (Barcelona); elution, gradient mode with H2O/CH3CN (30:70 to 10:90); flow 
rate, 1 ml/min; detection, UV 254 nm. The preparative HPLC conditions were: column, a 
Kromasil C18, 5 µm, 25 x 2 cm i.d., Teknokroma (Barcelona); elution, isocratic mode with 
H2O/CH3CN (15:85); flow rate, 12 ml/min corresponding to a back pressure ≈ 170 bar; 
detection, UV 254 nm; collection 40 seconds per fraction; running time, 60 min. The sample 
was dissolved in 3 ml of H2O/CH3CN (5:95) and filtered with 0.45 µm filter (Acrodisc 13 CR 
PTFE, 13 mm, Gelman) prior to injection. The eluates from 26.0-29.3 min were mixed 
together and dried under vacuum to obtain pure compound 59. 
Based on its spectral and physical data, the compound was identified as methyl 5,10-
dihydroxy-7-methoxy-1,1,3a-trimethyl-1a,2,3,3a,10c,10d-hexahydro-1H-4-oxacyclobuta[3, 
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4]indeno[5,6-a]naphthalene-9-carboxylate 59. The compound is a new naphthohydroquinone 
of the cyclol-type. 
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Methyl 5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-1a,2,3,3a, 10c,10d-hexahydro-1H-4-
oxacyclobuta[3,4]indeno[5,6-a]naphthalene-9-carboxylate 59: Yellow crystals (from 
hexane), mp 158.0-159.4 °C; [α]20D = +120.0° (c 1.15, CHCl3); ); UV (CHCl3) λmax (log ε) 
274.0 (4.53), 283.0 (4.56), 302.0 (3.86), 315.0 (3.91), 327.0 (3.76), 370.0 (3.97), 503.0 (2.37), 
505.0 (2.37), 515.0 (2.32) nm; IR νmax (KBr) 3409 (OH), 2953, 2860, 1660, 1626, 1517, 1449, 
1365, 1272, 1238, 1153, 1027, 800 cm-1; 1H NMR (CDCl3, 270 MHz) δ (ppm) 12.21 (1H, s, 
OH-10), 7.60 (1H, s, H-6), 6.93 (1H, s, H-8), 6.42 (1H, s, OH-5), 4.57 (1H, d, J = 9.6 Hz, H-
10c), 3.96 (3H, s, COOCH3-9), 3.92 (3H, s, OCH3-7), 2.70 (1H, dd, J1 = 9.6 Hz, J2 = 9.2 Hz, 
H-10d), 2.49 (1H, ddd, J1 = 9.2 Hz, J2 = 7.9 Hz, J3 = 4.4 Hz, H-1a), 2.00-2.07 (1H, m, H2-
3(1)), 1.64-1.80 (3H, m, H2-2 and H2-3(2)), 1.49 (3H, s, H3-1α), 1.36 (3H, s, H3-3a), 0.54 
(3H, s, H3-1β); 13C NMR (CDCl3, 67.5 MHz) δ (ppm) 172.22 (COOCH3-9), 157.90 (C-10), 
148.91 (C-5), 146.79 (C-7), 141.51 (C-4a), 127.81 (C-6a), 123.47 (C-10b), 119.08 (C-10a), 
102.68 (C-6), 102.32 (C-9), 99.53 (C-8), 85.41 (C-3a), 55.78 (OCH3-7), 52.09 (COOCH3-9), 
46.68 (C-1a), 41.83 (C-1), 41.28 (C-10d),  40.59 (C-3), 38.98 (C-10c), 33.95 (CH3-1α), 25.55 
(CH3-3a), 25.28 (C-2), 19.17 (CH3-1β); ESIMS m/z 399 [M+H]+ (100), 367 (60), 315 (42), 
289 (19), 277 (16). 
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II.2.1.2.3. Isolation of Methyl 8-hydroxy-1,4,6,7-tetramethoxy-2-naphthoate 60 
 
Fractions 1:20 to 1:26 were mixed together (4443.70 mg, 0.72 % yield), split into two equal 
parts (2221.85 mg, each) and each part submitted to a reversed phase separation with MPLC 
conditions (Table 2.6) to give 3 fractions (Table 2.7) monitored by TLC (RP18 plates). MPLC 
conditions were: column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample (each part) 
adsorbed on 12 g of RP18 and packed in a 230 x 36 mm i.d. sample column; flow rate 60 
ml/min at a back pressure < 40 bar; detection, LSD; collection 50 seconds per fraction). 
 
Table 2.6. Programme for separation of fractions 1:20-1:26 of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
Water/MeOH 50:50 0:100 10% 160 
 
Table 2.7. MPLC fractionation of fractions 1:20-1:26 of P. bussei. 
Fraction Eluate number Weight (mg) 
4:1 38-101 998.6 
4:2 102-168 938.4 
4:3 169-192 2217.0 
 
Fraction 4:1 (998.6 mg, 0.16 % yield) was subjected to CPC using n-hexane/EtOAc/MeOH/ 
H2O (3:7:5:5) as biphasic solvent system and under the following conditions: column 120 ml 
x 3; elution mode, head to tail, the upper phase as the stationary phase and the lower phase as 
mobile phase; flow rate 1 ml/min with a pressure ~ 90 psi; revolution speed, 1014 rpm; 
equilibrium volume, 97 ml; sample loop, 14 ml; detection, UV 254 nm and 280 nm; sample 
collection, 5 min per fraction; push out at 320 min with a flow rate of 4 ml/min collected at 16 
ml per tube; the sample was divided into 3 equal parts and chromatographed separately. The 
separation gave rise to 8 fractions listed in Table 2.8. 
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Table 2.8. CPC fractionation of fraction 4:1 of P. bussei 
Fraction Eluate number Weight (mg) 
5:1 10-22 604.8 
5:2 23-33 126.1 
5:3 34-52 27.6 
5:4 53-65 21.4 
5:5 66-69 28.2 
5:6 70-75 46.2 
5:7 76-79 92.6 
5:8 80-91 26.0 
 
Fractions 5:6 and 5:7 (138.80 mg, 0.023 % yield) were mixed together and 
rechromatographed over a reversed phase MPLC (Table 2.9) to afford 4 fractions (Table 
2.10). MPLC conditions used were: columns 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; 
sample adsorbed on 1 g of RP18 and packed in a 230 x 26 mm i.d. sample column; flow rate 
24 ml/min at back pressure < 40 bar; detection LSD; collection 25 seconds per fraction. 
 
Table 2.9. Programme for separation of fractions 5:6-5:7 of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 30:70 0:100 10% 90 
 
Table 2.10. MPLC fractionation of fractions 5:6–5:7 of P. bussei 
Fraction Eluate number Weight (mg) 
6:1 1-22 10.3 
6:2 23-47 54.3 
6:3 48-96 57.0 
6:4 97-216 15.8 
 
Fraction 6:2 (54.3 mg, 0.0089 % yield) was subjected to preparative TLC using n-hexane/ 
EtOAc (4:1) as eluent. Two bands were observed. The first band (blue under UV 254 and 365 
nm) with Rf 0.59 was scraped off and the compound removed from the adsorbent by 
extraction with EtOAc. Solvent removal by evaporation at reduced pressure yielded a white 
solid (19.7 mg, 0.00321% yield). The compound was additionally purified by HPLC on a 
RP18 column to afford a pure product (7.4 mg, 0.00120% yield). The analytical HPLC 
Pentas bussei                                                                                                                                        Experimental 
 45
conditions were the following: column, a Kromasil C18, 5µm, 10 x 0.4 cm i.d., Teknokroma 
(Barcelona); elution, gradient mode with H2O/MeOH (50:50 to 10:90); flow rate, 1 ml/min; 
detection, UV 254 nm. The preparative HPLC conditions were: column, a Kromasil C18, 5 
µm, 25 x 2 cm i.d., Teknokroma (Barcelona); elution, isocratic mode with H2O/MeOH 
(25:75); flow rate, 14 ml/min corresponding to a back pressure ≈ 185 bar; detection, UV 254 
nm; collection 45 seconds per fraction; running time, 120 min. The sample was dissolved in 3 
ml H2O/CH3CN (5:95) and filtered with 0.45 µm filter (Acrodisc 13 CR PTFE, 13 mm, 
Gelman) prior to injection. The eluates from 52.3-56.7 min were mixed and dried under 
vacuum to afford compound 60 as a reddish solid. 
 
Based on its spectral data and physical properties, the compound was identified as methyl 8-
hydroxy-1,4,6,7-tetramethoxy-2-naphthoate 60, which is a new compound. 
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Methyl 8-hydroxy-1,4,6,7-tetramethoxy-2-naphthoate 60: Amorphous reddish solid; mp 
167.9-169.4 °C; UV (MeOH) λmax (log ε) 231.4 (4.19), 260.2 (4.67), 295.5 (3.68), 308.7 
(3.45), 323.2 (3.52), 379.7 (3.88), 501.8 (2.94), 514.4 (2.79) nm; IR (KBr) νmax 3318 (OH), 
3020, 2930, 2855, 1715 (C=O), 1630 (C=C), 1607(C=C), 1514, 1472, 1429, 1369, 1218, 
1137, 1109, 1058, 762 cm-1; 1H NMR (270 MHz, CDCl3) δ (ppm) 9.85 (1H, s, OH-8), 7.14 
(1H, s, H-5), 7.11 (1H, s, H-3), 4.02 (3H, s, OCH3-1), 4.00 (3H, s, OCH3-6), 3.98 (3H, s, 
COOCH3-2), 3.97 (3H, s, OCH3-7), 3.96 (3H, s, OCH3-4); 13C NMR (67.5 MHz, CDCl3) δ 
(ppm) 165.99 (COOCH3-2), 155.22 (C-6), 152.36 (C-1), 150.62 (C-8), 147.99 (C-4), 135.05 
(C-7), 126.56 (C-4a), 115.11 (C-8a), 113.52 (C-2), 103.59 (C-3), 93.40 (C-5), 64.56 (OCH3-
1), 60.81 (OCH3-7), 55.92 (OCH3-6), 55.81 (OCH3-4), 52.34 (COOCH3-2); ESIMS m/z 323 
[M+H]+ (7), 291 (100). 
 
II.2.1.2.4. Isolation of Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61 
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Fraction 6:3 (57.0 mg, 0.0093 %) was recrystallised in MeOH to yield red needles. Analysis 
of the spectral data and the physical properties of the compound allowed to identify it as 
being the new highly oxygenated naphthohydroquinone methyl 1,8-dihydroxy-4,6,7-
trimethoxy-2-naphthoate 61. The compound is a novel natural product. 
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Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61: Reddish needles (from MeOH); 
mp 175.8-176.8 °C; UV (MeOH) λmax (log ε) 230.0 (4.25), 261.9 (4.56), 296.0 (3.64), 308.0 
(3.66), 322.1 (3.60), 379.1 (3.97), 502.1 (2.81), 514.0 (2.80) nm; IR (KBr) νmax 3341 (OH), 
2946, 2837, 1655 (C=O), 1638 (C=C), 1620 (C=C), 1522, 1480, 1450, 1434, 1376, 1337, 
1285, 1258, 1227, 1191, 1137, 1119, 1060, 1047, 1003, 794, 603 cm-1; 1H NMR (270 MHz, 
CDCl3) δ (ppm) 12.95 (1H, s, OH-1), 9.67 (1H, s, OH-8), 7.06 (1H, s, H-5), 6.82 (1H, s, H-3), 
3.98 (3H, s, OCH3-6), 3.97 (3H, s, COOCH3-2), 3.95 (3H, s, OCH3-7), 3.92 (3H, s, OCH3-4); 
13C NMR (67.5 MHz, CDCl3) δ (ppm) 171.71 (COOCH3-2), 156.04 (C-6), 155.79 (C-1), 
149.45 (C-8) 147.13 (C-4) 135.25 (C-7), 127.81 (C-4a), 110.17 (C-8a), 101.79 (C-2), 99.67 
(C-3), 93.74 (C-5), 60.75 (OCH3-7), 55.92 (OCH3-6), 55.61 (OCH3-4), 52.42 (COOCH3-2); 
ESIMS m/z 309 [M+H]+ (8), 277 (100). 
 
II.2.1.2.5. Isolation of 9-Methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62 
 
On the one hand, fraction 5:1 (604.8 mg, 0.099 % yield) (Table 2.8) was subjected to reversed 
phase MPLC (Table 2.11) yielding 4 fractions (Table 2.12) monitored by TLC (on RP18 
plates). MPLC conditions were: column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; 
sample adsorbed on 4.0 g of RP18 and packed in a 230 x 36 mm i.d. sample column; flow 
rate, 32 ml/min at back pressure < 40 bar; detection LSD; collection 45 seconds per fraction. 
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Table 2.11. Programme for separation of fraction 5:1 of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 50:50 50:50 ---- 10 
H2O/MeOH 40:60 0:100 10% 100 
 
Table 2.12. MPLC fractionation of fraction 5:1 of P. bussei 
Fraction Eluate number Weight (mg) 
7:1 1-33 34.4 
7:2 34-40 15.6 
7:3 41-92 458.6 
7:4 93-147 82.0 
 
On the other hand, fraction 4:2 (938.4 mg, 0.15 % yield) (Table 2.7) was submitted to CPC 
using n-hexane/EtOAc/MeOH/H2O (3:7:5:5) as biphasic solvent system to afford 4 fractions 
(Table 2.13) monitored by TLC (RP18 plates). The CPC conditions were: column 120 ml x 3; 
elution mode, head to tail, the upper phase as the stationary phase and the lower phase as 
mobile phase; flow rate 1 ml/min with a pressure ~ 85 psi; revolution speed, 1023 rpm; 
equilibrium volume, 106 ml; sample loop, 14 ml; detection, UV 254 nm and 280 nm; sample 
collection, 5 min per fraction; push out at 300 min with a flow rate of 4 ml/min collected at 16 
ml per tube; the sample was divided into 3 equal parts which were chromatographed 
separately. 
 
Table 2.13. CPC fractionation of fraction 4:2 of P. bussei 
Fraction Eluate number Weight (mg) 
8:1 13-19 139.5 
8:2 20-39 342.9 
8:3 47-54 19.7 
8:4 59-82 410.1 
 
Based on their identity (monitoring by TLC on RP18 plates), fractions 7:3, 7:4, 8:1 and 8:2 
were mixed together (1023.0 mg, 0.17 % yield) and submitted to a reversed phase MPLC 
under isocratic elution mode utilizing H2O/MeOH (3:7) as mobile phase to give rise to 3 
fractions (Table 2.14) monitored by TLC (RP18 plates). MPLC conditions were: column 460 
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x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 7.2 g of RP18 and packed in 
a 230 x 36 mm i.d. sample column; flow rate, 28 ml/min at a back pressure ≈ 30 bar; detection 
LSD; collection 45 sec per fraction; duration, 90 min.  
 
Table 2.14. MPLC fractionation of fraction 7:3-7:4 and 8:1-8:2 of P. bussei 
Fraction Eluate number Weight (mg) 
9:1 1-34 139.3 
9:2 35-64 601.6 
9:3 65-120 206.8 
 
Fraction 9:2 (601.6 mg, 0.098 % yield) was rechromatographed on a normal phase MPLC 
eluting with EtOAc/MeOH under a gradient mode (Table 2.15) to afford 4 fractions (Table 
2.16) monitored by TLC (RP18 plates; eluent: H2O/MeOH (2:3)). MPLC conditions were: 
column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 4 g of silica gel 
and packed in a 230 x 36 mm i.d. sample column; flow rate 40 ml/min at a back pressure < 40 
bar; detection LSD; collection, 15 seconds per fraction. 
 
Table 2.15. Programme for separation of fraction 9:2 of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
EtOAc/MeOH 100:0 70:30 10% 60 
EtOAc/MeOH 60:40 60:40 ---- 30 
 
Table 2.16. MPLC fractionation of fraction 9:2 of P. bussei 
Fraction Eluate number Weight (mg) 
10:1 1-137 34.5 
10:2 138-176 135.3 
10:3 177-188 21.5 
10:4 189-360 69.2 
Based on its spectral data and its physical properties, fraction 10:2 (135.3 mg, 0.022 % yield), 
which eluted at Rt = 45-65 min, was identified as 9-methoxy-2,2-dimethyl-2H-
benzo[h]chromene-7,10-diol 62. 
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9-Methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62: White solid (from 
hexane/(CH3)2CO (1:1)); mp 201.8-204.0 °C; UV (EtOH) λmax (log ε) 255.0 (4.12), 360.0 
(3.63) nm; IR (KBr) νmax 3430 (broad, OH), 2974, 1605 (broad), 1459, 1394, 1317, 1264, 
1202, 1162, 1138, 1118, 1046, 967, 876, 800, 727 cm-1; 1H NMR (270 MHz, CD3OD) δ 
(ppm) 8.07 (1H, d, J = 8.9 Hz, H-5), 7.62 (1H, d, J = 10.2 Hz, H-4), 7.36 (1H, s, H-8), 6.90 
(1H, d, J = 8.9 Hz, H-6), 5.51 (1H, d, J = 10.2 Hz, H-3), 3.79 (3H, s, OCH3-9), 1.39 (6H, s, 2 
x CH3-2); 13C NMR (67.5 MHz, CD3OD) δ (ppm) 156.63 (=Cq-O), 156.11 (2 x =Cq-O), 
150.92 (C-9), 129.11 (C-3), 128.12 (C-6a), 127.26 (C-5), 125.62 (C-4), 124.33 (C-10a), 
119.67 (C-6), 116.96 (C-4a), 109.56 (C-8), 77.14 (C-2), 57.52 (OCH3-9), 28.89 (2 x CH3-2); 
ESIMS m/z (rel. int.) 295 [M + Na]+ (9), 255 (100), 141 (15). 
 
II.2.1.2.6. Isolation 9-Methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo[h]chromene-
7,10-diol 63 
 
Fraction 9:3 (206.8 mg, 0.034 % yield) was submitted to normal phase MPLC using 
EtOAc/MeOH under a gradient mode (Table 2.17) and the following chromatographic 
conditions: column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample dissolved in 12 
ml of EtOAc and injected into a loop of 15 ml as maximum volume; flow rate, 40 ml at a back 
pressure < 40 bar; detection LSD; collection 15 sec per fraction. The separation yielded 3 
fractions (Table 2.18) monitored by TLC (RP18 plates; eluent: H2O/MeOH (2:3)). 
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Table 2.17. Programme for separation of fraction 9:3 of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
EtOAc/MeOH 100:0 70:30 10% 60 
 
Table 2.18. MPLC fractionation of fraction 9:3 of P. bussei 
Fraction Eluate number Weight (mg) 
11:1 1-81 45.9 
11:2 82-144 73.7 
11:3 145-240 22.0 
 
Fraction 11:3 (73.7 mg, 0.012 % yield) eluted at Rt = 38-54 min. Analysis of its spectral data 
and its physical properties allowed to identify it as 9-methoxy-2-methyl-2-(4-methyl-3-
pentenyl)-2H-benzo[h]chromene-7,10-diol 63. 
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9-Methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo[h]chromene-7,10-diol 63: White 
solid (from hexane/(CH3)2CO (1:1)); mp 174.5-176.4 °C; UV (EtOH) λmax (log ε) 254.1 
(4.25), 369.0 (3.70) nm; IR (KBr) νmax 3500 (broad, OH), 2855, 1595, 1563, 1453, 1428, 
1392, 1313, 1259, 1137, 1083, 1046, 814 cm-1; 1H NMR (CD3OD, 270 MHz) δ (ppm) 8.08 
(1H, d, J = 8.9 Hz, H-5), 7.72 (1H, d, J = 10.4 Hz, H-4), 7.34 (1H, s, H-8), 6.92 (1H, d, J = 
8.9 Hz, H-6), 5.51 (1H, d, J = 10.4 Hz, H-3), 5.09 (1H, broad t, J = 7.1 Hz, H-3'), 3.82 (3H, s, 
OCH3-9), 2.11-2.17 (2H, m, H2-2'), 1.66-1.72 (2H, m, H2-1'), 1.62 (3H, s, H3-5'), 1.55 (3H, s, 
H3-6'), 1.37 (3H, s, H3-7'); 13C NMR (67.5 MHz, CD3OD) δ (ppm) 155.54 (=Cq-O), 155.07 (2 
x =Cq-O), 149.74 (C-9), 132.36 (C-4'), 127.06 (C-6a), 126.88 (C-3), 126.05 (C-5), 125.41 (C-
3'), 124.78 (C-4), 123.05 (C-10a), 118.36 (C-6), 115.56 (C-4a), 108.26 (C-8), 78.27 (C-2), 
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56.30 (OCH3-9), 41.63 (C-1'), 26.04 (C-7'), 25.88 (C-5'), 23.84 (C-2'), 17.70 (C-6'), ESIMS 
m/z (rel. int.) 341 [M + H]+ (7), 323 (19), 286 (100), 256 (10). 
 
II.2.1.2.7. Isolation of (24S)-24-Ethylcholesta-5-(E)-22-dien-3-β-ol (β-Stigmasterol) 64 
 
A normal phase MPLC was applied to fractions 1:16 to 1:19 (Table 2.2) mixed together (46.8 
mg, 0.068 %), under an isocratic mode elution utilizing n-hexane/EtOAc (90:10) as solvent 
system. MPLC conditions were: column, 460 x 49 mm i.d.; sample adsorbed on 3 g of silica 
gel and packed in 230 x 36 mm i.d. sample column; flow rate 25 ml/min at a back pressure ≈ 
30-35 bar; detection, LSD; collection 60 seconds per fraction; running time, 180 min. The 
separation yielded 5 fractions (Table 2.19) monitored by TLC. 
 
Table 2.19. MPLC fractionation of fractions 1:16-1:19 of P. bussei 
Fraction Eluate number Weight (mg) 
12:1 7-23 51.3 
12:2 24-35 40.7 
12:3 36-51 125.4 
12:4 52-66 39.8 
12:5 67-180 118.6 
 
Fraction 12:3 (125.4 mg, 0.020 % yield) was submitted to preparative TLC using n-hexane/ 
acetone (3:2) as eluent. The sample was dissolved in 5 ml of a mixture 1:1 of n-hexane and 
acetone, and spotted on 3 preparative TLC plates, in a line 3 mm wide and 18 cm length at 1.5 
cm from the bottom edge of the plate. The compound, wich showed a Rf 0.63, was scraped off 
and extracted from the silica gel material with CH2Cl2 followed by filtration. Evaporation 
under reduced pressure afforded a white solid material (55.2 mg, 0.0090 % yield). 
 
According to its spectral data and physical properties, the compound was identified as (24S)-
24-ethylcholesta-5-(E)-22-dien-3β-ol (β-stigmasterol) 64. 
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(24S)-24-Ethylcholesta-5-(E)-22-dien-3β-ol (β-Stigmasterol) 64: White solid (from 
hexane); mp 164.0-165.9 °C, lit. mp 164.2-166.0 °C (115); IR νmax (KBr) 3414 (OH), 2940, 
2866, 1546, 1459, 1376, 1051, 712 cm-1; 1H NMR (CDCl3, 270 MHz) δ (ppm) 5.35-5.38 (1H, 
m, =CH), 4.96-5.18 (AB qd, ∆ν = 62.7 Hz, 2J = 15.2 Hz, 3J = 8.7 Hz and 8.4 Hz, CH=CH), 
3.46-3.61 (1H, m, CH-OH), 2.31-2.35 (1H, m, CH), 2.26 (1H, m, CH), 1.85 (2H, m, CH2), 
1.81 (1H, m, CH), 1.04 (3H, d, J = 6.8 Hz), 1.01 (3H, s, CH3), 0.84 (3H, d, J = 6.2 Hz, CH3), 
0.81 (3H, t, J = 7.0 Hz, CH3), 0.77 (3H, d, J = 6.4 Hz, CH3), 0.68 (3H, s, CH3); 13C NMR 
(CDCl3, 67.5 MHz) δ (ppm) 140.75 (=Cq), 138.33 (=CH), 129.27 (=CH), 121.72 (=CH), 
71.82 (CH-OH), 56.85 (CH), 55.94 (CH), 51.23 (CH), 50.15 (CH), 42.32 (CH2), 42.21 (Cq), 
40.50 (CH), 39.68 (CH2), 37.25 (CH2), 36.51 (Cq), 31.89 (CH2), 31.89 (CH), 31.89 (CH2), 
31.66 (CH2), 28.93 (CH2), 25.41 (CH3), 24.37 (CH2), 21.22 (CH3), 21.08 (CH3), 21.08 (CH2), 
19.41(CH3), 19.03 (CH), 12.26 (CH3), 12.04 (CH3); EIMS m/z (rel. int.): 412 (M+; 3%), 380 
(2), 299 (3), 255 (52), 240 (20), 227 (21), 179 (46), 163 (36), 143 (88), 133 (65), 121 (77) 109 
(53), 91 (76), 83 (98), 69 (75), 55 (100), 43(62). 
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Figure 2.2. Natural Products Isolated from the n-Hexane Extract of the Roots 
of Pentas bussei 
 
II.2.1.3. Study of the Dichloromethane Extract of the Roots of Pentas bussei 
 
The CH2Cl2 extract of the roots of Pentas bussei (16.65 g, 2.71 % yield) was submitted to a 
reversed phase MPLC separation under a gradient mode (Table 2.20) to afford 7 different 
fractions (Table 2.21) monitored by TLC (on RP18 plates). MPLC conditions were: column 
460 x 70 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 120 g of RP18, divided 
into 4 equal parts chromatographed separately and each part packed in a 230 x 36 mm i.d. 
sample column; flow rate 30 ml/min at a back pressure < 40 bar; detection LSD, collection 80 
seconds per fraction. 
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Table 2.20. Programme for separation of the CH2Cl2 extract of the roots 
of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 40:60 0:100 10% 175 
 
Table 2.21. MPLC fractionation of the CH2Cl2 extract of the roots of P. bussei 
Fraction Eluate number Weight (mg) 
13:1 7-23 662.7 
13:2 24-35 775.4 
13:3 36-51 424.1 
13:4 52-66 3973.8 
13:5 67-83 3306.2 
13:6 84-109 1485.0 
13:7 110-131 5309.9 
 
II.2.1.3.1. Isolation 7-Hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromene-8-carboxylic 
acid 65 
 
Fractions 13:4 and 13:5 were mixed together (7.28 g, 1.19 % yield), divided into 4 parts (1.82 
g per parts) and each part subjected to CPC with n-hexane/EtOAc/MeOH/H2O (1.5:1.5:1:1) 
as biphasic solvent system. The separation conditions were: column 120 ml x 3; elution mode, 
head to tail, the upper phase as the stationary phase; flow rate 1 ml/min with a pressure ~ 80 
psi; revolution speed, 1060 rpm; equilibrium volume, 72 ml; sample loop, 14 ml; detection, 
UV 254 nm and 280 nm; sample collection, 4 min per fraction; push out at 245 min with a 
flow rate of 5 ml/min collected at 16 ml per tube. The separation yielded the three fractions 
listed in Table 2.22. 
 
Table 2.22. CPC fractionation of fraction 13:4-13:5 of P. bussei 
Fraction Eluate number Weight (mg) 
14:1 13-23 2754.9 
14:2 73-88 3465.2 
14:3 91-105 56.3 
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Fraction 14:2 (3465.2 mg, 0.56 % yield) was rechromatographed with an isocratic reversed 
phase MPLC elution with H2O/MeOH (15:85) to yield 4 fractions (Table 2.23) monitored by 
TLC (RP18 plates). MPLC conditions were: 2 coupled columns 460 x 49 mm i.d. and 230 x 
49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 20 g of RP18 and split into 2 
equal parts, each one packed in a 230 x 36 mm i.d. sample column and eluted separately; flow 
rate 36 ml/min at a back pressure < 40 bar; detection, LSD; collection 65 seconds per fraction, 
run time 180 min. 
 
Table 2.23. MPLC fractionation of fraction 14:2 of P. bussei 
Fraction Eluate number Weight (mg) 
15:1 1-27 262.1 
15:2 28-72 643.8 
15:3 73-104 950.4 
15:4 105-167 720.6 
 
After solvent evaporation, fraction 15:3 afforded fine yellow crystals of compound 65. Based 
on its physical and spectral data, the compound was identified as 7-hydroxy-3,3-dimethyl-10-
methoxy-3H-benzo[f]chromene-8-carboxylic acid 65. 
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7-Hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromene-8-carboxylic acid 65: Yellow 
fine crystals (from CHCl3); mp 196.7-198.0 °C; UV (CHCl3) λmax (log ε) 259.1 (4.57), 261.0 
(4.57), 373.9 (4.17) nm; IR νmax (KBr) 3440 (OH), 2974 (broad), 2597, 1648, 1620, 1575, 
1509, 1445, 1396, 1301, 1274, 1224, 1201, 1136, 1119, 1041, 891, 869, 785, 737, 716 cm-1; 
1H NMR (400 MHz, Acetone-D6) δ (ppm) 8.22 (1H, d, J = 8.9 Hz, H-6), 7.75 (1H, dd, J1 = 
10.6 Hz, J2 = 0.7 Hz , H-1), 7.17 (1H, s, H-9), 7.11 (1H, dd, J1 = 8.9 Hz, J2 = 0.7 Hz, H-5), 
5.70 (1H, d, J = 10.6 Hz, H-2), 3.94 (3H, s, OCH3-10), 1.46 (6H, s, 2 x CH3-3); 13C NMR 
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(100 MHz, Acetone-D6) δ (ppm) 173.10 (COOH-8), 156.87 (C-7), 155.90 (C-4a), 150.06 (C-
10), 128.66 (C-2), 127.69 (C-10a), 126.04 (C-6), 123.46 (C-1), 122.23 (C-6a), 119.31 (C-5), 
115.76 (C-10b), 105.16 (C-9), 103.30 (C-8), 76.01 (C-3), 56.15 (OCH3-10), 27.60 (2 x CH3-
3); ESIMS m/z 301 [M+H]+(81), 271 (100), 257 (7), 199 (14),  146 (7). 
 
In addition, fraction 14:3 afforded compound 61, while the MPLC-RP18 fractionation of 
fraction 13:6 (Table 2.21) gave rise to compounds 58, 62 and 63. All these compounds were 
already isolated from the n-hexane extract of the roots of P. bussei (see description of these 
compound in Section II.2.1.2). 
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Figure 2.3. Natural Products Isolated from the Dichloromethane Extract of the Roots 
of Pentas bussei 
 
II.2.1.4. Study of the Ethyl Acetate Extract of the Roots of Pentas bussei 
 
A reversed phase (RP18) MPLC was applied to the ethyl acetate extract of the roots of P. 
bussei (1740 mg, 0.2834% yield) with elution under a gradient of acetonitrile/water (Table 
2.24) and the following conditions: column 460 x 46 mm i.d.; precolumn, 140 x 10 mm i.d.; 
sample adsorbed on 12 g of RP18 and packed in a 230 x 36 mm i.d. sample column; flow rate 
48 ml/min at a back pressure < 40 bar; detection LSD, collection 45 seconds per fraction. The 
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eluates obtained were combined into 6 different fractions (Table 2.25) depending upon the 
monitoring on TLC (RP18 plates). 
 
Table 2.24. Programme for separation of the ethyl acetate extract of the roots 
of P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/CH3CN 100:0 0:100 10% 165 
 
Table 2.25. MPLC fractionation of the ethyl acetate extract of the roots 
of P. bussei 
Fraction Eluate number Weight (mg) 
16:1 36-51 197.3 
16:2 52-80 154.7 
16:3 81-130 285.6 
16:4 131-154 183.9 
16:5 155-180 150.5 
16:6 229-243 60.5 
 
II.2.1.4.1. Isolation of Rubiadin-1-methyl ether 3-O-ß-primeveroside 55 
 
Fractions 16:1 and 16:2 were combined together (352.0 mg, 0.057 % yield) and submitted to 
a reversed phase MPLC eluted with a gradient (Table 2.26) of acetonitrile/water under the 
following conditions: 2 coupled columns 460 x 26 mm i.d. and 230 x 26 mm i.d.; precolumn, 
140 x 10 mm i.d.; sample dissolved in 12 ml of acetonitrile/water (1:9), filtered through a 
0.45 µm filter (25 mm syringe filter, PVDF, Alltech Associates, Inc.) and introduced into a 15 
ml sample loop; flow rate, 42 ml/min at a back pressure < 40 bar; detection LSD, collection 
80 seconds per fraction. The eluates were monitored by TLC (RP18 plates) and combined into 
5 different fractions (Table 2.27). 
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Table 2.26. Programme for separation of fractions 16:1-16:2 of  P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/CH3CN 100:0 90:0 5% 90 
 
Table 2.27. MPLC fractionation of fractions 16:1-16:2 of P. bussei 
Fraction Eluate number Weight (mg) 
17:1 24-38 21.2 
17:2 82-102 69.8 
17:3 104-122 29.5 
17:4 138-148 16.5 
17:5 160-180 51.7 
 
After solvent evaporation under reduced pressure, the fraction 17:3 (29.5 mg, 0.0049 % yield) 
afforded a yellowish solid. Analysis of its physical and spectral data, together with 
comparison with data available in the literature (112), allowed to elucidate the structure of the 
compound and to identify it as rubiadin-1-methyl ether 3-O-β-primeveroside 55. 
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Rubiadin-1-methyl ether 3-O-ß-primeveroside 55: mp 161.1 – 163.0 °C, lit. mp. 158-160 
°C (116); [α]22D = -90 ° (c 0.1, H2O); UV (H2O) λmax (log ε) 271.0 (4.53), 315.0 (4.09), 349.0 
(4.11), 370.0 (4.08), 374.1 (4.07), 422.9 (3.85), 442.0 (3.86) nm; IR νmax 3342 (br, hydrogen 
bonded OH), 2929, 1672 (C=O, unchelated), 1582, 1331, 1080 (br, C-O), 779, 714, 602 cm-1. 
1H NMR (C5D5N, 270 MHz) δ (ppm) 8.35 (1H, s, H-4), 8.30-8.32 (2H, m, H-5 and H-8), 
7.56-7.70 (2H, m, H-6 and H-7), 5.84 (1H, d, J = 6.3 Hz, H-1'), 4.93 (1H, broad d, J = 6.3 Hz, 
H-1''), 3.63-3.89 (the rest of the sugar protons), 3.97 (3H, s, OCH3-1), 2.36 (3H, s, CH3-2); 
13C NMR (67.5 MHz, DMSO-d6) δ (ppm) 182.19 (C-10), 180.52 (C-9), 160.00 (C-3), 159.78 
(C-1), 134.53 (C-7), 134.19 (C-10a), 133.80 (C-8a), 133.55 (C-6), 132.00 (C-4a), 128.84 (C-
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2), 126.59 (C-8), 126.16 (C-5), 120.05 (C-9a), 108.10 (C-4), 103.93 (C-1''), 100.18 (C-1'), 
76.30 (C-3''), 76.01 (C-3'), 75.56 (C-5'), 73.21 (C-2''), 73.06 (C-2'), 69.38 (C-4''), 69.04 (C-4'), 
67.92 (C-6'), 65.52 (C-5''), 60.77 (OCH3-1), 9.22 (CH3-2); ESIMS m/z 585[M+Na]+ (57), 563 
[M+H]+ (18), 431 (31), 381 (5), 269 (100). 
 
In addition, a series of reversed and normal phase MPLC separations was applied to fraction 
16:5 (150.5 mg, 0.025 % yield) which resulted in the isolation of the benzochromene 62, 
already isolated from the n-hexane and the dichloromethane extracts of the roots of P. bussei. 
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Figure 2.4. Natural Products Isolated from the Ethyl Acetate Extract of the 
Roots of P. bussei 
 
II.2.1.5. Study of the Methanol Extract of the Roots of Pentas bussei 
 
A portion of 10.55 g was taken from the methanol extract of the roots of P. bussei (31.27 g, 
5.095 % yield) and submitted to a CPC with EtOAc/n-BuOH/H2O (2:1:3) as biphasic solvent 
system under the following conditions: column 320 ml x 3; elution mode, head to tail, the 
upper phase as the stationary phase and the lower phase as mobile phase; flow rate 3 ml/min 
with a pressure ~ 80 psi; revolution speed 1065 rpm; equilibrium volume, 250 ml; sample 
loop, 14 ml; detection, UV 254 nm and 280 nm; sample collection, 2 min per fraction; push 
out at 360 min with a flow rate of 9 ml/min collected at 18 ml per tube; the sample was 
divided into 2 equal parts partitioned separately. Based on the TLC monitoring (on RP18 
plates), the eluates were combined into 5 different fractions listed in Table 2.28. 
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Table 2.28. CPC fractionation of the methanol extract of the roots of P. bussei 
Fraction Eluate number Weight (mg) 
18:1 38-45 8637.9 
18:2 46-69 808.4 
18:3 92-133 132.9 
18:4 141-156 210.8 
18:5 159-165 347.2 
 
 
II.2.1.5.1. Isolation of Damnacanthol-3-O-ß-primeveroside 57 
 
Fraction 18:2 (808.4 mg, 0.13 % yield) was rechromatographed (MPLC on reversed phase) 
under a gradient mode (Table 2.29) to afford 4 fractions (Table 2.30) after TLC monitoring on 
RP18 and combination of identical eluates. MPLC conditions were: column 460 x 36 mm i.d.; 
sample adsorbed on 6 g of RP18 and packed in a 230 x 36 mm i.d. sample column; flow rate 
36 ml/min at a back pressure < 40 bar; detection LSD; collection 40 seconds per fraction. 
 
Table 2.29. Programme for separation of fractions 18:2 of  P. bussei on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 80:20 60:40 10% 75 
H2O/MeOH 60:40 60:40 ---- 40 
 
Table 2.30. MPLC fractionation of the fraction 18:2 of P. bussei 
Fraction Eluate number Weight (mg) 
19:1 11-25 149.3 
19:2 26-47 99.8 
19:3 84-109 181.7 
19:4 117-175 159.9 
 
The solvent of fraction 19:3 (181.7 mg, 0.030 % yield) was evaporated to dryness to give rise 
to a yellow solid. Its physical and spectral data allowed to identify it as damnacanthol-3-O-ß-
primeveroside 57. The compound is already described in the literature (112). 
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Damnacanthol-3-O-ß-primeveroside 57: mp 138.4-140.6 °C, lit. mp 140-142 °C (112); [α]
16
D = -130 ° (c 0.1, H2O), lit. [α]20D = -94.8 ° (c 0.18, MeOH) (112); UV (EtOH) λmax (log ε) 
246.0 (3.50), 266.0 (3.64), 308.0. (2.98), 317.1 (2.99), 323.0 (2.99), 325.0 (3.00), 328.0 
(2.99), 374.0 (2.86) nm; IR (KBr) νmax 3391 (broad, OH groups), 2923, 1673 (unchelated 
C=O), 1579, 1454, 14091330, 1284, 1229, 1167, 1069 (br, C-O), 900, 715, 612 cm-1; 1H 
NMR (270 MHz, C5D5N) δ (ppm) 8.42 (1H, s, H-4), 8.26-8.34 (2H, m, H-5 and H-8), 7.22-
7.67 (2H, m, H-6 and H-7), 5.77 (1H, d, J = 6.6 Hz, H-1'), 5.12-5.17 and 5.22-5.28 (2H, 2 x d, 
J = 11.2 Hz, AB system CH2OH-2), 4.90-4.94 (1H, broad d, J = 6.3 Hz, H-1''), 4.17 (3H, s, 
OCH3-1), 3.68-4.87 (the rest of sugar protons); 13C NMR (67.5 MHz, DMSO-d6) δ (ppm) 
182.08 (C-10), 180.34 (C-9), 160.59 (C-3), 160.59 (C-1), 135.63 (C-10a), 134.64 (C-7), 
134.21 (C-8a), 133.58 (C-6), 131.91 (C-4a), 131.46 (C-2), 126.63 (C-8), 126.22 (C-5), 120.37 
(C-9a), 108.98 (C-4), 103.95 (C-1''), 100.77 (C-1'), 76.30 (C-5'), 75.76 (C-3'), 75.60 (C-3''), 
73.22 (C-2''), 73.15 (C-2'), 69.42 (C-4'), 69.07 (C-4''), 67.92 (C-6'), 65.53 (C-5''), 62.66 
(OCH3-1), 51.84 (CH2OH-2); ESIMS m/z (rel. int.) 285 (13), 283 [M – primeverosyl]+ (7), 
267 (12), 253 (100). 
 
II.2.1.5.2. Isolation of Lucidin-3-O-ß-primeveroside 56 
 
The above separation (Tables 2.29 and 2.30) also afforded fraction 19:4 (159.9 mg, 0.026 % 
yield). After solvent evaporation under reduced pressure, an orange red solid was obtained 
and identified as lucidin-3-O-ß-primeveroside 56 based on its physical and spectral data, 
together with the comparison of the latter with data available in the literature (112). 
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Lucidin-3-O-ß-primeveroside 56: mp 206.5-208.3 °C, lit. mp 208-210 °C (116); [α]17D = -
140 ° (c 0.05, H2O); UV (H2O) λmax (log ε) 247.0 (4.43), 265.0 (4.49) 362.0 (4.11) nm; IR ν
max 3399 (broad, OH groups), 2895, 1677 (unchelated C=O), 1635 (chelated C=O), 1593, 
1526, 1485, 1416, 1372, 1334, 1295, 1229, 1164, 1079 (br, C-O), 1005, 903, 796, 763, 717, 
611 cm-1; 1H NMR (270 MHz, C5D5N) δ (ppm) 8.20-8.34 (2H, m, H-5 and H-8), 8.16 (1H, s, 
H-4), 7.50-7.72 (2H, m, H-6 and H-7), 5.75 (1H, d, J = 6.6 Hz, H-1'), 5.17-5.25 and 5.34-5.41 
(2H, 2 x d, J = 11.5 Hz, AB system CH2OH-2), 4.90-4.94 (1H, broad d, J = 6.3 Hz, H-1''), 
3.63-4.88 (the rest of sugar protons); 13C NMR (67.5 MHz, DMSO-d6) δ (ppm) 187.11 (C-9), 
181.70 (C-10), 161.50 (C-3), 160.90 (C-1), 134.68 (C-7), 134.52 (C-6), 133.74 (C-10a), 
133.00 (C-8a), 132.81 (C-4a), 126.81 (C-8), 126.45 (C-5), 123.68 (C-2), 111.23 (C-9a), 
106.19 (C-4), 103.97 (C-1''), 100.66 (C-1'), 76.30 (C-5'), 75.81 (C-3'), 75.56 (C-3''), 73.19 (C-
2'), 73.19 (C-2''), 69.40 (C-4'), 69.04 (C-4''), 67.92 (C-6'), 65.53 (C-5''), 51.36 (CH2OH-2); 
ESIMS m/z (rel. int.) 547 (22), 269 (100). 
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Figure 2.5. Natural Products Isolated from the Methanol Extract 
of the Roots of Pentas bussei
 
II.3. Results and Discussion 
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II.3.1. Novel Natural Products from the Roots of P. bussei 
 
The present study is the first investigation of P. bussei. Seven novel natural products (58-63 
and 65) were isolated from the roots of the plants, together with four known compounds (55-
57 and 64). Five of the new compounds were naphthohydroquinones of the benzochromene 
type (58-59, 62-63 and 65), whereas the remaining two were highly oxygenated 
naphthohydroquinones (60-61). 
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The known compounds are the anthraquinone glycosides rubiadin-1-methyl ether-3-O-ß-
primeveroside 55, lucidin-3-O-ß-primeveroside 56 and damnacanthol-3-O-ß-primeveroside 
57, together with the ubiquitous β-stigmasterol 64. All the compounds were characterized by 
spectrometric methods (NMR, UV, IR and MS). 
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II.3.1.1. Naphthohydroquinone Derivatives of the Benzochromene Type 
 
II.3.1.1.1. Methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)- 
                3H-benzo[f]chromene-9-carboxylate 58 
 
A series of MPLC-Si fractionation of mixed fractions 1:8 to 1:11 (Table 2.2) from the hexane 
extract of the roots of P. bussei, followed by p-TLC and HPLC purification (Scheme 2.1) led 
to this isolation of compound 58 which is a novel natural product. 
 
Methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]chro-
mene-9-carboxylate 58, yellow solid (from hexane), mp 89.9-92.1 °C. HRMS provided the 
exact mass at m/z 399.1735 (calcd m/z 399.1808 [M + H]+), suggesting C23H26O6 as the 
molecular formula, with an unsaturation index of 11. The 1H NMR, 13C NMR and HMBC 
NMR spectra (Figures 2.6-2.7, Table 2.31) revealed the presence of a 4-methyl-3-pentenyl 
side chain from the observation of two methyl groups [δH 1.57 (3H, s), δC 17.62, C-5' and  δH 
1.66 (3H, s), δC 25.56, C-6'], two methylene groups [δH 1.76-1.86 (2H, m), δC 40.33, C-1' and  
δH 2.08-2.22 (2H, m), δC 22.78, C-2'], and one methine and a quaternary olefinic carbon 
forming a carbon-carbon double bond with the respective NMR spectral data  δH 5.04-5.14 
(1H, br t, J = 7.1 Hz), δC 123.82, C-3' and δC 131.96, C-4'. The data were similar to those 
found in the literature for this alkenyl chain in other compounds (117-120). 
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Scheme 2.1: Isolation of Methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3- 
Pentenyl)-3H-benzo[f]chromene-9-carboxylate 58 from the Roots of P. bussei. 
 
Besides, an oxygenated quaternary carbon was shown from the 13C NMR spectrum at δC 
78.95 (C-3). A cis vicinally coupled two-proton olefinic system (as AX coupling system) was 
observed in the 1H NMR spectrum and was confirmed by the 1H-1H COSY NMR. The two 
protons resonate at δH-2 5.66 and δH-1 8.02 (1H each, d, J = 10.4 Hz), respectively. The 13C 
NMR and HETCOR spectra showed that their corresponding carbons resonated at δC 123.37 
(C-1) and δC 127.81 (C-2). A further methyl group [δH 1.47 (3H, s); δC 25.61, C-7'] and an 
ester carbonyl carbon (δC 171.98) were also identified. 
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The long-range HMBC spectrum (Figures 2.8-2.9) showed that H-7', H-1 and H-2, together 
with H-1' and H-2' all gave a strong coupling with the oxygenated quaternary carbon C-3. 
This suggested that the side chain must be located at C-3. This was also supported by the 
observation of a fragment at m/z 315 (M+-83) in the ESI mass spectrum corresponding to [M - 
(CH2)2CH=C(CH3)2]+, a loss of the side chain by an ether α-cleavage (Scheme 2.2). This type 
of cleavage has been observed in similar compounds (117). The HMBC correlations showed a 
strong coupling between H-2 and the aromatic quaternary carbon C-10b (δC 117.35) and 
between H-1 with the aromatic carbon C-4a (δC 140.97), which was assigned as the 
oxygenated aromatic carbon C-4a involved in the pyran ring. 
 
In addition, a combination of 1H NMR, 13C NMR, DEPT and HETCOR spectra revealed the 
presence of two aromatic CH units, respectively [δH 6.92 (1H, s), δC 99.59, C-8 and δH 7.60 
(1H, s), δC 105.33, C-6], along with two methoxy groups [δH 3.91 (3H, s), δC 55.78, OCH3-7 
and δH 3.97 (3H, s), δC 52.15, COOCH3-9]. The two remaining signals were deduced as being 
two hydroxy protons substituted at aromatic rings  [δH 6.05 (1H, s), OH-5  and δH 12.26 (1H, 
s), OH-10]. The presence of a methoxycarbonyl group (COOCH3-9) was established first, 
from the 13C NMR spectrum which revealed an ester-like carbonyl carbon at δC 171.98 and, 
second, by the HMBC spectrum which showed a strong long-range coupling between the 
methyl protons (COOCH3-9) and the carbonyl carbon (COOCH3-9). 
 
The locations of this methoxycarbonyl, the two hydroxy groups as well as the methoxy group 
on the aromatic rings was established by HMBC. The significant deshielding of the OH-10 
proton was taken as an indication that this hydroxy group is located in an ortho position with 
respect to the methoxycarbonyl group. Long-range coupling of this proton with the two 
quaternary aromatic carbons δC 103.53 (C-9) and δC 115.98 (C-10a) confirmed this proposed 
arrangement. The hydroxyl proton was strongly coupled to a carbon at δC 157.60 which is 
unequivocally carbon C-10 (2J long-range coupling) on which the hydroxy group is directly 
substituted. In addition, long-range coupling of H-8 (δH 6.92) with the carbonyl carbon, C-9, 
and C-7 gave further evidence for the substitution pattern of H-8. The location of OH-5 was 
confirmed by a strong coupling of its proton with C-6 and with the oxygenated quaternary 
carbon C-4a (δC 140.97). The location of C-6 was confirmed by long-range coupling of the 
proton H-6 with C-4a, C-5, C-7 and C-10a.  
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The UV spectrum of compound 58 showed particular intense absorption at 272.0 and 283.0 
nm, in agreement with a naphthalene chromophore extended by lone-pair donating or by π-
bonded systems (121); in addition, IR spectrum showed an OH band (3455 cm-1), a band at 
1727 cm-1 typical to the α,β-unsaturated carbonyl of benzoate, together with bands belonging 
to conjugated C=C (1632 and 1593 cm-1). 
 
In conclusion, based on the analysis of all the spectroscopic data obtained, the structure of 
compound 58 was established as being the new natural product methyl 5,10-dihydroxy-7-
methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]-chromene-9-carboxylate 58 (122). 
This is the first time that a compound possessing this type of skeleton is isolated from a plant 
source. 
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Figure 2.6. 1H NMR Spectrum of Compound 58 (500 MHz, CDCl3), 
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Figure 2.7. 13C and DEPT NMR Spectra of Compound 58 (67.5 MHz, CDCl3) 
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Figure 2.8. HMBC Spectrum of Compound 58 (500 MHz, CDCl3), with a Standard 1H 
Spectrum and a Spin-echo Modulated 13C Spectrum 
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 Figure 2.9. Selective HMBC Correlations for Compound 58 
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Scheme 2.2: Main Fragmentation Patterns in the Mass Spectrum of Compound 58 
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Table 2.31. 13C and 1H NMR data (270 and 67.5 MHz, CDCl3), and observed HMBC (500 
MHz for 1H and 125 MHz for 13C) correlations for compound 58 (δ in ppm, J in Hz). 
Position δH, multiplicity, (J) δC  HMBC 
1 8.02 d (10.4) 123.37 H-2 
2 5.66 d (10.4) 127.81 H-1', H-7' 
3 - 78.95 H-1, H-2, H-1', H-2', H-7'  
4a - 140.97 H-1, OH-5 , H-6 
5 - 147.30 OH-5, H-6 
OH-5 6.05 s - - 
6 7.60 s 105.33 OH-5 
6a - 127.18 H-8 
7 - 146.96 H-6, H-8, OCH3-7 
8 6.92 s 99.59 - 
9 - 103.53 H-8, OH-10 
10 - 157.60 H-8, OH-10 
OH-10 12.26 s - - 
10a - 115.98 H-1, H-6, OH-10 
10b - 117.35 H-1, H-2 
1' 1.76-1.86 m 40.33 H-2, H-2', H-3', H-7' 
2' 2.08-2.22 m 22.78 H-1', H-3' 
3' 5.04-5.14  br t (7.1) 123.82 H-1', H-2', H-5', H-6' 
4' - 131.96 H-2', H-5', H-6' 
5' 1.57 s 17.62 H-3', H-6' 
6' 1.66 s 25.56 H-3', H-5' 
7' 1.47 s 25.61 H-1', H-2 
OCH3-7 3.91 s 55.78 - 
COOCH3-9 3.97 s 52.15 - 
COOCH3-9 - 171.98 H-8, COOCH3-9 
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II.3.1.1.2. Methyl 5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-1a,2,3,3a,10c,10d- 
                 hexahydro-1H-4-oxacyclobuta[3,4]indeno[5,6-a]naphthalene-9-carboxylate 59 
 
Preparative TLC of fraction 3:2 (Table 3.5) from the hexane extract of the roots of P. bussei 
followed by HPLC gave rise to the compound 59 (Scheme 2.3) in low yield (0.0036 % yield). 
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Scheme 2.3: Isolation of Methyl 5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-1a, 2, 3, 
3a,10c,10d-hexahydro-1H-4-oxacyclobuta[3,4]indeno[5,6-a]naphthalene- 
9-carboxylate 59 from the Roots of P. bussei. 
 
Methyl 5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-1a, 2, 3, 3a, 10c,10d-hexahydro-1H-
4-oxacyclobuta[3,4]indeno[5,6-a]naphthalene-9-carboxylate 59 was obtained as yellowish 
Pentas bussei                                                                                                                         Results and Discussion 
 74
dark crystals from hexane, mp 158.0-159.4 °C. ESIMS showed a base peak at m/z 399 
corresponding to [M+H]+. HRMS provided the exact mass at m/z 399.1736 (calcd m/z 
399.1808 [M+H]+), and therefore suggesting C23H26O6 as molecular formula which is 
accounting for 11 degrees of unsaturation. The IR spectrum showed absorption bands at 3409 
cm-1 and 1741 cm-1, assigned to the OH functions and the carbonyl group, respectively. 
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The 1H NMR and 13C NMR spectra (Figures 2.2.10-2.11, Table 2.32) of compound 59, along 
with DEPT and HETCOR spectra (Figures 2.12-2.13) showed twenty-two proton and twelve 
carbon signals in the aliphatic region corresponding to three CH3 [δH 0.54 (3H, s), δC 19.2, 
CH3-1(ß); δH 1.36 (3H, s), δC 25.6, CH3-3a; δH 1.49 (3H, s), δC 34.0, CH3-1(a)], two CH2 [δH 
1.64-1.80 (2H, m), δC 25.3, C-2, and δH 1.64-1.80/2.00-2.07 (2H, m), δC 40.6, C-3], three CH 
[δH 2.49 (1H, ddd, JH-2(1)/H-1a = 4.40, JH-1a/H-2(2) = 7.91, JH-1a/H-10d = 9.24 Hz), δC 46.7, C-1a; δH 
2.70 (1H, dd, JH-10d/H-10c = 9.57 Hz, JH-10d/H-1a = 9.24 Hz), δC 41.3, C-10d; and δH 4.57 (1H, d, 
JH-10c/H-10d = 9.57 Hz), δC 39.0, C-10c],  two OCH3 [δH 3.92 (3H, s), δC 55.8, OCH3-7; δH 3.96 
(3H, s), δC 52.1, COOCH3], and two aliphatic sp3 quaternary carbons at δC 41.8 and 85.4. The 
aromatic region showed two sp2 CH and eight sp2 quaternary carbons. In addition, an ester 
carbonyl carbon, and two OH groups, one of which is chelated (δH 12.21), were observed. 1H-
1H COSY spectrum showed the different coupling systems observed in the molecule (Figure 
2.14). HMBC analysis confirmed the proposed data attribution (Figure 2.15, Table 2.32). The 
relative stereochemistry in the alicyclic ring system was established by a DIFNOE and 
ROESY study which revealed NOE effects of 12% for H3-1(β)/H3-1(α), 9% for H3-1(α)/H-
1a, 5% for H-1a/H-10d, 11% for H-10d/H-10c, 4% for H-10c/H3-1(α), and 8% for H-10d/ H3-
3a (Figure 2.16). These results suggested an all cis configuration for H-1a, CH3-3a, H-10c, H-
10d, and CH3-1(α), and such a configuration is typical for this type of structure (123). 
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In addition, NMR data of the alicyclic system of compound 59 were fitting with those of 
eriobrucinol (123b) (Figure 2.17), although the effects of different aromatic rings may be 
accountable for the slight differences observed, particularly in the 13C NMR chemical shifts. 
The coupling systems observed therein , i.e. JH-10c/H-10d = 9.57 Hz, JH-10d/H-1a = 9.24 Hz, were 
also typical for the cyclol ring (123,124a) (Table 2.33). Highly shielded CH3 protons such as 
H3-1 resonating at δH 0.54 have been related to a puckered conformation of the cyclobutane 
ring which induces an equatorial-oriented anisotropy (124). However, shielding contributions 
from aromatic rings have also to be taken into account (125). A Dreiding model of compound 
59 showed that the CH3-1(β) is almost lying within the shielding cone of the aromatic current, 
and therefore its protons resonating at high fields. This was also supported by ROESY effects 
observed between H3-1(β)/H2-3 and which are possible if the cyclobutane and cyclopentane 
are puckered in such a way that CH3-1(ß) and CH2-3 are brought closer each other, and 
therefore CH3-1(ß) is positioned over the pyranonaphthoquinone ring. A part from the 
alicyclic system, the observed spectral data for the aromatic ring system and its substituents 
were similar to those observed for compound 58 from which it may derive through the 
cyclisation of the homoprenyl side chain. Based on all the previous data, the structure of 
compound 59 was established as methyl 5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-
1a,2,3,3a, 10c,10d-hexahydro-1H-4-oxacyclobuta[3,4]indeno[5,6-a]naphthalene-9-
carboxylate. This type of compound is structurally attached to the class of meroterpenes. To 
the best of our knowledge, no natural quinonic cyclol is yet reported in the literature. 
 
The biosynthetic pathways leading to the new naphthohydroquinone type compound  could be 
the same as proposed in the case of natural meroterpenoid coumarins (126). Biogenetic 
condensation of terpenes with natural acetate-derived phenols leads to “meroterpene” 
metabolites. “Terpenylphenols”, formed in the first instance, such as the geranylphenol 66, 
are likely starting products for elaboration in vivo, giving rise to chromenes 67 and more 
structurally complex systems such as those known generically as “citrans” 68 and “cyclols” 
69 (126) (Scheme 2.4). Compound 59 may derive, through a (2+2) concerted process, from 
the homoprenylated benzochromene 58 (122) by a light-induced mechanism (Scheme 2.5). 
However, the intramolecular cycloaddition required for the formation of cyclols from 
appropriate prenylated compounds has been induced both photochemically, but also 
thermally, and with acid catalysis (125a,127). 
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“Cyclol” units are characterised by a tricyclic terpenoid core involving a dihydropyran, a 
cyclopentane, and a cyclobutane ring. These units have already been found integrated into the 
structure of natural phenolic compound such us cannabinoids, i.e. cannabicyclol 70 
(127a,128) isolated from Cannabis sativa L. (Cannabaceae), of terpenoid alkaloids isolated 
from the Rutaceae plant Murraya koenigii Spreng, e. g., bicyclomahanimbine 71 (125a,129), 
and more recently, of eriobrucinol 72 (and its angular regioisomers 73 and 74) and 
hydroxyeriobrucinol 75, a set of coumarins isolated from another rutaceous plant, Eriostemon 
brucei F. Muell (123,130) (Figure 2.13). The common spectral features of all these 
compounds are an all cis configuration for the three aliphatic methines arising from the 
cyclisation, together with highly shielded protons belonging to one of the two methyl groups 
substituted on the cyclobutane ring. 
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Table 2.32. 1H  and 13C NMR data (270 and 67.5 MHz, CDCl3), and observed HMBC (300 
MHz for 1H and 75 MHz for 13C) correlations for compound 59 (δ in ppm, J in Hz). 
 
Position δH, multiplicity, (J) δC HMBC 
1 - 41.83 H3-1(α), H3-1(ß), H-10c, H-10d 
1a 2.49 ddd (4.40; 7.91; 9.24) 46.68 H2-3, H-10d, H-10c, H3-1(α), 
H3-1(ß) 
2 1.64–1.80 m 25.28 H2-3, H-10d 
3 1.64–1.80 m, H2-3(1) 40.59 H-10d, H-1a, H3-3a 
 2.00–2.07 m, H2-3(2)  - 
3a - 85.41 H-10c, H2-3, H3-3a 
4a - 141.51 H-10c, OH-5, H-6 
5 - 148.91 OH-5, H-6 
OH-5 6.42 s - - 
6 7.60 s 102.68 OH-5 
6a - 127.81 H-8 
7 - 146.79 H-8, OCH3-7, H-6 
8 6.93 s 99.53 - 
9 - 102.32 OH-10, H-8 
10 - 157.90 OH-10, H-8 
OH-10 12.21 s - - 
10a - 119.08 OH-10, H-6, H-10c 
10b - 123.47 H-10c 
10c 4.57 d (9.57) 38.98 H-1a, H-10d, H3-1(α), H3-1(ß) 
10d 2.70 dd (9.57; 9.24) 41.28 H2-3, H2-2, H3-1(α), H3-1(ß) 
CH3-1 (α) 1.49 s 33.95 H3-1(ß), H-10c 
CH3-1 (β) 0.54 s 19.17 H3-1(α), H-10c 
CH3-3a 1.36 s 25.55 H2-3, H-10d 
OCH3-7 3.92 s 55.78 - 
COOCH3-9 3.96 s 52.09 - 
COOCH3-9 - 172.22 COOCH3-9, H-8 
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Figure 2.10. 1H NMR Spectrum of Compound 59 (300 MHz, CDCl3) 
 
 
 
Figure 2.11. 13C NMR Spectrum of Compound 59 (75 MHz, CDCl3) 
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Figure 2.12. DEPT NMR Spectrum of Compound 59 (75 MHz, CDCl3): aliphatic region 
 
 
 
Figure 2.13. HETCOR Spectrum of Compound 59 (270 MHz, CDCl3) 
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Figure 2.14. 1H-1H COSY Spectrum of Compound 59 (270 MHz, CDCl3) 
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Figure 2.15. HMBC Spectrum of Compound 59 (300 MHz, CDCl3) 
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Figure 2.16. Major NOE Effects in the Alicyclic Moiety of Compound 59 
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Scheme 2.4: Meroterpenes: From Geranylphenols to Complex Structures 
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Scheme 2.5: Possible Biogenetic Pathway Leading to Compound 59 
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Figure 2.17. Some Examples of Natural Occurring “Cyclol” Derivatives 
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Table 2.33. Comparison of the NMR data (1H  and 13C) of the alicyclic moiety (δ (ppm), 
multiplicity, J in Hz) of compound 59 and eriobrucinol isomers 73 and 74 (ref. 123b). 
 
Compound 591 Eriobrucinol 722 
(ref. 123b) 
Eriobrucinol 
(Regioisomer A) 733 
(ref. 123b) 
Eriobrucinol 
(Regioisomer B) 744 
(ref. 123b) 
Position 1H 13C Position 1H 13C 1H 13C 1H 13C 
1 - 41.83 7’ - 39.1 - - - - 
1a 2.49 ddd 
(4.4; 7.9; 
9.2) 
46.68 6’ 2.49 t  
(7.4) 
46.5 2.49 t (7.4) - 2.31 t (7.6) - 
2 1.64-1.80 m 25.28 5’ 1.65 m and  
1.92 dt  
(12.0; 6.8) 
25.7 2.12 m - 1.90 m 
 
- 
3 1.64-1.80 
and 
2.00-2.07 m 
40.59 4’ 1.71-1.74 m 38.8 1.55 dt 
(11.8; 7.6) 
and 1.62 m 
- 1.50-1.75 m - 
3a - 85.41 3’ - 84.7 - - - - 
10c 4.57 d (9.6) 38.98 1’ 3.09 d (9.7) 35.7 3.31 d (9.5) - 3.26 d (9.4) - 
10d 2.70 dd 
(9.6; 9.2) 
41.28 2’ 2.67 dd  
(9.7; 7.4) 
37.4 2.56 dd 
(9.5, 7.6) 
- 2.60 dd (9.4; 
7.4) 
- 
Me-1(α) 1.49 s 33.95 Me-7’(α) 1.46 s 34.6 1.46 s - 1.52 s - 
Me-1(β) 0.54 s 19.17 Me-7’(β) 0.80 s 18.3 0.96 s - 0.77 s - 
Me-3a 1.36 s 25.55 Me-3’ 1.42 s 27.4 1.44 s - 1.42 s - 
NMR run at: 1 270 MHz in CDCl3, 2 400 MHz in CDCl3, 3 250 MHz in C5D5N, 4 250 MHz in CDCl3. 
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II.3.1.1.3. 7-Hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromene-8-carboxylic 
                 acid 65 
 
The fractionation of the mixture of fractions 13:4 and 13:5 (Table 2.21) from the CH2Cl2 
extract of the roots of P. bussei with MPLC-RP18 and CPC (Scheme 2.6) led to the isolation 
of compound 65. The compound is a new natural product isolated for the first time. 
 
F3 F4 F5 F6F2F1 F7
F3F2F1
F3F2F1
OH O
OH
OCH3
O
MPLC-RP18:
H2O/MeOH
Gradient
CPC:
Hex/EtOAc/MeOH/ H2O
 (1.5:1.5:1:1)
CH2Cl2 extract       
(16.65 g)
Pentas bussei
(roots, 613.83 g)
Extraction with 
CH2Cl2 (Sonication)
MPLC-RP18:
H2O/MeOH  (15:85), 
Isocratic
65
1
2
3
4
4a
5
6 6a 7
8
9
1010a10b
    
 
Scheme 2.6: Isolation of 7-Hydroxy-3,3-dimethyl-10-methoxy-3H- 
benzo[f]chromene-8-carboxylic acid 65 from the Roots of P. bussei. 
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7-Hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromene-8-carboxylic acid 65, yellow 
crystals, mp 196.7-198.0 °C. The ESI mass spectrum of compound 65 displayed the 
pseudomolecular ion peak at 301 ([M + H]+ (81%) consistent with the molecular formula 
C17H16O5. The UV spectrum displayed two intense bands at 259.1 nm (logε 4.57) and 373.9 
nm (logε 4.17). This pattern is typical for a naphthalene ring with the extension of the 
conjugation by substituents. 
 
The 1H NMR spectrum (in acetone-D6) of compound 65 displayed a relatively simple pattern 
(Figure 2.18a): two methyl groups [δH 1.46 (6H, s, 2 x CH3-3)], one methoxy group [δH 3.94 
(3H, s, OCH3-10)], two clear olefinic AX coupling systems, i.e. H-1 [δH 7.75, dd, J1 = 10.6 
Hz, J2 = 0.7 Hz]/H-2 [δH 5.70, d, J = 10.6 Hz] and H-5 [δH 7.11, dd, J1 = 8.9 Hz, J2 = 0.7 
Hz]/H-6 [δH 8.22, d, J  = 8.9 Hz], together with an additional olefinic proton at δH 7.17 (1H, s, 
H-9). Closer inspection of the 1H NMR spectrum of compound 65 performed in benzene-D6 
(Figure 2.18b) revealed the presence of two OH groups at δH 12.01 (1H, broad s, COOH-8; 
1H, broad s, OH-7). An absorption band at 3440 cm-1, together with an other large and intense 
band between 3270 and 2517 cm-1 (overlapping with the usual band of C-H) in the IR 
spectrum (Figure 2.19) are indicative of the presence of OH groups. This latter band between 
3270 and 2517 cm-1 is typical to the absorption of the OH groups of carboxylic acid dimers 
(121b). The small coupling constant (J2 = 0.7 Hz) observed between H-1/H-5 is a 
characteristic of a "zigzag" configuration which results in a 5J coupling (117,120). As a 
consequence of this coupling, the two doublets are flattened and their heights are near the half 
of their counterparts in the respective AX systems (Figure 2.18). 
 
Apart from the protonated carbons assigned with the help of DEPT and HETCOR spectra, the 
13C NMR spectrum (Figure 2.16) showed the presence of a carbonyl carbon δC 173.10 
(COOH-8), an oxygenated sp3 carbon at δC 76.01 (C-3), together with seven additional sp2 
carbon quaternary carbons (Table 2.34). An absorption band at 1648 cm-1 in the IR spectrum 
confirmed this C=O functional group, the absorption frequency of which is lessened by 
intramolecular hydrogen bond bridges (121b). The intense band at 259.1 nm observed in the 
UV spectrum can be attributed to the α,β-unsaturated carbonyl of the carboxylic acid (141). 
The values of the δC 76.01 (C-3) is within the typical chemical shift range for the sp3 Cq-O 
found in pyran rings. In addition, the "zigzag" coupling path observed between H-1 and H-5 
indicated the fusion of this pyran ring (holding the AX system H-1/H-2) with the aromatic 
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one on which is located the other AX system (H-5/H-6), in a such a way that this type of 
coupling is allowed.  
 
HMBC analysis (Figures 2.21-2.22, Table 2.34) allowed an unequivocal assignment for the 
quaternary carbons. One of the key quaternary carbons is C-10a (δC 127.66) whose 
correlations both with H-1, H-6 and H-9 located in the three different ring systems confirmed 
the arrangement proposed for the latter. Additional refinements came from the following 
observed correlations: H-2/C-10b, H-5/C-6a, H-6/C-4a, H-6/C-7, H-9/C-7 and H-9/COOH. 
 
Finally, the skeletal arrangement proposed for compound 65 was confirmed by the 
comparison of its 1H spectral data, particularly concerning the two AX coupling systems, with 
those of teretifolione B 76 (120) isolated from the Australian shrub Conospermum sp. 
(Proteaceae). The two compounds showed an identical 1H spectrum pattern in the aromatic 
region (Figure 2.23a-b). 
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Table 2.34. NMR Spectral data: 1H, 13C NMR and observed HMBC (at 300 MHz for 1H and 
100 MHz for 13C, Acetone-D6) of compound 65 (δ in ppm, J in Hz) 
Position δH*, multiplicity, (J) δC HMBC 
1 7.75 dd (10.6; 0.7) 123.46  
2 5.70 d (10.6) 128.66 2 x CH3-3 
3 - 76.01 H-1, H-2, 2 x CH3-3 
4a - 155.90 H-5, H-1, H-6 
5 7.11 dd (8.9; 0.7) 119.31  
6 8.22 d (8.9) 126.04  
6a - 122.23 H-5 
7 - 156.87 H-6, H-9 
8 - 103.30 H-9 
9 7.17 s 105.16  
10 - 150.06 H-9, OCH3-10 
10a - 127.69 H-9, H-1, H-6 
10b - 115.76 H-1, H-2, H-5 
2 x CH3-3 1.46 (each) 27.60 (each) H-2 
OCH3-10 3.94 56.15  
COOH - 173.10 H-9 
*Signals of OH-7 and COOH-8 observed around δH  12.01(spectrum run in benzene-D6) 
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Figure 2.18a. 1H NMR Spectrum of Compound 65 (400 MHz, Acetone-D6) 
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Figure 2.18b. 1H NMR Spectrum of Compound 65 (400 MHz, Benzene-D6) 
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Figure 2.19. IR Spectrum (in KBr) of Compound 65 
 
 
 
Figure 2.20. 13C NMR Spectrum of Compound 65 (100 MHz, Acetone-D6) 
(Single Pulse Decoupling Experiments) 
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Figure 2.21. HMBC Spectrum of Compound 65 (400 MHz, Acetone-D6) 
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Figure 2.22. Key HMBC Correlations for Compound 65 
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Figure 2.23a. AX Coupling Systems (1H NMR spetra) for  
Compound 65 (at 400 MHz in Acetone-D6) 
 
 
Figure 2.23b. AX Coupling Systems (1H NMR spetra) for 
Teretifolione B 76 (at 500 MHz in CDCl3, ref. 120). 
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II.3.1.1.4. 9-Methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62 
 
The fractionation of the mixture of the fractions 6:3, 6:4, 8:1 and 8:2 (Tables 2.10 and 2.13), 
both from the hexane extract of the roots of P. bussei, by MPLC on RP18 followed by further 
purification by MPLC on silica gel, gave rise to compound 62. The complete separation of 
this new benzochromene is described in Scheme 2.7. 
 
9-Methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62: White solid from 
hexane/acetone (1:1), mp 201.8-204.0 °C. A spectral pattern similar to that of compound 65 
was observed in the UV spectrum of the benzochromene 62, with maximum absorption bands 
at 255.0 nm (log ε  4.12) and 360.0 nm (log ε  3.63). These data are compatible with a 
naphthalene ring substituted with functional groups enhancing delocalisation of electrons 
(121). 
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The 1H NMR spectrum of compound 62 in CD3OD (Figure 2.24a, Table 2.35) showed the 
major features found in the benzochromene 65, especially the spectral part concerning the 
aromatic area and the methoxy group. Two AX coupling systems, i.e. H-3 [δH 5.51, d, J = 
10.2 Hz]/ H-4 [δH 7.62, d, J = 10.2 Hz] and H-5 [δH 8.07, d, J  = 8.9 Hz]/H-6 [δH 6.90, d, J = 
8.9 Hz] were observed also in compound 62. However, the zigzag coupling pattern (with 5J = 
0.7 Hz) existing between the AX systems of the benzochromene 65 are not present in 
compound 62. The methoxy (OCH3-9) protons resonate at δH 3.79, while the two methyl 
groups gave a unique singlet at δH 1.39. In addition, a singlet at δH 7.36 was assigned to H-8. 
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Scheme 2.7: Isolation of 9-Methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62 from 
the Roots of P. bussei. 
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The location of H-8, in ortho position from the OCH3 was confirmed by a DIFNOE 
experiment which showed effects of 6% on OCH3 following the irradiation of H-8 and of 5% 
on H-8, following the irradiation of the OCH3-9 protons (Figure 2.25). Although the 1H NMR 
spectrum in CD3OD did not show OH signals, the 1H spectrum run in acetone-D6 (Figure 
2.24b) displayed OH signals at δH 3.20-3.40 and 13.43, respectively. The very high value of  
δH 13.43 is consistent with an extended conjugation existing in the molecule. The presence of 
OH groups was additionally confirmed by the IR spectrum (Figure 2.26) which showed a 
particular large band at 3430 cm-1, typical to intramolecular hydrogen bond bridges of 
phenolic hydroxy groups. Besides, another large band observed at 1605 cm-1 (C=C) is 
compatible with an unsaturated, broadly conjugated system(121b). 
 
The 13C NMR spectrum (Figure 2.27, Table 2.35) showed fourteen different signals. 
Combination of 13C NMR, HETCOR and DEPT spectra allowed to unequivocally assign all 
protonated carbons. From all these spectra, it was clear that the two methyl groups are 
overlapping in the 13C NMR spectrum (δC 28.89). The OCH3-9 signal appears at δC 57.52, 
while the typical oxygenated quaternary carbon C-3 of the pyran ring resonates at δC 77.14. 
The high field position of C-8 (δC 109.56) is compatible with the double ortho substitution by 
the electron giving functional groups OH-7 and OCH3-9. In addition to the rest of the 
protonated sp2 carbons (see data in Table 2.35), in the aromatic region appeared signals of 
three non-oxygenated (=Cq) and three oxygenated (=Cq-O) quaternary carbons. 
 
HMBC analysis (Figures 2.28-2.29) brought in some additional refinements for the structural 
elucidation of compound 62, especially concerning the arrangement of the rings, together 
with the number of =Cq-O. Two observed correlations, i.e. H-3/C-4a and H-6/C-4a, were 
indicative of the fusion of the pyran and the benzene rings. Furthermore, the lack of the 
zigzag coupling relationship between the AX systems, as observed in compound 65 which is 
of the benzo[f]chromene type, helped to rule out this type of configuration, and therefore, led 
to the conclusion that the fusion of the pyran and benzene rings in compound 62 is of the 
benzo[h]chromene type. Concerning the number of =Cq-O, on the one hand, the correlation 
between OCH3-9/C-9 allowed to unequivocally assign the δC 150.92 to C-9. On the other 
hand, all the four protons H-4, H-5, H-6 and H-8 displayed correlations with =Cq-O 
resonating in lower fields (δC 156.11 and 156.63) than C-9. Closer observation allowed to 
establish the correlation of H-6 with the most deshielded of the =Cq-O (dot located in lower 
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fields than the dots corresponding to H-4, H-5 and H-8) which is evidently C-7 consequently 
assigned  with δC 156.63. As both the protons H-4, H-5 and H-8 are correlated to =Cq-O 
resonating at δC 156.11, it is unequivocally evident that this chemical shift may be attributed 
to C-10 and C-10b, the signals of which are therefore overlapping in the 13C NMR spectrum. 
 
The ESI mass spectrum of compound 62 displayed a pseudomolecular ion peak at m/z 295 
([M + Na]+, 9%), consistent with the molecular composition of C16H16O4 with an unsaturation 
index of 9. 
 
Compound 62 structurally belongs to the class of 1,4-naphthohydroquinones. Its chemistry 
may therefore be similar to that of the elementary 1,4-benzenediol or hydroquinone. It is well 
known that because they are highly conjugated, quinones are rather closely balanced (Scheme 
2.8), energetically, against the corresponding hydroquinones (131).  
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Scheme 2.8: Oxydation-Reduction Relationship Between Hydroquinone 
and p-Benzoquinone 
 
The oxidation-reduction processes leading to the interconversion lie in a series of proton and 
electron transfers and have been largely documented (132). Many properties of quinones 
result from their tendency to form the aromatic hydroquinone system, and nature makes much 
use of this type of oxidation-reduction to transport a pair of electrons from one substance to 
another in enzyme-catalyzed reactions. The hydrogen transportation function may be the 
reason why p-benzoquinones have enzymatic activity on 5-lipoxygenase to reduce the 
biosynthesis of SRS-A (slow reacting substance of anaphylaxis) which will result in treatment 
of asthma (132c, 133) or against the porcine lens aldose reductase which would be effective 
in preventing cataract formation in diabetes (134). 
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Closer inspection of the 13C NMR spectrum of the compound 62 confirmed the presence of 
the above mentioned tendency to balance between the hydroquinone and the quinone form. 
After repeated purification and spectral analysis, the spectrum of the compound always 
displayed two slight pseudo signals at δC 109-110 and 179-180, whereas a high variability of 
the shape (from sharp to flattened) was observed for the most deshielded =Cq-O (δC 156.63). 
On the one hand, the position of δC 109-110 corresponds to the chemical shift of CH-8, and 
on the other hand, δC 156.63 corresponds to C-7, whereas δC 179-180 is a suitable chemical 
shift for a conjugated ketone (such as in the case of the quinone form). Besides, when kept in 
solution, even light-protected, the compound slowly turned to a slight greenish colour. It is 
well-known that because of their high conjugation, quinones are coloured (131a). These 
findings constitute an additional argument supporting the structure proposed for compound 
62. It is the first time that a compound possessing this type of skeleton is isolated from a plant 
of the genus Pentas. 
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Table 2.35. NMR Spectral data: 1H NMR (270 MHz, CD3OD), 13C NMR (67.5 MHz, 
CD3OD) and observed HMBC (at 400 MHz for 1H and 100 MHz for 13C) 
for compound 62 (δ in ppm, J in Hz). 
 
Position δH, multiplicity, (J) δc HMBC 
2 - 77.14 H-3, H-4, 2 x CH3-2 
3 5.51 d (10.2) 129.11 2 x CH3-2 
4 7.62 d (10.2) 125.62 H-5 
4a - 116.96 H-3, H-6 
5 8.07 d (8.9) 127.26  
6 6.90 d (8.9) 119.65  
6a - 128.12 H-5, H-8 
7 - 156.63 H-6 
8 7.36 s 109.56  
9 - 150.92 OCH3-9 
OCH3-9 3.79 s 57.52  
10 - 156.11 H-8 
10a - 124.33 H-6 
10b - 156.11 H-4, H-5 
2 x CH3-2 1.39 s 28.89  
OH 3.20-3.40 - - 
OH 13.43 - - 
Signal of OH protons observed at δH 3.20-3.40 and 13.43 ppm were displayed in the spectrum 
run in acetone-D6 
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Figure 2.24a. 1H NMR Spectrum of Compound 62 (270 MHz, CD3OD) 
 
 
 
 
Figure 2.24b. 1H NMR Spectrum of Compound 62 (270 MHz, Acetone-D6) 
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Figure 2.25. Pertinent DIFNOE Effects for Compound 62 
 
 
 
 
Figure 2.26. IR Spectrum of Compound 62 (in KBr) 
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Figure 2.27. 13C NMR Spectrum of Compound 62 (270 MHz, CD3OD) 
 
 
Figure 2.28. HMBC Spectrum of Compound 62 (400 MHz , CD3OD) 
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Figure 2.29. Key HMBC Correlations for Compound 62 
 
II.3.1.1.5. 9-Methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo[h]chromene-7,10-diol 63 
 
The fractionation of the fraction 9:3 (Table 2.14) by MPLC on silica gel afforded compound 
63 which is a new naphthohydroquinone of the benzochromene type. Scheme 2.9 describes 
the complete isolation of this new naphthohydroquinone of the benzochromene type from the 
roots of P. bussei. 
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Scheme 2.9: Isolation of 9-Methoxy-2-methyl-2-(4-methyl-3-pentenyl)- 
2H-benzo[h]-chromene-7,10-diol 63 from the Roots of P. bussei. 
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9-Methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo[h]chromene-7,10-diol 63, white 
solid from hexane/acetone (1:1), mp 174.5-176.4 °C. The UV spectrum of the compound 63 
displayed exactly the same pattern as the one observed in the case of the benzochromene 62, 
showing the maximum absorption bands at 254.1 nm (log ε 4.25) and 369.0 nm (log ε 3.70). 
This pattern is consistent with a conjugated naphthalene ring (121). 
 
The IR spectrum of compound 63 (Figure 2.30) showed the typical OH absorption band 
already observed in the benzochromene 62 at 3423 cm-1 (121b). Although the general pattern 
of the spectrum is similar to that of the latter compound, the C=C absorption band of 
compound 63 appeared rather complex with maxima at 1626, 1595 and 1560 cm-1. This 
complexity is due to the presence of an additional olefinic double bond at C-3'=C-4'. 
 
The 1H NMR spectrum in CD3OD (Figure 2.31a, Table 2.36) displayed three major features 
already observed in compound 62, i.e. two AX systems, H-3 [δH 5.51, d, J = 10.4 Hz]/H-4 [δH 
7.72, d, J = 10.4 Hz] and H-5 [δH 8.08, d, J = 8.9 Hz]/H-6 [δH 6.92, d, 8.9 Hz], a singlet at δH 
7.34 (H-8) and a singlet at δH 3.82 belonging to the OCH3-9 protons. The differences with 
compound 62 originate from the observation of a total of three methyls at δH 1.37 (H3-7’), 
1.55 (H3-6’) and 1.62 (H3-5’), three methylenes at δH 1.66-1.72 (H2-1’) and 2.11-2.17 (H2-2’), 
together with a methine at δH 5.09 (H-3’). From these differences, it is evident that the 
structure of compound 63 contains a homoprenyl side chain. In addition, the 1H NMR 
spectrum in acetone-D6 (Figure 2.31b) displayed two OH signals at δH 3.60-3.80 and 13.40, 
the latter high value being an indication of a broad conjugation in the molecule. 
 
The 13C and DEPT NMR spectra (Figure 2.32, Table 2.36) confirmed the presence of the 
homoprenyl side chain, the data of which are δC 41.63 (C-1’), 23.84 (C-2’), 125.41 (C-3’), 
132.36 (C-4’), 25.88 (C-5’) and 17.70 (C-6’). The rest of the data match together in the two 
compounds 62 and 63. Thus, the differences observed between the 1H and 13C NMR data of 
the two compound are due to the homoprenyl side chain. 
 
The ESI mass spectrum of compound 63 displayed an ion peak at m/z 341 [M + H]+ (5 %). 
The molecular formula was deduced as being C21H24O4, with an unsaturation
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index of 10. 
 
In addition, the slight pseudo-signals observed in the 13C NMR spectrum of the compound 62 
and related to the hydroquinone/quinone balance, together with the tendency to turn to a 
green colour in solution, were also observed in the case of the compound 63. All these 
findings lead to the establishment of the structure of the homoprenylated benzochromene 63 
as proposed. 
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Table 2.36. 1H NMR (270 MHz, CD3OD) and 13C NMR (67.5 MHz, CD3OD) spectral data of 
compound 63 (δ in ppm, J in Hz). 
 
Position δH, multiplicity, (J) δc 
2 - 78.27 
3 5.51 d (10.2) 127.06 
4 7.62 d (10.2) 124.78 
4a - 115.56 
5 8.07 d (8.9) 126.05 
6 6.90 d (8.9) 118.36 
6a - 126.88 
7 - 155.54 
8 7.36 s 108.26 
9 - 149.74 
OCH3-9 3.79 s 56.30 
10 - 155.07 
10a - 123.05 
10b - 155.07 
1' 1.66-1.72 m 41.63 
2' 2.11-2.17 m 23.84 
3' 5.09 br t (6.9) 125.41 
4' - 132.36 
5' 1.62 s 25.88 
6' 1.55 s 17.70 
7' 1.37 s 26.04 
OH 3.60-3.80 - 
OH 13.45 - 
Signal of OH protons observed at δH 3.60-3.80 and 13.45 ppm were 
displayed in the spectrum run in acetone-D6 
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Figure 2.30. IR Spectrum of Compound 63 (in KBr) 
 
 
 
Figure 2.31a. 1H NMR Spectrum of Compound 63 (270 MHz, CD3OD) 
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Figure 2.31b. 1H NMR Spectrum of Compound 63 (270 MHz, Acetone-D6) 
 
 
 
 
Figure 2.32. 13C and DEPT NMR Spectra of Compound 63 (67.5 MHz, CD3OD) 
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Compounds 58-59, 62-63 and 65 are novel natural products isolated for the first time from a 
plant species. Since the isolation of mollugin 38 and pentalongin 39 from the root bark of P. 
longiflora (92,93), these five compounds isolated from the roots of P. bussei form a new 
series of pyranonaphthoquinone derivativatives from the plant genus Pentas. 
 
II.3.1.2. Highly Oxygenated Naphthohydroquinones 
 
The fractions 5:6 and 5:7 (Table 2.8) were mixed and fractionated by MPLC, followed, on the 
one hand, by p-TLC and HPLC, and, on the other hand, by recrystallisation in MeOH, to 
afford the two compounds 60 and 61. The complete separation of these two highly 
oxygenated naphthohydroquinones is described in Scheme 2.10. 
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Scheme 2.10: Isolation of Methyl 8-hydroxy-1,4,6,7-tetramethoxy-2-naphthoate 60 and 
Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61 from the Roots of P. bussei. 
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II.3.1.2.1. Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61 
 
Compound 61 crystallised as reddish needles from MeOH, mp 175.8-176.8 °C. The IR 
spectrum diplayed an OH absorption band at 3341 cm-1. The band of the C=O appeared at the 
frequency of 1655 cm-1, the value of which is lower than that usually observed for a normal 
ester (∼ 1740 cm-1). This low frequency is evidently due to hydrogen bond bridges between 
OH-1 and the C=O, but also to the conjugation of the latter with the ring system (121b). 
 
The 1H NMR spectrum (Figure 2.33, Table 2.37) displayed a relatively simple pattern 
consisting of four singlets of the OCH3 groups at δH 3.92, 3.95, 3.97 and 3.98 ppm, two 
singlets of aromatic protons at δH 6.92 and 7.06, and two OH protons signals at δH 9.67 and 
12.95. The low field position of the latter OH is consistent with its ortho position next to the 
methoxycarbonyl group on the ring B of the α-naphthol moiety. The value of δH 12.95 was 
therefore assigned to OH-1, and this is compatible with hydrogen bond formation evoked in 
the IR analysis. 
 
The 13C NMR (Figure 2.34, Table 2.37) and DEPT spectra showed three non-oxygenated sp2 
hybridized carbons at δC 101.79, 110.7 and 127.81ppm, respectively, together with five 
oxygenated sp2 hybridized carbons at δC 135.25, 147.13, 149.45, 155.79 and 156.04 ppm. In 
addition, the carbonyl carbon resonated at 171.71 ppm. Combination of 13C NMR, DEPT and 
HETCOR spectra allowed to assign all protonated carbons. The four methoxy groups were 
assigned as OCH3-4 [δH 3.92, s; δC 55.61], OCH3-6 [δH 3.98, s; δC 55.92], OCH3-7 [δH 3.95, s; 
δC 60.75] and COOCH3-2 [δH 3.97, s; δC 52.42], whereas, the two sp2 methine groups were 
assigned as =CH-3 [δH 6.82, s; δC 99.67] and =CH-5 [δH 7.06, s; δC 93.74]. The high-field 
positions of these methine signals in the 13C NMR spectrum is compatible with their ortho 
positions next to the methoxy groups (121b). 
 
The HMBC NMR spectrum (Figures 2.35-2.37, Table 2.37) allowed to unequivocally 
attribute all =Cq-O bearing the hydroxy and the methoxy groups by displaying the following 
the six correlations OH-1/C-1, OCH3-4/C-4, OCH3-6/C-6, OCH3-7/C-7, OH-8/C-8 and 
COOCH3-2/COOCH3-2. Figure 2.34 shows particularly and distinctly all methoxy bearing sp2 
carbons. The chemical shifts δC 101.79 and 127.81 were attributed to C-2 and C-4a, following
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the observation of the correlations OH-1/C-2 and H-3/C-4a, respectively. Besides, it was 
evident to attribute the δC 110.17 to C-8a due to the three observed correlation dots OH-1/C-
8a, H-5/C-8a and OH-8/C-8a. DIFNOE experiments (Figure 2.38) confirmed the ortho 
positions of H-3 next to OCH3-4 and H-5 next to OCH3-6. 
 
The ESI mass spectrum of compound 61 showed an ion peak at m/z 309 ([M + H]+, 8%) 
which is compatible with a molecular formula of C15H16O7. In addition, the base peak (100%) 
was displayed at m/z 277. The formation of this fragment can be explained by the expulsion 
of methanol from the ion [M + H]+ by the "ortho effect" (121b), generating the ketene ion at 
m/z 277 (Scheme 2.11). 
 
O
CH3
O
O
H
OH
H3CO
H3CO
OCH3
C
O
H3CO
H3CO
OCH3
O
OH
m/z 309 (8%)
- CH3OH
m/z 277 (100%)
+ H + H
 
 
Scheme 2.11: Formation of the Mass Spectral Fragment at m/z 277 (100%) from 
Compound 61 
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Table 2.37. 1H NMR (270 MHz, CDCl3) and 13C NMR (67.5 MHz, CDCl3) 
spectral data, with observed HMBC (at 400 MHz for 1H and 100 MHz for 13C) 
for compound 61 (δ in ppm). 
 
Position δH, multiplicity δc HMBC 
1 - 155.79 OH-1, H-3 
OH-1 12.95 s -  
2 - 101.79 OH-1 
3 6.82 s 99.67  
4 - 147.13 H-3, H-5, OCH3-4 
4a - 127.81 H-3 
5 7.06 s 93.74  
6 - 156.04 H-5, OCH3-6 
7 - 135.25 H-5, OH-8, OCH3-7 
8 - 149.45 OH-8 
OH-8 9.67 s -  
8a - 110.17 OH-1, H-5, OH-8 
COOCH3-2 3.97 s 52.42  
COOCH3-2 - 171.71 H-3, COOCH3-2 
OCH3-4 3.92 s 55.61  
OCH3-6 3.98 s 55.92  
OCH3-7 3.95 s 60.75  
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Figure 2.33. 1H NMR Spectrum of Compound 61 (270 MHz, CDCl3) 
 
 
 
Figure 2.34. 13C NMR Spectrum of Compound 61 (67.5 MHz, CDCl3) 
 
Pentas bussei                                                                                                                         Results and Discussion 
 116
 
 
Figure 2.35. HMBC Spectrum of Compound 61 (400 MHz, CDCl3): portion corresponding 
to the aromatic and low-field regions on the 1H NMR spectrum 
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Figure 2.36. HMBC spectrum of compound 61 (400 MHz, CDCl3): methoxy 
bearing sp2 carbons 
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Figure 2.37. Main HMBC correlations               Figure 2.38. DIFNOE experiments of
                    of compound 61                                                   compound 61
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II.3.1.2.2. Methyl 8-hydroxy-1,4,6,7-tetramethoxy-2-naphthoate 60 
 
Compound 60 was isolated as an amorphous reddish solid, mp 167.9-169.4 °C. The spectral 
data  of this compound were closely similar to those of compound 61. The 1H NMR spectrum 
did not show any highly deshielded OH proton, while displaying an additional OCH3 group at 
δH 4.02, in comparison with compound 61. The lack of this OH was confirmed by the IR 
spectrum which showed the C=O band at 1715 cm-1, a frequency which is higher than that 
observed for compound 61 (1655 cm-1) and perfectly compatible with the lack of OH group in 
ortho position. Such an OH may, indeed, form hydrogen bonds with the carbonyl oxygen, the 
final effect being the decreasing of the frequency of absorption of the carbonyl group (121b). 
Therefore, it is understandable that the unique difference between the two compounds lies in 
the substituent located at the 1-position and which is a methoxy group for compound 60 and a 
hydroxyl group in the case of compound 61. However, the IR spectrum of compound 60 
displayed a broad band at 3318 cm-1, typical to phenolic hydroxy groups (121b). 
 
The 13C NMR spectrum, compared to that of compound 61, confirmed the presence of an 
additional OCH3 at δC 64.56. This very high chemical shift is completely located in the low-
field part of the usual shift region (∼ 51.3 – 67.1 ppm) for the methyl group in ethers (121b). 
Such a deshielding of this methoxy carbon can be understood as an effect due to the carbonyl 
group through resonance, and can be considered as an indirect confirmation of the location of 
the methoxy group in ortho position next to the methoxycarbonyl group. 
 
In the same way, the high-field position observed for the carbonyl group (δC 165.99) can also 
be explained in terms of the shielding effect of the OCH3-1 protons via hydrogen bond 
formation with the carbonyl oxygen. All 1H and 13C NMR data of the compound 60 are listed 
in Table 2.38. 
 
From the ESI mass spectrum was deduced the molecular formula of C16H18O7 following the 
observation of an ion peak at m/z 323 corresponding to [M + H]+ (7%). The base peak (100%) 
observed at m/z 291 may derive from the ion [M + H]+ by the loss of MeOH  which is typical 
to ortho-substituted benzoates (121b). Compounds 60 and 61 are new natural products 
isolated for the first time from a plant source. 
Table 2.38. 1H NMR (270 MHz, CDCl3) and 13C NMR (67.5 MHz, CDCl3) 
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spectral data: for compound 60 (δ in ppm). 
 
Position δH, multiplicity δc 
1 - 152.36 
2 - 113.52 
3 7.11 s 103.59 
4 - 147.99 
4a - 126.56 
5 7.14 s 93.40 
6 - 155.22 
7 - 135.05 
8 - 150.62 
OH-8 9.85 s - 
8a - 115.11 
OCH3-1 4.02 s 64.56 
COOCH3-2 3.98 s 52.34 
COOCH3-2 - 165.99 
OCH3-4 3.96 s 55.81 
OCH3-6 4.00 s 55.92 
OCH3-7 3.97 s 60.81 
 
II.3.2. Anthraquinone Glycosides 
 
II.3.2.1. Rubiadin-1-methyl ether-3-O-β-primeveroside 55 
 
Fractionation of fractions 16:1 and 16:2 (Table 2.25) from the ethyl acetate extract of the 
roots of P. bussei by a couple of MPLC on RP18 afforded the anthraquinone glycoside 
rubiadin-1-methyl ether-3-O-β-primeveroside 55. Scheme 2.12 describes the complete 
isolation of compound 55 from the plant. 
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Scheme 2.12: Isolation of Rubiadin-1-methyl ether-3-O-β-primeveroside 55 
from the Roots of P. bussei. 
 
Rubiadin-1-methyl ether-3-O-β-primeveroside 55 was isolated as a yellowish solid, mp 
161-163 °C, lit. mp. 158-160 °C (116). The IR spectrum of the compound 55 displayed two 
strong and broad bands at 3342 and 1079 cm-1 indicating the presence of a carbohydrate 
moiety as already observed in various natural glycosides (116,135). In addition, an absorption 
band ascribed to an unchelated C=O was observed at 1672 cm-1. 
 
The 1H NMR spectrum in C5D5N (Figure 2.39) displayed signals for four aromatic signals in 
a symmetrical AA'BB' type pattern and one isolated aromatic proton at δH 7.56-7.70 (m), 
8.30-8.32 (m) and 8.35 (s), respectively, together with one methoxy (δH 3.97, s) and one 
Pentas bussei                                                                                                                         Results and Discussion 
 121
methyl group (δH 2.36, s). Besides, the spectrum also disclosed the presence of the 
carbohydrate moiety by showing a typical complex pattern in between δH 3.60 – 6.00 ppm, 
together with two clearly separated anomeric protons at δH 4.93 (d, J = 6.3 Hz, H-1") and δH 
5.84 (d, J = 6.3 Hz, H-1'). The 13C NMR (Figure 2.40) and HETCOR NMR spectra (in 
DMSO-d6) showed a pair of two carbonyl signals at δC 180.52 and 182.19 which are typical 
of anthraquinones, two sp2 Cq-O (δC 159.78 and 160.0), together with signals ascribed to the 
already observed (in the 1H NMR spectrum) CH3 and OCH3 groups at δC 9.22 and 60.77, 
respectively. Furthermore, the 13C NMR and DEPT NMR spectra confirmed the disaccharide 
nature of the sugar moiety which is composed of a hexose and a pentose by displaying eleven 
signals, nine of which range in between 65 – 77 ppm, whereas two methylenes (δC 65.52 and 
67.92) and two anomeric carbons (δC 100.18 and 103.93) were also observed. 
 
The δC 100.18 ppm ascribed to C-1' is typical of an anomeric carbon bonded to a O-aglycone 
in a phenolic glycoside (136). The δC 103.93 of C-1' is indicative of a primary alcoholic β-D-
glucopyranoside (137) and is also in agreement with the observed δH-1" 4.93 ppm which 
strongly suggested that C-1" is linked to an alcoholic oxygen rather a phenolic one, i.e. δH-1'  
5.84 ppm (116). Comparison of the sugar carbon resonances with published data revealed that 
the signal at δC 67.92 assigned to C-6' of glucose was downfield shifted by 7 ppm from that of 
methyl-β-D-glucose (138). Thus, the terminal xylosyl moiety should be attached to the 
glucosyl part at C-6' through (1→6)-β-linkage. Moreover, the diaxial coupling constant 
observed for the two anomeric protons H-1' and H-1", i.e. J = 6.3 Hz is consistent with a β-
configuration of the anomeric linkages (135). From all the previous spectral observations and 
from the comparison of the observed data with those available in the literature (139), the 
sugar moiety was deduced as being the primeverosyl or xylopyranosyl-(1→6)-O-β-
glucopyranosyl moiety. 
 
Partial acid hydrolysis in an HCl atmosphere on TLC (140) of the anthraquinone glycoside 
(see Chapter I. Materials and Methods) readily liberates the xylose residue and glucose 
residue thereafter, therefore suggesting compound 55 to be an O-glycoside between the 
anthraquinone and the glucosyl moiety, and confirming the terminal position for xylose in the 
sugar moiety sequence. The presence of both glucose (Rf 0.4) and xylose (Rf 0.6) residues in 
the hydrolysate was monitored by comparison of their Rf with reference samples. 
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The four aromatic protons in a symmetrical AA'BB' type pattern, the isolated aromatic proton, 
the CH3, OCH3 and primeverosyl substituents observed in the 1H NMR spectrum, together 
with the presence of the two C=O and the two =Cq-O in the 13C NMR spectrum, all these data 
were compatible with rubiadin-1-methyl ether-3-O-β-primeveroside as structure of compound 
55. 
 
The aglycone rubiadin-1-methyl ether (Rf 0.8) was also released in the acidic hydrolysate and 
confirmed by comparison of its Rf with the one of a reference sample. The possible reversion 
of substituents at C-1 and C-3 was ruled out by the 13C NMR chemical shift of the OCH3 (δC 
60.77 ppm, i.e. over 60 ppm) which is in agreement with an ortho,ortho-disubstituted 
arrangement (116), whereas the CH3 was placed in position 2 on biogenetic grounds 
(27,71,141). The ESI mass spectrum of compound 55 displayed peaks at m/z 563 (18%) and 
585 (57%) corresponding to [M + H]+ and [M + Na]+, respectively, and from which was 
deduced the molecular formula of C27H30O13. 
 
The spectral data of the isolated compound 55 are in full agreement with those available in 
the literature (112,116), confirming the structure proposed for the compound as mentioned 
above (Table 2.39). Rubiadin-1-methyl ether-3-O-β-primeveroside has previously been 
isolated from another Pentas species, i.e. P. zanzibarica (112). 
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Table 2.39. Comparison of NMR data of rubiadin-1-methyl ether-3-O-β-primeveroside 
55 (1H, 270 MHz, C5D5N; 13C, 67.5 MHz, DMSO-d6; this work) with data from 
the literature (1H/13C, 400 MHz/100 MHz, DMSO-d6; ref. 112): δ (ppm), J (Hz). 
Position This work ref. 112 
 1H* 13C 1H* 13C 
1 - 159.78a - 160.0a 
2 - 128.84 - 129.2 
3 - 160.00a - 160.2a 
4 8.35 s 108.10 7.69 s 108.4 
4a - 132.00b - 132.2b 
5 8.30-8.32 m 126.16c 8.15 dd (2,8) 126.3c 
6 7.56-7.70 m 133.55d 7.89 dd (8, 8) 133.7d 
7 7.56-7.70 m 134.53d 7.89 dd (8, 8) 134.7d 
8 8.30-8.32 m 126.59c 8.15 dd (2, 8) 126.8c 
8a - 133.80b - 134.0b 
9 - 180.52e - 180.2e 
9a - 120.05 - 120.3 
10 - 182.19e - 182.4e 
10a - 134.19b - 134.4b 
CH3-2 2.36 s 9.22 2.27 s 9.4 
OCH3-1 3.97 s 60.77 3.83 s 61.0 
1' 5.84 d (6.3) 100.18 5.15 d (7.5) 100.4 
2'  73.06  73.3 
3'  76.01f  76.3f 
4'  69.04g  69.4g 
5'  75.56f  75.8f 
6'  67.92  68.2 
1" 4.93 d (6.3) 103.93 4.12 d (7.5) 104.1 
2"  73.21  73.4 
3"  76.30f  76.5f 
4"  69.38g  69.6g 
5"  65.52  65.7 
a-g Assignments may be reversed in the same column 
* For the sugar moiety, only the anomeric δH values are shown 
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Figure 2.39. 1H NMR Spectrum of Compound 55 (270 MHz, C5D5N) 
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Figure 2.40. 13C NMR Spectrum of Compound 55 (67.5 MHz, DMSO-d6) 
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II.3.2.2. Lucidin-3-O-β-primeveroside 56 
 
The CPC fractionation of the methanol extract of the roots of P. bussei followed by a MPLC 
fractionation of fraction 18:2 (Table 2.28) led to the isolation of lucidin-3-O-β-primeveroside 
56 (fraction 19:4 of Table 2.30) as described on the Scheme 2.13. 
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Scheme 2.13: Isolation of Lucidin-3-O-β-primeveroside 56 
from the Roots of P. bussei. 
 
Lucidin-3-O-β-primeveroside 56 was isolated as an orange red solid, mp 206.5-208.3 °C, lit. 
mp 208-210 °C (116). The UV spectrum of this compound displayed an absorption band at 
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247.0 nm which is typical to anthraquinones (121a). The IR spectrum showed absorptions 
band of an unchelated C=O and a chelated one at 1677 and 1635 cm-1, respectively. The 
presence of these bands is consistent with a quinone nature of the compound. Two broad 
bands ascribed to the sugar moiety at 3399 and  1079 cm-1 were also observed. 
 
The 1H, 13C and 2D NMR data of compound 56 disclosed the presence of a primeverosyl 
moiety, the data of which were compared to and found matching with those observed in 
rubiadin-1-methyl ether-3-O-β-primeveroside 55. The anomeric shifts were observed at δH 
4.90-4.94 (1H, br d, J = 6.3 Hz, H-1")/δC 103.97 (C-1") and δH 5.75 (1H, d, J = 6.6 Hz, H-1')/
δC 100.66 (C-1'). Partial hydrolysis (see Chapter 1. Materials and Methods) in an HCl 
atmosphere on TLC (140) confirmed the release of xylose and glucose, the two 
monosaccharides constituting primeverose. The same pattern as in compound 55 was also 
observed for 56 in the 1H NMR spectrum regarding the aromatic protons, i.e. four protons in a 
symmetrical AA'BB' type pattern and one isolated aromatic proton at δH 7.50-7.72 (m), 8.20-
8.34 (m) and 8.16 (s), respectively. 
 
     
HO
HO
OH
O
O
O
OH
HO
HO
O
HOH2C
OH
O
O
     4'' 5''
3''
2'' 1'' 6'
5'
4'
3'
2'
1'
4a
9a
10a
8a
10
9
8
7
6
54
3
2
1
56
 
 
However, compared to NMR spectral data of the anthraquinone glycoside 55, compound 56 
displayed two major distinct features. On one hand its 1H NMR spectrum showed an AB 
coupling systems ascribed to the two protons of the hydroxymethyl group in 2-position at δH 
5.17-5.25 and 5.34-5.41 (2H, d, J = 11.5 Hz, each). The δH of the CH2OH-2 was observed at 
51.36 ppm. On the other hand, the 13C NMR spectrum displayed a large ∆δC value of 5.41 
ppm between the two carbonyl carbons (∆δC 1.67 for 55), and this difference in chemical shift 
is consistent with hydrogen bonding (already observed in the IR) between the oxygen of one 
of the carbonyl (C-9) and a peri-hydroxyl proton. Consequently, the OH group must be 
located at the 1-position. No methoxy or methyl group was observed in the spectra of 56. 
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The four aromatic protons in a symmetrical AA'BB' type pattern and the isolated one 
indicated that one aromatic ring in the anthraquinone was unsubstituted, whereas the other 
was trisubstituted. Therefore, this is compatible with the location of the OH, the 
hydroxymethyl and the O-primeverosyl substituents on the same aromatic ring with proton H-
4 resonating at δH 8.16 (s)/δC 106.19. 
 
The possibility of locating the primeverosyl moiety on the CH2OH was ruled out by two 
major reasons, namely 1) the CH2O should have shifted (up to 60 ppm) to lower field, 2) the 
anomeric carbon C-1' (δC 100.66), thus linked to a primary alcohol should have shifted (i.e. to 
104 ppm) to lower field (154), whereas the anomeric proton H-1' (δH 5.75) should have 
shifted to higher field (∼ 4.70-4.90 ppm) (116). 
 
The ESI mass spectrum of compound 56 displayed an ion peak at at m/z 547 (22 %) which 
may correspond to the fragment [M + H - H2O]+. The molecular formula was deduced as 
C26H28O14. 
 
Based on all the above spectral data, compound 56 was elucidated as being the known 
lucidin-3-O-β-primeveroside. The assigned structure was in full agreement (Table 2.40) with 
data found in the literature (112,116). The anthraquinone glycoside has also been isolated 
from Pentas zanzibarica (112) and from other Rubiaceae species (138a,142). 
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Table 2.40. Comparison of NMR data of lucidin-3-O-β-primeveroside 56 (1H, 270 MHz, 
C5D5N; 13C, 67.5 MHz, DMSO-d6; this work) with data from the literature 
(1H/13C, 400 MHz/100 MHz, DMSO-d6; ref. 112): δ (ppm), J (Hz). 
Position This work ref. 112 
 1H* 13C 1H* 13C 
1 - 160.90a - 161.8a 
2 - 123.68 - 123.7 
3 - 161.50a - 162.0a 
4 8.16 s 106.19 7.40 s 106.5 
4a - 132.81b - 132.6b 
5 8.20-8.34 m 126.45c 8.12 dd (2,8) 126.4c 
6 7.50-7.72 m 134.52d 7.88 dd (8, 8) 134.6d 
7 7.50-7.72 m 134.68d 7.88 dd (8, 8) 134.7d 
8 8.20-8.34 m 126.81c 8.12 dd (2,8) 126.8c 
8a - 133.00b - 132.8b 
9 - 187.11 - 186.9 
9a - 111.23 - 111.3 
10 - 181.70 - 181.3 
10a - 133.74b - 133.7b 
CH2OH-2 5.17-5.25 d (11.5) 
5.34-5.41 d (11.5) 
51.36 4.55 and 4.62 d (12) 51.0 
1' 5.75 d (6.6) 100.66 5.11 d (7.5) 100.9 
2'  73.19  73.3 
3'  75.81e  75.9e 
4'  69.40f  69.5f 
5'  76.30e  76.4e 
6'  67.92  68.0 
1" 4.90-4.94 br d (6.3) 103.97 4.14 d (7.5) 104.0 
2"  73.19  73.3 
3"  75.56e  75.8e 
4"  69.04f  69.3f 
5"  65.53  65.6 
a-g Assignments may be reversed in the same column 
* For the sugar moiety, only the anomeric δH values are shown 
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II.3.2.3. Damnacanthol-3-O-β-primeveroside 57 
 
The fractionation of fraction 18:2 (Table 2.28) by MPLC-RP18 additionally led to the 
isolation (Scheme 2.14) of the anthraquinone glycoside damnacanthol-3-O-β-primeveroside 
57 (fraction 19:3 of Table 2.30). 
 
MeOH extract    
   (31.27 g)
Pentas bussei
(roots, 613.83 g)
Extraction with
 MeOH (Sonication)
MPLC-RP18:
H2O/MeOH,
Gradient
F3 F4 F5F2F1
CPC:
EtOAc/1-BuOH/H2O
(2:1:3)
F3 F4F2F1
O
O
HOH2C
OOHO
HO
8
7
6
5
10a
10
4a
4
3
2
1 9a
9
6'
3'
1'
1''
5''
57
OH
8a
O
OHO
HO OH
O
H3C
 
Scheme 2.14: Isolation of Damnacanthol-3-O-β-primeveroside 57 
from the Roots of P. bussei. 
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Damnacanthol-3-O-β-primeveroside 57 was isolated as a yellow solid, mp 138.4-140.6 °C, 
lit. mp 140-142 °C (112). The UV spectrum of the compound displayed the typical absorption 
band of an anthraquinone at 246.0 nm (121a). In addition to the broad bands ascribed to the 
OH and the carbinyl carbon (C-O) groups of the sugar moiety at 3391 and 1069 cm-1, 
respectively, the IR spectrum showed an unchelated C=O band at 1673 cm-1. This lack of 
hydrogen bonding is consistent with the presence of a substituent other than a hydroxy group 
at 1-position. 
 
As for the anthraquinone glycosides 55 and 56, the 1H, 13C and 2D NMR spectra disclosed the 
presence of the primeverosyl residue, the anomeric data of which were observed at δH 4.90-
4.94 (1H, d, J = 6.3 Hz, H-1'')/δC 103.95 (C-1'') and δH 5.77 (1H, d, J = 6.6 Hz, H-1')/δC 
100.77 (C-1'). Partial acid hydrolysis (see Chapter 1. Materials and Methods) in an HCl 
atmosphere on TLC (140) confirmed the presence of the two components of primeverose, i.e. 
xylose and glucose. The methoxy group was observed at δH 4.17 (3H, s, OCH3-1)/δC 62.66. 
These low field shifts, both in 1H and 13C NMR, are compatible with the peri location of the 
OCH3 from the oxygen of the carbonyl in 9 position. Moreover, the low ∆δC between the two 
carbonyl carbons (1.74 ppm) is in agreement with this configuration. In addition, as the 
anthraquinone 56, spectra of 57 displayed signals ascribed to the hydroxymethyl group with 
its typical AB coupling system at δH 5.15-5.19 and 5.22-5.28 (2H, d, J = 11.2 Hz, each), 
whereas its δC was observed at 51.84 ppm. The latter low value indicated that the alcohol is 
not glycosylated (116). The aromatic protons displayed the pattern observed in the case of 
compounds 55 and 56, i.e. four protons in a symmetrical AA'BB' type pattern and one isolated 
aromatic proton at δH 7.22-7.67 (m), 8.26-8.34 (m) and 8.42 (s), respectively, although 
differences in δH were observed, specially for H-4, due to the nature of the substituents.   
 
The ESI mass spectrum of the compound displayed an ion peak at m/z 283 (7%) which may 
derive from the molecular ion (not seen) through the loss of the primeverosyl moiety. 
Therefore, the molecular formula C27H30O14 was deduced for the compound. 
 
All these spectral findings led to the elucidation of the compound as being damnacanthol-3-
O-β-primeveroside 56. The structure is in full agreement with data observed in the literature 
(Table 2.41) which show that the compound was isolated for the first time from Pentas  
zanzibarica (112). 
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Table 2.41. Comparison of NMR data of damnacanthol-3-O-β-primeveroside 57 (1H, 
270 MHz, C5D5N; 13C, 67.5 MHz, DMSO-d6; this work) with data from the 
literature (1H/13C, 400 MHz/100 MHz, DMSO-d6; ref. 112): δ (ppm), J (Hz). 
Position This work ref. 112 
 1H* 13C 1H* 13C 
1 - 160.59 - 160.7a 
2 - 131.46 - 131.6 
3 - 160.59 - 160.8a 
4 8.42 s 108.98 7.71 s 109.2 
4a - 131.91a - 132.0b 
5 8.26-8.34 m 126.22b 8.14 dd (2,8) 126.2c 
6 7.22-7.67 m 133.58c 7.88 dd (8, 8) 133.6d 
7 7.22-7.67 m 134.64c 7.88 dd (8, 8) 134.8d 
8 8.26-8.34 m 126.63b 8.14 dd (2,8) 126.7c 
8a - 134.21a - 134.4b 
9 - 180.34d - 180.5e 
9a - 120.37 - 120.4 
10 - 182.08d - 182.2e 
10a - 135.63a - 135.8b 
OCH3-1 4.17 s 62.66 3.87 s 62.8 
CH2OH-2 5.12-5.17 d (11.2) 
5.22-5.28 d (11.2) 
51.84 4.60 d (12) 52.0 
1' 5.77 d (6.6) 100.77 5.10 d (7.5) 101.0 
2'  73.15  73.4 
3'  75.76e  75.8f 
4'  69.42f  69.6g 
5'  76.30e  76.4f 
6'  67.92  68.0 
1" 4.90-4.92 br d (6.3) 103.95 4.15 d (7.5) 104.4 
2"  73.22  73.4 
3"  75.60e  75.7f 
4"  69.07f  69.2g 
5"  65.53  65.6 
a-g Assignments may be reversed in the same column 
* For the sugar moiety, only the anomeric δH values are shown 
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II.3.3. Steroidal Compound: β-Stigmasterol 64 
 
The application of MPLC-Si on the fractions 1:16-1:19 (Table 2.2) followed by preparative 
TLC gave rise to the steroid (24S)-24-ethylcholesta-5-(E)-22-dien-3β-ol (β-stigmasterol) 64. 
Scheme 2.15 describes the isolation of compound 64 from the hexane extract of the roots of 
P. bussei. 
 
F3 F4 F5 F6 F8 F9 F10 F12F13 F15 F17F18F19F20F21F22F2F1 F7 F11 F14 F16 F23F24F25F26
F1 F2 F3 F4 F5
Hexane extract     
  (7.52 g)
Pentas bussei
(roots, 613.83 g)
Extraction with
hexane (Sonication)
MPLC-Si:
Hex/CH2Cl2,
Gradient
p-TLC
Hex/Acetone
(3:2)
MPLC-Si:
Hex/EtOAc,
Isocratic
HO
H
64
1
3
5
6
14
12
19
18
21
17
20
9
26
27
22
23
10
 
Scheme 2.15: Isolation of (24S)-24-Ethylcholesta-5-(E)-22-dien-3β-ol (β-Stigmasterol) 64 
from the Roots of P. bussei 
 
(24S)-24-Ethylcholesta-5-(E)-22-dien-3β-ol (β-stigmasterol) 64: White solid (from hexane), 
mp 164.0-165.9 °C, lit. mp 164.2-166.0 °C (115). The IR spectrum of compound 64 showed 
the free OH group at 3406 cm-1. The EI mass spectrum displayed a molecular ion peak M+ at 
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m/z 412 (3%) which is compatible with the molecular composition of C29H48O with an 
unsaturation index of 6. 
 
The 1H NMR spectrum disclosed two signals which are typical of steroidal compounds at δH 
3.46-3.61 (1H, m, H-3) ascribed to the proton of the methine bearing the OH group, and at δH 
5.35-5.38 (1H, m, H-6) attributed to the olefinic proton in the ring B. In addition, a particular 
AB coupling system with a ∆ν of 62.7 Hz was observed at 4.96-5.18 (2H, qd, 2J = 15.2 Hz, 3J 
= 8.7 Hz and 8.4 Hz, H-22 and H-23) and was consistent with the presence of an olefinic unit 
CH=CH in the side chain. 
 
Combined analysis of the 1H, the DEPT and the HETCOR NMR spectra indicated the 
presence of three methyl groups having their protons resonating as doublet at δH 0.77 (3H, d, 
J = 6.4 Hz, CH3), 0.84 (3H, d, J = 6.2 Hz, CH3) and δH 1.04 (3H, d, J = 6.8 Hz, CH3), together 
with another one with protons resonating as triplet at δH 0.81 (3H, d, J = 6.4 Hz, CH3). 
Furthermore, the 13C NMR and DEPT NMR spectra displayed signals for six methyl groups, 
nine sp3 methylene groups, eight sp3 methine groups, three sp2 methine groups, two sp3 
quaternary carbons and one sp2 quaternary carbon. 
 
Comparison of all the above mentioned data with those of various steroidal compounds (143) 
led to the identification of the compound as (24S)-24-ethylcholesta-5-(E)-22-dien-3β-ol (β-
stigmasterol) 64. The spectral data of compound 64 are well matching (Tables 2.42 - 2.43) 
with those found in the literature (111,115). 
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Table 2.42. Comparison of characteristic 1H NMR data of β-stigmasterol 64 
(270 MHz, CDCl3; this work) with literature data (400 MHz, CDCl3; ref. 111) 
 This work δ (ppm) ref. 111 
δ (ppm) Proton, mult., J δ (ppm) Proton, mult., J 
0.68 3H, s, CH3 0.69 3H, s, CH3 
0.77 3H, d, J = 6.4,  CH3 0.79 3H, d, J = 6.5,  CH3 
0.81 3H, t, J = 7.0,  CH3 0.80 3H, t, J = 7.5,  CH3 
0.84 3H, d, J = 6.2,  CH3 0.84 3H, d, J = 6.5,  CH3 
1.01 3H, s, CH3 1.01 3H, s, CH3 
1.04 3H, d, J = 6.8,  CH3 1.02 3H, d, J = 6.5,  CH3 
3.46-3.61 1H, m, HO-CH-3 3.52 1H, m, HO-CH-3 
4.96-5.18 2H, AB qd, 
∆ν = 62.7 Hz 
2J = 15.2 Hz 
3J = 8.7 Hz,  8.4 Hz, 
H-22 and H-23 
5.01 and 5.15 2H, AB qd, 
∆ν = 65 Hz 
2J = 15 Hz 
3J = 9 Hz,  9 Hz 
H-22 and H-23 
5.35-5.38 1H, m, H-6 5.35 1H, m, H-6 
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Table 2.43. Comparison of 13C NMR data of β-stigmasterol 64 (67.5 MHz, 
CDCl3; this work) with literature data (100 MHz, CDCl3; ref. 111): δ (ppm) 
Carbon This work ref. 111 
CH3-18 12.04 12.0 
CH3-29 12.26 12.3 
CH-27 19.03 19.0 
CH3-19 19.41 19.4 
CH2-11 21.08 21.1 
CH3-26 21.08 21.1 
CH2-21 21.22 21.2 
CH2-15 24.37 24.4 
CH3-28 25.41 25.4 
CH2-16 28.93 28.9 
CH2-2 31.66 31.6 
CH2-7 31.89 31.9 
CH-8 31.89 31.9 
CH2-25 31.89 31.9 
Cq-10 36.51 36.5 
CH2-1 37.25 37.2 
CH2-12 39.68 39.7 
CH-20 40.50 40.5 
Cq-13 42.21 42.2 
CH2-4 42.32 42.3 
CH-9 50.15 50.1 
CH-24 51.23 51.2 
CH-17 55.94 55.9 
CH-14 56.85 56.8 
HO-CH-3 71.82 71.8 
=CH-6 121.72 121.7 
=CH-23 129.27 129.2 
=CH-22 138.33 138.3 
=Cq-5 140.75 140.7 
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Chapter III. STUDY OF THE ROOTS OF PENTAS LANCEOLATA 
 
III.1. Introduction 
 
Pentas lanceolata (Forsk.) Deflers is an erect branched shrub or woody herb of about 0.5-1.3 
m high, with ovate-lanceolate leaves and mauve to white flowers in corymbs. Inflorescence 
with terminal and axillary components combined into a single cluster. Flowers often 
trimorphic, either with style exserted and anthers included, anthers exserted and style 
included or both. This very variable species is widespread in forest edges. There are two main 
population types, one that is dimorphic in its corolla tube length (as well as in the stamen and 
style length) and the other which is not. Occasionally these two may be found together. In 
Kenya where it was collected, the plant is mainly found in highlands (69,144). The plant also 
has an ornamental usage. No previous phytochemical study of these species is found in the 
literature. P. suswaensis Verdc. and P. zanzibarica (Klotzch) Vatke are two other species 
from the same genus and which are reported to be botanically similar to P. lanceolata (144). 
 
 
Figure 3.1. Pentas lanceolata (Forsk.) Deflers 
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III.2. Experimental 
 
III.2.1. Extraction and Purification 
 
III.2.1.1. Extraction 
 
The ground dried roots of the plant (643.25 g) were extracted exhaustively (x 3) with n-
hexane, dichloromethane (CH2Cl2), ethyl acetate (EtOAc) and methanol (MeOH), 
respectively. A volume of 0.75 litres of each solvent was used for each extraction. The 
solvent was removed and the sample dried before the extraction with a new solvent started. 
Extraction was executed in a sonication bath at room temperature. The filtration and the 
concentration of the extracts under reduced pressure with a rotavapor at 40 °C yielded a 
yellowish n-hexane residue (1.34 g, 0.21 % yield), a yellow CH2Cl2 residue (4.09 g, 0.64 % 
yield), a yellow EtOAc residue (6.87 g, 1.07 % yield), and a yellow red MeOH residue (76.46 
g, 11.89 % yield). 
 
III.2.1.2. Study of the Hexane Extract of the Roots of Pentas lanceolata 
 
The n-hexane extract (1.34 g, 0.21 % yield) was submitted to MPLC on silica using an n-
hexane/EtOAc/MeOH gradient (Table 3.1) to give 7 different fractions (Table 3.2) monitored 
by TLC. The MPLC conditions  were: 2 coupled columns 460 x 49 mm i.d. (columns 
coupling aimed at the improvement of separation by increasing length); precolumn, 140 x 10 
mm i.d.; sample adsorbed on 9.5 g of silica gel and packed in a 230 x 36 mm i.d. sample 
column; flow rate 40 ml/min at a back pressure < 40 bar; detection, LSD; collection 50 
seconds per fraction.  
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Table 3.1. Programme for fractionation of the n-hexane extract of the roots of P. 
lanceolata on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane-EtOAc 100:0 100:0 ---- 5 
n-Hexane-EtOAc 90:10 90:10 ---- 10 
n-Hexane-EtOAc 80:20 0:100 10% 180 
EtOAc- MeOH 95:5 95:5 ---- 10 
 
Table 3.2. MPLC fractionation of the n-hexane extract of the roots of P. lanceolata. 
Fraction Eluent number Weight (mg) 
1:1 1-19 299.5 
1:2 22-30 220.9 
1:3 31-39 80.6 
1:4 40-61 281.2 
1:5 62-75 30.0 
1:6 76-162 246.3 
1:7 163-246 157.6 
 
III.2.1.2.1. Isolation of (24S)-24-Ethylcholesta-5-(E)-22-dien-3β-ol (β-Stigmasterol) 64 
 
Fraction 1:4 (281.2 mg, 0.044 % yield) was recrystallized in n-hexane (2% acetone) to yield a 
white solid. The  compound was  identified as  of (24S)-24-ethylcholesta-5-(E)-22-dien-3β-ol  
(β-stigmasterol) according to the spectra and physical data analysis. The latter were totally 
identical to those obtained for the same compound isolated from P. bussei. 
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(24S)-24-Ethylcholesta-5-(E)-22-dien-3β-ol (β-stigmasterol) 64. White solid (from 
hexane); mp 164.1-166.0 °C, lit. mp 164.2-166.0 °C (115). The compound displayed spectral 
data (IR, 1H and 13C, MS) similar to those observed in the case of the sample isolated from P. 
bussei (see Chapter II). 
 
III.2.1.3. Study of the Dichloromethane Extract of the Roots of Pentas lanceolata 
 
The dichloromethane extract (4.09 g, 0.64 % yield) was chromathographed on reversed phase 
MPLC under a gradient mode (Table 3.3). The eluates were combined together into 5 
fractions (Table 3.4), the result of their monitoring by TLC with H2O/MeOH (2:3). MPLC 
conditions were: column 460 x 70 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 
15 g of RP18 and packed in a 230 x 36 mm i.d. sample column; flow rate, 30 ml/min at a back 
pressure < 40 bar; detection, LSD; collection, 80 seconds per fraction. 
 
Table 3.3. Programme for fractionation of the dichloromethane extract of the roots 
of Pentas lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 40:60 0:100 10% 120 
 
Table 3.4. MPLC fractionation of the dichloromethane extract of the roots of 
P. lanceolata. 
Fraction Eluent number Weight (mg) 
2:1 27-33 200.1 
2:2 38-42 166.1 
2:3 45-56 415.2 
2:4 59-78 295.0 
2:5 79-113 62.6 
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III.2.1.3.1. Isolation of Damnacanthol 77 
 
Fraction 2:2 (166.1 mg, 0.026 % yield) was submitted to reversed phase MPLC under a 
gradient mode (Table 3:5) to yield 3 different fractions (Table 3:6). Eluates were monitored 
by TLC on RP18 plates and eluted with H2O/MeOH (5:5). MPLC conditions were: 2 coupled 
columns, 460 x 26 mm i.d. and 230 x 26 mm i.d.; precolumn, 140 x 10 mm i.d.; sample 
adsorbed on 1 g of RP18 and packed in a 230 x 26 mm i.d. sample column; flow rate, 60 
ml/min at a back pressure < 40 bar; detection, LSD; collection, 40 seconds per fraction. 
 
Table 3.5. Programme for fractionation of fraction 2:2 from the roots of Pentas 
lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 40:60 0:100 10% 60 
 
Table 3.6. MPLC fractionation of fraction 2:2 from the roots of P. lanceolata. 
Fraction Eluent number Weight (mg) 
3:1 47-58 73.5 
3:2 59-65 30.1 
3:3 66-90 42.9 
 
Fraction 3:1 was dried by solvent removal under reduced pressure to yield a yellow solid 
(73.5 mg, 0.011 % yield). Based on its spectral and physical data, the compound was 
identified as damnacanthol (3-hydroxy-2-hydroxymethyl-1-methoxy-9,10-anthraquinone) 77. 
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Damnacanthol (3-hydroxy-2-hydroxymethyl-1-methoxy-9,10-anthraquinone) 77: Yellow 
solid ; mp 284.8-287.1 °C, lit. mp 286-288 °C (145); UV (EtOH) λmax (log ε) 239.0 (3.39), 
249.0 (3.30), 280.0 (3.42), 392.0 (2.70), 374.0 (2.68), 420.0 (2.45), 442.0 (2.40), 447.0 (2.39) 
nm; IR νmax (KBr) 3308 (OH groups), 2939, 1673, 1651, 1567, 1425, 1339, 1282, 1119, 1069, 
969, 715, 612 cm-1; 1H NMR (270 MHz, DMSO-d6) δ (ppm) 8.09-8.17 (2H, m, H-5 and H-8), 
7.84-7.90 (2H, m, H-6 and H-7), 7.49 (1H, s, H-4), 4.57 (2H, s, CH2OH-2), 3.86 (3H, s, 
OCH3-1) ; 13C NMR (67.5 MHz, DMSO-d6) δ (ppm) 182.58 (C-10), 179.82 (C-9), 162.75 (C-
3), 161.54 (C-1), 135.27 (C-10a), 134.52 (C-7), 134.52 (C-8a), 133.26 (C-6), 131.95 (C-4a), 
128.70 (C-2), 126.87 (C-8), 126.02 (C-5), 117.41 (C-9a), 109.93 (C-4), 62.26 (OCH3-1), 52.4 
(CH2OH-2) ; ESIMS m/z (rel. int.) 307 [M + Na]+ (80), 285 [M + H]+ (45), 267 [M-H2O + 
H]+ (100). 
 
III.2.1.3.2. Isolation of Rubiadin-1-methyl ether 36 
 
Fraction 2:3 (415.2 mg, 0.065 % yield) was rechromatographed by reversed phase MPLC 
under a gradient mode (Table 3.7). Eluates obtained were combined into 4 fractions (Table 
3.8), based on their TLC monitoring on RP18 plates eluted with H2O/MeOH (3:7). MPLC 
conditions were: 2 coupled columns: 460 x 26 mm i.d. and 230 x 26 mm i.d.; precolumn, 140 
x 10 mm i.d.; sample adsorbed on 3 g of RP18 and packed in a 230 x 26 mm i.d. sample 
column; flow rate, 45 ml/min at a back pressure < 40 bar; detection, LSD; collection, 15 
seconds per fraction. 
 
Table 3.7. Programme for fractionation of fraction 2:3 from the roots of P. lanceolata  
on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 30:70 0:100 10% 40 
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Table 3.8. MPLC fractionation of fraction 2:3 from the roots of P. lanceolata. 
Fraction Eluent number Weight (mg) 
4:1 1-53 58.9 
4:2 54-86 92.5 
4:3 87-145 55.0 
4:4 146-160 38.5 
 
Evaporation of the solvent to dryness from fraction 4:2 afforded a yellow solid. The spectral 
data of the compound, together with its physical data, allowed to identify it as the known 
rubiadin-1-methyl ether (3-hydroxy-1-methoxy-2-methyl-9,10-anthraquinone) 36 (86-
87,112). 
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Rubiadin-1-methyl ether (3-hydroxy-1-methoxy-2-methyl-9,10-anthraquinone) 36: 
Yellow crystals; mp 289.3-291.2 °C, lit. mp 292-294 °C (146a); UV (EtOH) λmax (log ε) 239.9 
(3.44), 250.0 (3.31), 280.0 (3.60), 313.9 (2.87), 317.1 (2.87), 350.0 (2.84), 353.0 (2.84), 355.0 
(2.84), 360.0 (2.84), 374.0 (2.81), 413.0 (2.56) nm; IR νmax (KBr) 3304 (OH), 2978, 1673 
(C=O), 1651 (C=O), 1567, 1449, 1411, 1338, 1277, 1223, 1121, 1068, 981, 885, 757, 712 cm-
1; 1H NMR (270 MHz, DMSO-d6) δ (ppm) 8.08-8.16 (2H, m, H-5 and H-8), 7.83-7.92 (2H, 
m, H-6 and H-7), 7.50 (1H, s, H-4), 3.79 (3H, s, OCH3-1), 2.16 (3H, s, CH3-2); 13C NMR 
(67.5 MHz, DMSO-d6) δ (ppm) 182.51 (C-10), 180.10 (C-9), 161.60 (C-3), 160.50 (C-1), 
134.43 (C-10a), 134.37 (C-7), 133.60 (C-8a), 133.26 (C-6), 131.93 (C-4a), 126.54 (C-8), 
126.09 (C-2), 125.93 (C-5), 117.75 (C-9a), 108.91 (C-4), 60.48 (OCH3-1), 8.93 (CH3-2); 
EIMS m/z (rel. int.) 268 [M]+ (6), 232 (3), 194 (72), 162 (85), 131 (100), 121 (37), 91 (49), 77 
(10), 55 (8), 40 (9). 
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III.2.1.3.3. Isolation of Rubiadin 53 
 
Fraction 2:4 (295.0 mg, 0.046 % yield) was submitted to a normal phase MPLC separation 
under a gradient mode (Table 3.9) and the following MPLC conditions: 2 coupled columns 
460 x 36 mm i.d. and 230 x 36 mm i.d.; precolumn 140 x 10 mm i.d.; sample adsorbed on 2 g 
of silica gel and packed in 230 x 26 mm i.d. sample column; flow rate, 35 ml/min at a back 
pressure < 40 bar; detection, LSD, collection, 30 seconds per fraction. The eluates were 
monitored by TLC on silica gel plates eluting with n-hexane/EtOAc (4:1) and combined into 
2 fractions (Table 3.10). 
 
Table 3.9. Programme for fractionation of fraction 2:4 from the roots of 
P. lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane/EtOAc 80:20 50:50 10% 90 
 
Table 3.10. MPLC fractionation of fraction 2:4 from the roots of P. lanceolata. 
Fraction Eluent number Weight (mg) 
5:1 1-88 60.7 
5:2 89-184 113.4 
 
After solvent evaporation to dryness, fraction 5:2 afforded a yellow solid (113.4 mg, 0.018 % 
yield) which was identified as the known rubiadin (1,3-dihydroxy-2-methyl-9,10-
anthraquinone) 53 (112). 
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Rubiadin (1,3-dihydroxy-2-methyl-9,10-anthraquinone) 53 : Yellow solid; mp 299.8-
301.4 °C, lit. mp 300 °C (147); UV (EtOH) λmax (log ε) 239.9 (3.37), 244.9 (3.36), 280.0 
(3.37), 357.0 (2.83), 362.0 (2.83), 374.0 (2.86), 391.1 (2.87), 413.0 (2.89), 420.0 (2.89) nm; 
IR νmax (KBr) 3392 (OH groups), 2915, 1661 (C=O, unchelated), 1624 (C=O, chelated), 
1589, 1433, 1339, 1312, 1122, 866, 829, 806, 745, 711, 639, 595 cm-1; 1H NMR (270 MHz, 
DMSO-d6) δ (ppm) 13.09 (1H, s, OH-1), 8.10-8.18 (2H, m, H-5 and H-8), 7.89 (2H, m, H-6 
and H-7), 7.22 (1H, s, H-4), 2.05 (3H, s, CH3-2); 13C NMR (67.5 MHz, DMSO-d6) δ (ppm) 
186.00 (C-9), 181.65 (C-10) ; 162.80 (C-3), 162.31 (C-1), 134.39 (C-7), 134.28 (C-6), 132.83 
(C-8a), 132.70 (C-10a), 131.52 (C-4a), 126.54 (C-8), 126.20 (C-5), 117.21 (C-2), 108.73 (C-
9a), 107.28 (C-4), 7.94 (CH3-2) ; ESIMS m/z (rel. Int.) 255 [M + H]+ (42), 205 (27), 171 (40), 
149 (100), 117 (40). 
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Figure 3.2. Natural Products Isolated from the Dichloromethane Extract of 
the Roots of P. lanceolata 
 
III.2.1.4. Study of the Ethyl Acetate Extract of the Roots of Pentas lanceolata 
 
The ethyl acetate extract (6.87 g, 1.07 % yield) of the roots of P. lanceolata was subjected to 
a reversed phase MPLC separation under a gradient mode elution (Table 3.11) to afford four 
different fractions (Table 3.12) after combination of the eluates. The MPLC conditions were: 
Column, 460 x 36 mm i.d.; precolumn 140 x 10 mm i.d.; sample adsorbed on 30 g of RP18 
(divided into 2 equal parts) and each part packed in 230 x 36 mm i.d. sample column; flow 
rate, 48 ml/min at a back pressure < 40 bar; detection, LSD, collection, 25 seconds per 
fraction. The combination of eluates was based on the TLC monitoring on RP18 plates using 
H2O/MeOH (1:1) as eluent. 
Table 3.11. Programme for fractionation of the ethyl acetate extract of the roots of P. 
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lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 50:50 0:100 10% 75 
 
Table 3.12. MPLC fractionation of the ethyl acetate extract of the roots of P. lanceolata. 
Fraction Eluent number Weight (mg) 
6:1 1-6 42.9 
6:2 9-20 498.6 
6:3 22-62 2756.4 
6:4 63-180 2903.2 
 
Fraction 6:4 (2903.2 mg, 0.45 % yield) was rechromatographed by MPLC on reversed phase 
under a short gradient mode elution (Table 3.13) and the following conditions: 2 coupled 
columns 460 x 26 mm i.d.; sample adsorbed on 13 g of RP18 and packed in a 230 x 36 mm 
i.d. sample column; flow rate, 50 ml/min at a back pressure < 40 bar; detection, LSD, 
collection, 30 seconds per fraction. The eluates were monitored by TLC on RP18 plates 
utilizing H2O/MeOH (2:3) as eluent and combined into 4 fractions (Table 3.14). 
 
Table 3.13. Programme for fractionation of fraction 6:4 of P. lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 40:60 20:80 10% 105 
 
Table 3.14. MPLC fractionation of fraction 6:4 of  P. lanceolata. 
Fraction Eluent number Weight (mg) 
7:1 9-17 190.2 
7:2 25-35 286.4 
7:3 36-93 938.3 
7:4 94-210 1475.9 
 
Fractions 6:3 (Table 3.12) and 7:3 were mixed together (3694.7 mg, 0.57 % yield) and 
submitted to a MPLC separation on normal phase under a gradient mode elution (Table 3.15) 
and the following separation conditions: 2 coupled columns 460 x 49 mm i.d. and 230 x 49 
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mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 20 g of silica gel and packed in a 
230 x 36 mm i.d. sample column; flow rate 45 ml/min at a back pressure < 40 bar; detection, 
LSD, collection, 50 seconds per fraction. After monitoring by TLC on silica gel plates 
utilizing n-hexane/EtOAc (1:4) as eluent the eluates were combined into 7 fractions (Table 
3.16). 
Table 3.15. Programme for fractionation of fraction 6:3 and 7:3 of P. lanceolata  
on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane/EtOAc 80:20 40:60 10% 150 
n-Hexane/EtOAc 40:60 0:100 20% 40 
EtOAc/MeOH 100:0 90:10 5% 30 
EtOAc/MeOH 90:10 50:50 10% 80 
 
Table 3.16. MPLC fractionation of fraction 6:3 and 7:3 of  P. lanceolata. 
Fraction Eluent number Weight (mg) 
8:1 79-116 56.2 
8:2 117-136 84.5 
8:3 137-197 434.1 
8:4 198-252 375.6 
8:5 253-280 114.0 
8:6 281-306 350.5 
8:7 307-364 745.1 
 
III.2.1.4.1. Isolation of 1,3-Dihydroxy-2-methoxymethyl-9,10-anthraquinone (Lucidin-ω-
methyl ether) 78 
 
Fraction 8:7 (745.1 mg, 0.12 % yield) was submitted to a further MPLC separation on normal 
phase and under a gradient mode elution (Table 3.17). TLC monitoring on silica gel plates 
utilizing n-hexane/EtOAc (7:3) as eluent and combination of the eluates resulted in 9 different 
fractions listed in Table 3.18. The MPLC conditions were: 2 coupled columns 460 x 49 mm 
i.d. and 230 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 4 g of silica gel 
and packed in a 230 x 26 mm i.d. sample column; flow rate, 48 ml/min at a back pressure < 
40 bar; detection, LSD, collection, 28 seconds per fraction. 
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Fraction 9:8 (Table 3.18) was further purified by preparative TLC (p-TLC) eluting with n-
hexane/EtOAc (7:3). The sample was dissolved in 5 ml of EtOAc/EtOH (1:1) before its 
application to 3 p-TLC plates. 
 
Table 3.17. Programme for fractionation of fraction 8:7 of P. lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane/EtOAc 100:0 50:50 10% 120 
 
Table 3.18. MPLC fractionation of fraction 8:7 of  P. lanceolata. 
Fraction Eluent number Weight (mg) 
9:1 1-35 49.0 
9:2 36-59 15.6 
9:3 60-81 22.7 
9:4 82-103 115.3 
9:5 104-123 50.9 
9:6 124-135 8.7 
9:7 136-161 15.4 
9:8 162-224 43.2 
9:9 225-262 72.5 
 
After the development of the plates, the spot of Rf = 0.43 was scraped off and the compound 
extracted from silica gel with EtOAc. Solvent removal under reduced pressure yielded an 
amorphous yellow compound which was identified as 1,3-dihydroxy-2-methoxymethyl-9,10-
anthraquinone (lucidin-ω-methyl ether) 78, based on its spectral and physical data. 
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1,3-Dihydroxy-2-methoxymethyl-9,10-anthraquinone (lucidin-ω-methyl ether) 78: 
Amorphous yellow powder; mp 169.8-172.4 °C, lit. mp 170 °C (148); UV (EtOH) λmax (log ε) 
242.0 (4.67), 246.0 (4.67), 280.0 (4.65), 420.0 (3.89); IR νmax (KBr) 3393 (OH) 3196 (OH), 
2925, 2851, 1673 (unchelated C=O), 1626 (chelated C=O), 1592, 1475, 1405, 1368, 1334, 
1275 (C-O-C), 1159, 1130, 1099, 936, 874, 788, 746, 710, 620 cm-1; 1H NMR (270 MHz, 
CDCl3) δ (ppm) 13.31 (1H, s, OH-1), 9.43 (1H, s, OH-3), 8.25-8.29 (2H, m, H-5 and H-8), 
7.77-7.79 (2H, m, H-6 and H-7), 7.32 (1H, s, H-4), 4.94 (2H, s, CH2OCH3-2), 3.58 (3H, s, 
CH2OCH3-2); 13C NMR (67.5 MHz, CDCl3) δ (ppm) 186.88 (C-9), 182.23 (C-10), 164.08 (C-
3), 161.88 (C-1), 134.12 (C-6), 134.12 (C-7), 134.12 (C-4a), 133.51 (C-10a), 132.43 (C-8a), 
127.35 (C-8), 126.70 (C-5), 114.37 (C-2), 109.74 (C-4), 109.63 (C-9a), 68.89 (CH2OCH3-2), 
59.35 (CH2OCH3-2); ESIMS m/z (rel. int.) 307 [M + Na]+ (14), 275 (14), 253 (100). 
 
III.2.1.4.2. Isolation of Damnacanthol-3-O-methyl ether 79 
 
Fraction 7:2 (286.4 mg, 0.044 % yield) (Table 3.14) was submitted to a MPLC separation on 
RP18 phase under a short gradient elution (Table 3.19). The MPLC conditions were: 2 
coupled columns 460 x 26 mm i.d.; precolumn 140 x 10 mm i.d.; sample adsorbed on 2 g of 
RP18 and packed in a 230 x 26 mm i.d. sample column; flow rate, 40 ml/mn at a back 
pressure < 40 bar; detection, LSD; collection, 50 seconds per fraction. Based on the TLC 
monitoring on RP18 plates utilizing H2O/MeOH (35:65), the eluates were combined into 3 
different fractions (Table 3.20). 
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Table 3.19. Programme for fractionation of fraction 7:2 of P. lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 40:60 30:70 5% 45 
 
Table 3.20. MPLC fractionation of fraction 7:2 of  P. lanceolata. 
Fraction Eluent number Weight (mg) 
10:1 1-12 47.1 
10:2 13-21 97.2 
10:3 27-55 89.8 
 
Fraction 10:3 and 8:6 (Table 3.16) were combined (440.3 mg, 0.068 % yield) and repurified 
by an isocratic elution MPLC separation on reversed phase (RP18). Chromatographic 
conditions were: 2 coupled column 460 x 26 mm i.d.; precolumn, 140 x 10 mm i.d.; sample 
adsorbed on 3 g of RP18 and packed in a 230 x 26 mm i.d. sample column; flow rate 30 
ml/min at a back pressure < 40 bar; detection, LSD; collection, 80 seconds per fraction; 
eluting solvent system, H2O/CH3CN (30:70); elution time, 240 min. Eluates 23-49 were put 
together. Solvent elimination by evaporation under reduced pressure gave rise to a yellow 
solid. The compound was identified as being the known anthraquinone 1,3-dimethoxy-2-
hydroxymethyl-9,10-anthraquinone (damnacanthol-3-O-methyl ether) 79. 
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1,3-Dimethoxy-2-hydroxymethyl-9,10-anthraquinone (damnacanthol-3-O-methyl ether) 
79: Amorphous yellow powder; mp 173.8-175.2 °C, lit. mp 173.5-174.0 °C (149); UV 
(EtOH) λmax (log ε) 259.0 (4.09), 271.0 (4.12), 276.0 (4.13), 360.1 (3.77), 361.9 (3.77), 370.0 
(3.76), 374.0 (3.75), 420.0 (3.62), 442.0 (3.60), 446.9 (3.59) nm; IR νmax (KBr) 3445 (OH), 
2927, 2855, 1673 (C=O), 1650 (C=O), 1568, 1282, 1100, 970, 804, 715, 577 cm-1; 1H NMR 
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(270 MHz, C5D5N) δ (ppm) 8.27-8.42 (2H, m, H-5 and H-8), 7.99 (1H, s, H-4), 7.63-7.71 
(2H, m, H-6 and H-7), 5.37 (2H, s, CH2OH-2), 4.23 (3H, s, OCH3-1), 3.62 (3H, s, OCH3-3); 
13C NMR (67.5 MHz, C5D5N) δ (ppm) 183.37 (C-9), 180.86 (C-10), 163.99 (C-3), 162.46 (C-
1), 135.02 (C-10a), 134.86 (C-7), 134.46 (C-8a), 133.21 (C-6), 133.10 (C-4a), 129.97 (C-2), 
127.29 (C-8), 126.59 (C-5), 118.96 (C-9a), 110.94 (C-4), 62.82 (OCH3-1), 54.73 (CH2OH-2), 
49.68 (OCH3-3); ESIMS m/z (rel. int.) 285 (36), 267 (100). 
 
In addition, further purification of fractions 7:4 (Table 3.14) and 8:3 (Table 3.16) gave rise to 
rubiadin-1-methyl ether 36 and rubiadin 53 already isolated from the dichloromethane extract 
of the roots of the plant (vide supra). 
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Figure 3.3. Natural Products Isolated from the Ethyl Acetate Extract of the 
Roots of P. lanceolata 
 
III.2.1.5. Study of the Methanol Extract of the Roots of Pentas lanceolata 
 
A sample amount of 3260.3 mg (4.26 % of the total extract) from the methanol extract of the 
roots of P. lanceolata (76.46 g, 11.89 % yield) was submitted to CPC using EtOAc/n-
BuOH/H2O (2:1:3) as solvent system. The separation conditions were: column 320 ml x 3; 
elution mode, head to tail, the upper phase used as the stationary phase and the lower phase as 
mobile phase; flow rate 3 ml/min with a pressure ∼ 70 psi; revolution speed, 1080 rpm; 
equilibrium volume 248 ml; sample loop 15 ml; detection, UV 254 nm and 280 nm; sample 
collection, 2 min per fraction; push out at 300 min with a flow rate of 7 ml/min dissolved into 
42 ml of a mixture of the upper and the lower phase (1:1), divided into 3 equal parts 
partitioned separately. Based on the TLC monitoring on RP18 plates, developed with 
H2O/MeOH (1:1), the eluates were combined into 6 fractions (Table 3.21). 
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Table 3.21. CPC fractionation of the Methanol extract of the roots of P. lanceolata 
Fraction Eluate Number Weight (mg) 
11:1 34-45 1921.1 
11:2 46-53 77.2 
11:3 54-72 110.6 
11:4 74-95 174.4 
11:5 110-134 84.0 
11:6 135-156 325.1 
 
III.2.1.5.1. Isolation of Rubiadin-1-methyl ether-3-O-β-primeveroside 55 
 
Fraction 11:4 (174.4 mg, 0.027 % yield) was submitted to a reversed phase MPLC separation 
under a gradient elution mode (Table 3.22) and under the following conditions: column, 460 x 
26 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed on 2 g of RP18 and packed in a 
230 x 26 mm i.d. sample column; flow rate 30 ml/min at a back pressure of < 40 bar; 
detection LSD; collection, 80 seconds per fraction. The eluates were monitored by TLC on 
RP18 plates developed in H2O/MeOH (2:3) and combined into 4 different fractions (Table 
3.23). 
 
Table 3.22. Programme for fractionation of fraction 11:4 from P. lanceolata on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 50:50 50:50 --- 20 
H2O/MeOH 40:60 0:100 20% 30 
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Table 3.23. MPLC fractionation of fraction 11:4 from  P. lanceolata. 
Fraction Eluent number Weight (mg) 
12:1 1-15 5.3 
12:2 16-23 12.9 
12:3 25-31 137.8 
12:4 32-43 8.1 
 
Solvent removal from fraction 12:3 under reduced pressure afforded a yellowish solid (137.8 
mg, 0.021 % yield) which was identified as rubiadin-1-methyl ether-3-O-β-primeveroside 55, 
according to its spectral and physical data. This compound has already been isolated from 
another species of the same plant genus, P. zanzibarica (112). 
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Rubiadin-1-methyl ether 3-O-ß-primeveroside 55: mp 160.7 – 162.5 °C, lit. mp 158-160 
°C (116); [α]22D = -90 ° (c 0.1, H2O). The anthraquinone glycoside displayed both the UV, the 
IR, the NMR (1H, 13C, 2D) and the mass spectral data which were similar to those observed 
for the sample isolated from P. bussei (see Chapter II). 
 
In addition, MPLC fractionation of fraction 11:6 (Table 3.21) gave rise to rubiadin-1-methyl 
ether 36 and rubiadin 53 already isolated from the dichloromethane and the EtOAc extracts. 
Also lucidin-ω-methyl ether 78, already isolated from the EtOAc extract of the same plant, 
was isolated from P. lanceolata. 
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Figure 3.4. Natural Products Isolated from the Methanol Extract of the  
Roots of P. lanceolata 
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III.3. Results and Discussion 
 
The fractionation by various chromatographic methods of the dichloromethane, the ethyl 
acetate and the methanol extracts of the roots of P. lanceolata resulted in the isolation of the 
five anthraquinones rubiadin-1-methyl ether 36, rubiadin 53, damnacanthol 77, lucidin-ω-
methyl ether 78 and damnacanthol-3-methyl ether 79, together with the anthraquinone 
glycoside rubiadin-1-methyl ether-3-O-β-primeveroside 55.The hexane extract also afforded 
the steroid β-stigmasterol 64. 
 
III.3.1. Anthraquinones 
 
III.3.1.1. Rubiadin-1-methyl ether 36 
 
The MPLC fractionation of the fraction 2:3 (Table 3.4) from the dichloromethane extract 
afforded the anthraquinone rubiadin-1-methyl ether 36. Scheme 3.1 describes the isolation of 
the compound from the plant sample. 
 
Rubiadin-1-methyl ether (3-Hydroxy-1-methoxy-2-methyl-9,10-anthraquinone) 36: 
Yellow crystals; mp 289.3-291.2 °C, lit. mp 292-294 °C (146a). The IR spectrum of 
compound 36 displayed an absorption band of a phenolic hydroxy group at 3304 cm-1. The 
spectrum also showed bands of the carbonyl groups at 1673 and 1651 cm-1, respectively. 
 
The 1H NMR spectrum of the compound in DMSO-d6 displayed signals of a methyl group at 
δH 3.79 (3H, s, OCH3-1), whereas a singlet at δH 7.50 (1H, s, H-4) and an AA'BB' coupling 
system of four protons at δH 7.83-7.92 (2H, m, H-5 and H-8) were observed in the aromatic 
region. The latter system indicated that all the substituents were on one aryl ring. The 13C 
NMR spectrum showed sixteen signals from which those of the two carbonyl carbons at δC 
180.10 and 182.51 ppm. In addition, two =Cq-O signals were observed at δC 160.50 and 
161.60 ppm, whereas the methoxy carbon resonated at δC 60.48 (OCH3-1). Such a high δC 
value for the methoxy carbon is consistent with its peri location (1-position) from the 
carbonyl in 9-position, as observed in several compounds with the same configuration (135). 
Based on biogenetic grounds, the methyl group may be located in the 2-position (27,71,141). 
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The EI mass spectrum of the compound displayed an ion peak at m/z 268 (6%) which is 
consistent with the molecular formula of C16H12O4. 
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Scheme 3.1: Isolation of Rubiadin-1-methyl ether 36 
From the Roots of P. lanceolata 
 
Based on all the above spectral data, the compound was identified as rubiadin-1-methyl ether 
(3-hydroxy-1-methoxy-2-methyl-9,10-anthraquinone) 36. The assigned structure was 
confirmed by comparison (Table 3.24) of its spectral data with those observed in the literature 
(112). The compound has also been isolated from Pentas zanzibarica (112) and from various 
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other Rubiaceae plant species (146). 
 
Table 3.24. Comparison of NMR data of rubiadin-1-methyl ether 36 (1H, 270 MHz; 
13C, 67.5 MHz; DMSO-d6; this work) with data from the literature 
(1H/13C, 400 MHz/100 MHz, DMSO-d6; ref. 112): δ (ppm). 
 This work ref. 112 
Position 1H 13C 1H 13C 
1 - 160.50a - 160.4a 
2 - 126.09 - 126.0 
3 - 161.60a - 161.5a 
4 7.50 s 108.91 7.56 s 109.1 
4a - 131.93b - 131.9b 
5 8.08-8.16 m 125.93c 8.07 dd (2,8) 125.6c 
6 7.83-7.92 m 133.26d 7.80 dd (8, 8) 133.1d 
7 7.83-7.92 m 134.37d 7.80 dd (8, 8) 134.3d 
8 8.08-8.16 m 126.54c 8.07 dd (2,8) 126.3c 
8a - 133.60b - 133.6b 
9 - 180.10e - 180.1e 
9a - 117..75 - 117.7 
10 - 182.51e - 182.4e 
10a - 134.43b - 134.4b 
OCH3-1 3.79 s 60.48 3.86 s 60.3 
CH3-2 2.16 s 8.93 2.20  s 8.6 
a-e Assignments may be reversed in the same column 
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III.3.1.2. Rubiadin 53 
 
The application of a normal phase MPLC on the fraction 2:4 (Table 3.4) of the 
dichloromethane extract of the roots of Pentas lanceolata afforded the anthraquinone rubiadin 
(1,3-dihydroxy-2-methyl-9,10-anthraquinone) 53 as shown in Scheme 3.2. 
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Scheme 3.2: Isolation of Rubiadin (1,3-Dihydroxy-2-methyl-9,10- 
anthraquinone) 53 from the Roots of P. lanceolata 
 
Rubiadin (1,3-Dihydroxy-2-methyl-9,10-anthraquinone) 53: Yellow solid; mp 299.8-301.4 
°C, lit. mp 300 °C (147). The UV spectrum of the compound displayed a pattern 
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characterisitic of an anthraquinone with two absorption bands at 244.9, 280.0 and 413.0 nm 
(121a). The IR spectrum showed an absorption band of phenolic hydroxy groups at 3392 cm-
1, together with both non-hydrogen and hydrogen bonded carbonyl groups at 1661 and 1623 
cm-1, respectively. 
 
The 1H NMR spectrum of the compound displayed a low-field OH proton signal at δH 13.09 
ppm, whereas the 13C NMR spectrum showed that the chemical shifts of the two carbonyl 
carbons were largely separated at δC 181.65 (C-10) and δC 186.00 ppm (C-9) with a ∆δC value 
of 4.35 ppm. Therefore, a hydroxy group is unequivocally located in the peri position from 
carbonyl in 9-position, and this is consistent with the chelation observed in the IR spectrum. 
In addition, the NMR spectra (1H NMR, 13C NMR and HETCOR) showed one methyl at δH 
2.05 (1H, s, CH3-2)/ δC 7.94 (CH3-2), a =CH at δH 7.2 (1H, s, H-4)/ δC 107.28 (C-4), together 
with two =Cq-O at δC 162.31 and 162.80 ppm. The 1H NMR and COSY NMR spectra 
particularly disclosed a four protons AA'BB' coupling system at δH 7.89 (2H, m, H-6 and H-7) 
and 8.18 (2H, m, H-5 and H-8), which is consistent with the location of the aromatic proton 
H-4, the two hydroxy groups and the methyl group on one aryl ring. Comparison of 
compound 36 and compound 53 showed that, apart from the presence of the OH-1 in 53 
(OCH3-1 in 36) which consequently brought in hydrogen bonding, the spectral data of the two 
compounds were closely related. 
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The ESI mass spectrum of compound 53 displayed a pseudomolecular ion peak at m/z 255 
(42%) corresponding to the ion [M + H]+ and from which was deduced the molecular formula 
C15H10O4. 
 
From all the above presented data, the structure of the compound was elucidated as being the 
known anthraquinone rubiadin (1,3-dihydroxy-2-methyl-9,10-anthraquinone) 53. The spectral 
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data observed for the compound are in full agreement (Table 3.25) with those available in the 
literature (112,147). The compound has already been isolated from another Pentas species, 
i.e. P. zanzibarica (112) and from other plant species from the Rubiaceae (146a-b,147). 
 
Table 3.25. Comparison of NMR data of rubiadin 53 (1H, 270 MHz; 13C, 67.5 MHz; 
DMSO-d6; this work) with data from the literature (1H, 270 MHz, DMSO-d6, 
ref. 147; 13C, 100 MHz, CD3OD, ref. 112): δ (ppm). 
 This work Literature 
Position 1H 13C 1H (ref. 147) 13C (ref. 112) 
1 - 162.31a - 162.4a 
2 - 117.21 - 121.2 
3 - 162.80a - 162.8a 
4 7.22 s 107.28 7.20 s 107.3 
4a - 131.52b - 131.6b 
5 8.10-8.18 m 126.20c 8.10 m 126.2c 
6 7.89 m 134.28d 7.82 m 134.3d 
7 7.89 m 134.39d 7.82 m 134.4d 
8 8.10-8.18 m 126.54c 8.10 m 126.6c 
8a - 132.83b - 132.9b 
9 - 186.00 - 186.1 
9a - 108.73 - 108.8 
10 - 181.65 - 181.7 
10a - 132.70b - 132.8b 
OH-1 13.09 s - 12.90 s - 
CH3-2 2.05 s 7.94 2.05 s 7.9 
OH-3  - 10.02 s - 
a-d Assignments may be reversed in the same column 
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III.3.1.3. Damnacanthol 77 
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Fraction 2:2 (Table 3.4) was subjected to a reversed phase MPLC to afford the anthraquinone 
damnacanthol (3-hydroxy-2-hydroxymethyl-1-methoxy-9,10-anthraquinone) 77. Scheme 3.3 
describes the complete isolation of the compound from the roots of P. lanceolata. 
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H2O/MeOH,
Gradient
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Scheme 3.3: Isolation of Damnacanthol (3-hydroxy-2-hydroxymethyl-1- 
methoxy-9,10-anthraquinone) 77 from the Roots of P. lanceolata 
 
 
Damnacanthol (3-hydroxy-2-hydroxymethyl-1-methoxy-9,10-anthraquinone) 77: Yellow 
solid, mp 284.8-287.1 °C, lit. mp (synthetic compound) 286-288 °C (146). The UV spectrum 
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of the compound was compatible with an anthraquinone structure by showing absorption 
bands at 239.0, 249.0 and 280.0 nm (121a). The IR spectrum showed absorption bands of OH 
groups at 3308 cm-1, together with bands ascribed to carbonyl groups at 1673 and 1651 cm-1. 
 
From combined analysis of the 1H, 13C and the HETCOR NMR spectra were disclosed the 
methoxy group at δH 3.86 (3H, s, OCH3-1)/δC 62.26 (OCH3-1) and the hydroxymethylene 
group at δH 4.57 (2H, s, CH2OH-2)/δC 52.4 (CH2OH-2) and a sp2 CH at δH 7.49 (1H, s, H-4)/δ
C 109.93 (C-4). The low-field δC value (62.26 ppm) of the OCH3-1 is compatible with its 
location at 1-position, a peri location from the carbonyl group in 9-position (135). 
Furthermore, no influence of the hydrogen bond was observed, neither in the IR spectrum, nor 
in the 13C NMR δC values of the two carbonyl carbons (∆δC 2.76 ppm). 
 
The 1H and COSY NMR spectra showed a four proton AA'BB' coupling system 
corresponding to the four adjacent aryl protons. The 13C NMR spectrum showed sixteen 
signals. Two carbonyl carbons were observed at δC 179.82 and 182.58 ppm, whereas two  
=Cq-O resonated at δC 161.54 and 162.75 ppm, respectively. It is obvious that the isolated 
aromatic proton is located on the trisubstituted ring. The ESI mass spectrum displayed ions at 
m/z 307 (80%), 285 (45%) and 267 (100%), corresponding to the fragments [M + Na]+, [M + 
H]+ and [M – H2O + H]+, respectively. From this pattern was deduced a molecular formula of 
C16H12O5 for the compound. 
 
The above spectral data, together with literature search led to the identification of the 
compound as damnacanthol (3-hydroxy-2-hydroxymethyl-1-methoxy-9,10-anthraquinone) 
77. Although the compound has been isolated from various plants and particularly from 
several Rubiaceae species (146a,150), this is the first time it is isolated from a plant species of 
the Pentas genus. However, its 3-O-β-primeverosyl glycoside has been isolated from P. 
zanzibarica (112) and from P. bussei (see Chapter II of this work). 
 
About its spectral characterization, only the 1H NMR data (in acetone-D6) of the synthesised 
product are reported in the literature (146). Here in this work, the 13C NMR data of the natural 
compound 77 are reported for the first time. Table 3.26 provides a comparison of the 1H NMR 
data of the isolated compound with those of the synthesised compound (145) (Table 3.26a), 
and of the 13C NMR data of the isolated compound with those of the aglycone of the 
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corresponding damnacanthol-3-O-β-primeveroside 57 (112). The relatively large δH 
difference observed for the OCH3-1 proton (Table 3.26a) may be due to a solvent effect. The 
upfield shift of C-2 and C-9a in damnacanthol 77 comparatively to damnacanthol-3-O-β-
primeveroside 57 (Table 3.26b) is easily explained by the shielding effect of the free OH-3 on 
the ortho and para carbons, as already observed in such a case (116). Obviously, in the 13C 
NMR spectrum, C-3 shifts to downfield in 77 relative to 57. All the rest of the 13C NMR data 
of damnacanthol 77 are compatible with those observed for the aglycone moiety of 
damnacanthol-3-O-β-primeveroside 57. 
 
Table 3.26a. Comparison of the 1H NMR data of the isolated damnacanthol 77 (270 
MHz, DMSO-d6; this work) with those of the synthetised compound (100 
MHz, DMSO-d6; ref. 145) 
Proton This work 
δ (ppm) 
ref. 145 
δ (ppm) 
H-4 7.49 7.41 
H-5 8.09-8.17 8.26 
H-6 7.84-7.90 7.95 
H-7 7.84-7.90 7.95 
H-8 8.09-8.17 8.26 
OCH3-1 3.86 4.16 
CH2OH-2 4.57 4.67 
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Table 3.26b. Comparison of the 13C NMR data of the isolated damnacanthol 77 
(67.5 MHz, DMSO-d6; this work) with data of the aglycone moiety of 
damnacanthol-3-O-β-primeveroside 57 (100 MHz, DMSO-d6; ref. 112) 
This work ref. 112 (aglycone) 
Carbon δC (ppm) Carbon δC (ppm) 
1 161.54a 1 160.7a 
2 128.70 2 131.6 
3 (=C-OH) 162.75a 3 (=C-O-prim.)* 160.8a 
4 109.93 4 109.2 
4a 131.95b 4a 132.0b 
5 126.02c 5 126.2c 
6 133.26d 6 133.6d 
7 134.52d 7 134.8d 
8 126.87c 8 126.7c 
8a 134.52b 8a 134.4b 
9 179.82e 9 180.5e 
9a 117.41 9a 120.4 
10 182.58e 10 182.2e 
10a 135.27b 10a 135.8b 
OCH3-1 62.26 OCH3-1 62.8 
CH2OH-2 52.24 CH2OH-2 52.0 
a-e Assignments may be reversed in the same column 
* prim. = primeverose 
 
III.3.1.4. 1,3-Dihydroxy-2-methoxymethyl-9,10-anthraquinone (Lucidin-ω-methyl ether) 78 
 
A series of chromatographic separations including MPLC-RP18, MPLC-Si and preparative 
TLC was applied on the fractions 6:3 and 6:4 (Table 3.12) from the ethyl acetate extract of 
the roots P. lanceolata (Scheme 3.4) to afford the anthraquinone 1,3-dihydroxy-2-
methoxymethyl-9,10-anthraquinone (lucidin-ω-methyl ether) 78. 
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Scheme 3.4: Isolation of 1,3-Dihydroxy-2-methoxymethyl-9,10-anthraquinone 
(Lucidin-ω-methyl ether) 78 from the Roots of P. lanceolata 
 
1,3-Dihydroxy-2-methoxymethyl-9,10-anthraquinone (lucidin-ω-methyl ether) 78: 
Amorphous yellow powder; mp 169.8-172.4 °C, lit. mp 170 °C (148). The UV spectrum of 
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the compound showed absorption bands at 242.0, 246.0 and 280.0 nm which are consistent 
with an anthraquinone structure (121a). In the IR spectrum, the absorption bands of the OH 
groups were observed at 3393 and 3196 cm-1. The absorption of carbonyl groups were 
observed at 1673 cm-1 (unchelated C=O) and 1626 cm-1 (chelated C=O), whereas a C-O-C 
group absorbed at 1275 cm-1.  
 
The 1H NMR spectrum (in CDCl3) displayed a hydroxy proton signal in low-field at δH 13.31 
(1H, s, OH-1), obviously corresponding to the OH-1 in peri position from the carbonyl 
oxygen in 9-position. This OH-1 was associated with the hydrogen bonding observed in the 
IR spectrum. An additional hydroxy group was observed at δH 9.43 (1H, s, OH-3). Besides, 
the aromatic proton signals were typical of an anthraquinone having a non-substituted and a 
trisubstituted aryl ring by showing a symmetrical AA'BB' coupling system of four protons  at 
δH 7.77-7.79 (2H, m, H-6 and H-8) and δH 8.25-8.29 (2H, m, H-5 and H-8), together with an 
aromatic proton singlet at δH 7.32 (1H, s, H-4). The methoxy and the oxymethylene protons 
were observed at 3.58 and 4.94 ppm respectively. 
 
As expected from the conjugation and the hydrogen bonding effect of the OH-1, the 13C NMR 
spectrum showed largely different chemical shifts for the two carbonyl carbons at δC 182.23 
(C-10) and 186.88 (C-9). The two =Cq-O were observed at δC 161.88 and 164.08 ppm. The 
location of the methoxy group in 3-postion was ruled out by the presence of the OH-3 proton 
signal at δH 9.43 in the 1H NMR spectrum. Moreover, the strongest evidence of the 
benzylalkyl ether nature (rather than an arylalkyl one) for compound 78 came from the 13C 
NMR spectrum which showed the chemical shifts values δC 68.89 (CH2OCH3-2) and δC 59.35 
(CH2OCH3-2). These values are typical of ethers for which the two alkoxy groups give rise to 
a reciprocal shift to down-field of more than 10 ppm in 13C NMR, relatively to the 
corresponding alcohols. The two carbons exert to each other a reciprocal influence similar to 
that of a C-β in alkanes, the oxygen atom being considered as a C-α (121b). The fragment [M 
+ Na]+ was observed at m/z 307 (14%) in the ESI mass spectrum. Therefore, the molecular 
formula was deduced as being C16H12O5. 
 
On the basis of all the above discussed spectroscopic data, the structure of the compound was 
established as lucidin-ω-methyl ether (1,3-dihydroxy-2-methoxymethyl-9,10-anthraquinone) 
78. The structure proposed was supported by the literature survey findings. The UV and IR 
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data were fully fitting with those already reported for the compound (150,151). The 1H and 
13C NMR data were also in excellent agreement (Table 3.27a and 3.27b) with those already 
published (150,152). 
 
Although the compound has been isolated from the roots, the rhizomes, the bark (or the whole 
plant) of many other Rubiaceae (153) and from the tissue and cell cultures of some rubiaceous 
plants (152,154), lucidin-ω-methyl ether 78 has been thought to be an artefact of the 
genuinely occurring lucidin as a result of the extraction and/or the isolation with methanol 
(71,155). 
 
Table 3.27a. Comparison of the 1H NMR data of the isolated lucidin-ω-methyl ether 78 
(270 MHz, CDCl3; this work) with data from the literature (200 MHz, 
CDCl3, ref. 150) 
Proton This work 
δ (ppm) 
ref. 150 
δ (ppm) 
H-4 7.32 7.29 
H-5 8.25-8.29 8.24-8.32 
H-6 7.77-7.79 7.76-7.84 
H-7 7.77-7.79 7.76-7.84 
H-8 8.25-8.29 8.24-8.32 
OH-1 13.31 13.27 
CH2OCH3-
2 
4.94 4.92 
CH2OCH3-
2 
3.58 3.57 
OH-3 9.43 9.38 
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Table 3.27b. Comparison of the 13C NMR data of the isolated lucidin-ω-methyl ether 78 
(67.5 MHz, CDCl3; this work) with data from the literature (100 MHz, 
CDCl3, ref. 152) 
This work ref. 152 
Carbon δC (ppm) Carbon δC (ppm) 
1 161.88a 1 161.8a 
2 114.37 2 114.3 
3 164.08a 3 164.0a 
4 109.74 4 109.8 
4a 134.12b 4a 134.1b 
5 126.70c 5 126.7c 
6 134.12d 6 134.1d 
7 134.12d 7 134.0d 
8 127.35c 8 127.3c 
8a 132.43b 8a 133.5b 
9 186.88 9 186.9 
9a 109.63 9a 109.6 
10 182.23 10 182.2 
10a 133.51b 10a 133.5b 
CH2OCH3-2 68.89 CH2OCH3-2 68.9 
CH2OCH3-2 59.35 CH2OCH3-2 59.4 
a-d Assignments may be reversed in the same column 
 
III.3.1.5. Damnacanthol-3-O-methyl ether 79. 
 
An isocratic elution using MPLC-RP18 with H2O/ACN (3:7) as mobile phase was applied on 
the combined fraction 8:6 (Table 3.16) and 10:3 (Table 3.20) obtained from the EtOAc 
extract of the roots of P. lanceolata, as shown in Scheme 3.5. The separation gave rise to 
damnacanthol-3-O-methyl ether (1,3-dimethoxy-2-hydroxymethyl-9,10-anthraquinone) 79. 
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Scheme 3.5: Isolation of Damnacanthol-3-O-methyl ether (1,3-dimethoxy-2- 
hydroxymethyl-9,10-anthraquinone) 79 from the Roots of P. lanceolata 
 
Damnacanthol-3-O-methyl ether (1,3-dimethoxy-2-hydroxymethyl-9,10-anthraquinone) 
79: Amorphous yellow powder; mp 173.8-175.2 °C, lit. mp 173.5-174.0 °C (149). The IR 
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spectrum of the compound displayed an OH absorption band at 3445 cm-1. Two non-hydrogen 
bonded carbonyl absorption bands were observed at 1673 and 1650 cm-1, respectively, 
therefore indicating that compound 79 was an anthraquinone without any OH group in the 
peri position. 
 
The 1H NMR spectrum (in C5D5N) displayed the general pattern of a one-side-trisubstituted 
anthraquinone. Two multiplets (AA'BB' system) of the non-substituted aryl ring were 
observed at δH 7.63-7.71 (2H, m, H-6 and H-7) and δH 8.27-8.42 (2H, m, H-5 and H-8), 
whereas the isolated proton located at the trisubstituted ring resonated at δH 7.99 (1H, s, H-4).  
 
The 13C NMR spectrum showed the presence of non-chelated carbonyl groups which 
resonated at δC 183.37 and 180.86 ppm (∆δC 2.51 ppm). The two =Cq-O bearing the OCH3 
groups were observed at 163.99 and 162.46 ppm. The three substituents, two methoxy groups 
and a hydroxymethylene one, displayed the following NMR data: δH 3.62 (3H, s, OCH3-3)/δC 
49.68 (OCH3-3), δH 4.23 (3H, s, OCH3-1)/δC 62.82 (OCH3-1) and δH 5.37 (2H, s, CH2OH-2)/ 
δC 54.73 (CH2OH-2). The low-field value of the OCH3-1 (62.82 ppm) is consistent with its 
peri position from the carbonyl in C-9 as observed in similar compounds (135). 
 
The possibility of having benzylalkyl ether (methylation of CH2OH-2) was ruled out by the 
13C chemical shift of 54.73 ppm observed for the CH2OH-2. The replacement of the OH by a 
OCH3 group should have deshielded the methylene carbon about 10 ppm up to low field 
(121b). 
 
The ESI mass spectrum showed a base peak (100%) at m/z 267. This fragment may derive 
from the ion [M + H]+ via the loss of neutral MeOH. The molecular formula of C17H14O5 was 
deduced for compound 79. 
 
From all these spectroscopic findings, the structure of the compound was established as 
damnacanthol-3-O-methyl ether (1,3-dimethoxy-2-hydroxymethyl-9,10-anthraquinone) 79. 
To the best of our knowledge, it is the first time that this compound is isolated from a plant 
material. However, successful synthesis of the compound has been designed (145,149) as 
shown in Scheme 3.6. 
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Scheme 3.6: Synthesis of Damnacanthol-3-O-methyl ether (1,3-dimethoxy-2- 
hydroxymethyl-9,10-anthraquinone) 79 (145) 
 
The 1H NMR data of the isolated damnacanthol-3-O-methyl ether 79 were found consistent 
with those of the synthesised product (Table 3.28). The 13C NMR data are reported here for 
the first time.  
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Table 3.28. Damnacanthol-3-O-methyl ether 79: Comparison of its 1H NMR data (270 
MHz, C5D5N; this work) with the 1H NMR data from the literature (200 
MHz, CDCl3, ref. 145) and presentation of its 13C NMR data (67.5 MHz, 
C5D5N, this work): δ (ppm) 
 1H 13C 
Position This work 
(In C5D5N) 
ref. 145 
(In CDCl3) 
 
1 - - 162.46a 
2 - - 129.97 
3 - - 163.99a 
4 7.99 s 7.67 110.94 
4a - - 133.10b 
5 8.27-8.42 m 8.24 m 126.59c 
6 7.63-7.71 m 7.7 m 133.21d 
7 7.63-7.71 m 7.7 m 134.86d 
8 8.27-8.42 m 8.24 m 127.29c 
8a - - 134.46b 
9 - - 183.37e 
9a - - 118.96 
10 - - 180.86e 
10a - - 135.02b 
OCH3-1 4.23 4.05 62.82 
CH2OH-2 5.37 5.67 54.73 
OCH3-3 3.62 3.98 49.68 
a-e Assignments may be reversed in the same column 
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III.3.2. Anthraquinone Glycoside: Rubiadin-1-methyl ether 3-O-β-primeveroside 55 
 
The partition by CPC followed by an MPLC fractionation of the MeOH extract of the roots of 
P. lanceolata as described in Scheme 3.7 afforded the anthraquinone glycoside rubiadin-1-
methyl ether 3-O-β-primeveroside 55 (Fraction 12:3 of Table 3.23). Its physical and spectral 
data were compared to those observed for the sample isolated from P. bussei, and were found 
identical. The structure elucidation was also achieved on the basis of the comparison of these 
data with those found in the literature (112,121b). The structural discussion on the compound 
is provided in Chapter II, Section II.3.1.3. 
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Scheme 3.7: Isolation of Rubiadin-1-methyl ether 3-O-β-primeveroside 55 
from the Roots of P. lanceolata 
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P. suswaensis Verdc. and P. zanzibarica (Klotzch) Vatke are two other species from the same 
genus and which are reported to be botanically similar to P. lanceolata (144). The 
anthraquinones (35, 36, 53) and anthraquinone glycosides (54-57) have been isolated from P. 
zanzibarica (112). The several anthraquinones (36, 53, 77-79) and the anthraquinone 
glycoside (55) isolated from P. lanceolata through the present investigation may be regarded 
as a chemotaxonomical evidence for the resemblance (144) observed between the two Pentas 
species, P. zanzibarica and P. lanceolata. 
 
III.3.3. Steroidal Compound: β-Stigmasterol 64 
 
The ubiquitous steroid (24S)-24-ethylcholesta-5-(E)-22-dien-3β-ol (β-stigmasterol) 64 was 
isolated from the hexane extract of the roots of P. lanceolata trough a one-step fractionation 
by MPLC on silica gel (Scheme 3.8). The physical and spectroscopical data of the compound 
were found fitting with those of the sample isolated from the roots of P. bussei and with the 
data from the literature (111,115). The structural discussion is given in Chapter II, Section 
II.3.3. 
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Scheme 3.8: Isolation of (24S)-24-Ethylcholesta-5-(E)-22-dien-3β-ol 
(β-stigmasterol) 64 from the Roots of P. lanceolata 
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Chapter IV. STUDY OF THE ROOTS OF PENTAS PARVIFOLIA 
 
IV.1. Introduction 
 
Pentas parvifolia Hiern is an erect pubescent shrub up to 0.5-2.5 m high, sometimes 
scrambling to 3.5 m, often having irregularly branched stems but not a true Liane. Stems are 
pale or purplish brown, woody, pubescent with white or ferruginous hairs above, glabrous 
below and the epidermis often peeling. Leaves are ovate or elliptic, base cuneate, apex acute, 
1-10.5 by 0.3-2 cm, sparsely pubescent above, fine-pubescent beneath. Dense or lax 
corymbose heads of bright red flowers, in (sub)terminal few-to many-flowered cymes; 
flowers scarlet, rarely pink and white, mostly dimorphic, but sometimes particularly 
trimorphic corolla tube 7-18, lobes 2.5-10 mm long. Fruit oblong, 3-6 mm long (113).  
 
 
Figure 4.1. Pentas parvifolia Hiern 
 
The plant is common in rocky sites in dry bushland and wooded grassland, on the coast 
usually in dry forest, in between 1-2400 m. Different names are given to the plant in Kenya 
by local tribes, such as "Kakalla", "Kirere", "Gora" or "Kinyeri" (113). No phytochemical 
investigation of this species is reported in the literature. 
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IV.2. Experimental 
 
IV.2.1. Extraction and Purification 
 
IV.2.1.1. Extraction 
 
The ground dried roots of the plant (451.49 g) were extracted exhaustively (x 3) with n-
hexane, dichloromethane (CH2Cl2), ethyl acetate (EtOAc) and methanol (MeOH), 
respectively. A volume of 0.50 litres of each solvent was used for each extraction. The 
solvent was removed and the sample dried before the extraction with a new solvent started. 
Extraction was executed under sonication at room temperature. The extracts were filtered and 
concentrated under reduced pressure on a rotavapor at 40 °C to afford a dark green n-hexane 
residue (4.24 g, 0.94 % yield), a dark CH2Cl2 residue (8.33 g, 1.84 %  yield), a dark EtOAc 
residue (1.59 g, 0.35 % yield), and a dark brown MeOH residue (14.05 g, 3.11 % yield). 
 
IV.2.1.2. Study of the Hexane Extract of the Roots of Pentas parvifolia 
 
The n-hexane extract (4.24 g, 0.94 % yield) was partitioned between the biphasic solvent 
system n-hexane/EtOAc/MeOH/H2O (9:1:7:1). After decantation and removal of the solvent, 
2 residues were obtained from the light and heavy phases, respectively, namely "hexane-1" 
(1.44g, 0.32 % yield) and "hexane-2" (2.76 g, 0.61 % yield). 
 
IV.2.1.2.1. Isolation of (24 S)-24-Ethylcholesta-5-(E)-22-dien-3-β-ol (Stigmasterol) 64 
 
The "hexane-1" fraction residue (1.44 g) was subjected to MPLC over a normal phase elution 
using a n-hexane/acetone/MeOH gradient (Table 4.1) (column 460 x 49 mm i.d.; precolumn, 
140 x 10 mm i.d.; sample adsorbed on 10.2 g of silica gel and packed in a 230 x 36 mm i.d. 
sample column; flow rate 50 ml/min at a back pressure < 40 bar; detection, LSD; collection 
70 seconds per fraction) to afford 7 fractions monitored by TLC (Table 4.2). 
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Table 4.1. Programme for fractionation of the "hexane-1" fraction of the roots 
of P. parvifolia on MPLC 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane/Acetone/MeOH 100:0:0 95:5:0 5% 55 
n-Hexane/Acetone/MeOH 90:10:0 70:30:0 10% 60 
n-Hexane/Acetone/MeOH 50:50:0 50:50:0 ---- 40 
n-Hexane/Acetone/MeOH 50:45:5 50:45:5 ---- 40 
 
Table 4.2. MPLC fractionation of the "hexane-1" fraction of the roots of P. parvifolia. 
Fraction Eluate number Weight (mg) 
1:1 1-44 706.5 
1:2 45-85 52.4 
1:3 86-102 44.3 
1:4 103-115 117.3 
1:5 116-126 94.0 
1:6 127-155 86.4 
1:7 156-168 144.4 
 
Fraction 1:4 (117.3 mg, 0.026 % yield) was submitted to p-TLC developed with n-hexane/ 
acetone (3:2). The sample was dissolved in 5 ml of a mixture of n-hexane and acetone (1:1) 
and spotted on the plate, in a line 3 mm wide and 19 cm length at 1.5 cm from the bottom 
edge of the plate. The compound which, after development showed a Rf 0.63 was scraped off 
and extracted from silica gel with acetone, followed by filtration. According to the spectral 
data, it was identified as β-stigmasterol 64 (47.6 mg, 0.01 % yield). Spectral data were 
completely identical to those obtained for the same compound isolated from P. bussei, and P. 
lanceolata (Chapters II and III). 
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(24S)-24-Ethylcholesta-5-(E)-22-dien-3β-ol (β-stigmasterol) 64. White solid (from 
hexane); mp 164.4-166.1 °C, lit. mp 164.2-166.0 °C (115). The compound displayed spectral 
data (IR, 1H and 13C, MS) similar to those observed in the case of the sample isolated from P. 
bussei (see Chapter II). 
 
IV.2.1.2.2. Isolation of Methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)-
3H-benzo[f]chromene-9-carboxylate 58 
 
The "hexane-2" fraction residue was submitted to a further fractionation by CPC (3 x run, 
0.92 g sample weight each time) with n-hexane/EtOAc/MeOH/H2O (7:7:8:2) to give 10 
fractions (Table 4.3). The CPC conditions were: column 120 ml x 3; elution mode, head to 
tail, the upper phase as the stationary phase and the lower phase as the mobile phase; flow 
rate 1 ml/min with a pressure ≈ 80 psi; revolution speed, 1069 rpm; equilibrium volume, 80 
ml; sample loop, 14 ml; detection, UV 254 nm and 280 nm; sample collection, 5 min per 
fraction; push out at 330 min with a flow rate of 8ml/min collected at 16 ml per tube. 
 
Fractions 2:1 to 2:3 were mixed together (320.5 mg, 0.07 % yield) and the total sample 
submitted to reversed phase MPLC under a gradient mode (Table 4.4) to yield 5 fractions 
(Table 4.5) monitored by TLC (RP-18 plates, H2O/MeOH (2:3) as eluting solvent system). 
MPLC conditions were: column, 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample 
adsorbed on 2.27 g of RP-18 and packed in a 230 x 36 mm i.d. sample column; flow 35 
ml/min at a back pressure < 40 bar; detection, LSD; collection 36 seconds per fraction. 
 
 
Table 4.3. CPC fractionation of the "hexane-2" fraction of the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
2:1 1-18 133.7 
2:2 19-26 77.5 
2:3 27-32 109.3 
2:4 33-41 318.4 
2:5 42-47 565.3 
2:6 48-53 49.9 
2:7 54-61 43.9 
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2:8 62-83 1132.2 
2:9 84-89 286..2 
2:10 90-97 124.7 
 
Table 4.4. Programme for separation of fraction 1 :1-1 :3 of P. parvifolia 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 100:0 90 :10 5% 15 
H2O/MeOH 90:10 0 :100 10% 153 
 
Table 4.5. MPLC fractionation of fractions 1 :1-1 :3 of the roots of P. parvifolia. 
Fraction Eluate number Weight (mg) 
3:1 72-165 46.5 
3:2 167-187 18.5 
3:3 189-214 30.8 
3:4 215-255 58.7 
3:5 267-280 143.1 
 
Fraction 3:5 (143.1 mg, 0.032 % yield) was submitted to a normal phase MPLC separation 
under a gradient mode (Table 4.6) to afford 5 fractions (Table 4.7) monitored by TLC on 
silica gel. MPLC conditions were: column 460 x 26 mm i.d.; precolumn, 140 x 10 mm i.d., 
sample adsorbed on 1.0 g of silica and packed in a 230 x 26 mm i.d. sample column; flow, 50 
ml/min at a back pressure < 40 bar; detection, LSD; collection 30 seconds per fraction. 
 
 
 
Table 4.6. Programme for separation of fraction 3:5 from the roots of P. parvifolia 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End stepwise Start 
n-Hexane/EtOAc 100:0 60:40 20% 20 
n-Hexane/EtOAc 50:50 50:50 ---- 10 
n-Hexane/EtOAc 40:60 40:60 ---- 10 
n-Hexane/EtOAc 20:80 0:100 10% 20 
n-Hexane/EtOAc 95:5 80:20 5% 65 
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Table 4.7. MPLC fractionation of fraction 3:5 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
4:1 12-25 11.6 
4:2 37-57 24.3 
4:3 152-177 15.0 
4:4 178-198 26.9 
4:5 199-250 40.7 
 
Fraction 4:2 (24.3 mg, 0.005 %) was subjected to p-TLC eluted with n-hexane/EtOAc (3:2). 
The spot at Rf = 0.65 (yellow and blue band under UV light at 254 and 365 nm, respectively) 
was scraped off and the compound removed from the adsorbent by extraction with acetone. 
The solvent was evaporated to dryness to yield 11.4 mg (0.0025 % yield) of a yellow solid. 
Based on its spectral and physical data, the compound was identified as methyl-5,10-
dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]chromene-9-
carboxylate 58, already isolated from the hexane extracts of the roots of P. bussei (see 
Chapter II). 
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Methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]chro-
mene-9-carboxylate 58: Yellow solid (from hexane); mp 89.9-92.1 °C; [α]21D +34.8° (c 0.05, 
CHCl3). Both the UV, the IR, the NMR (1H, 13C, 2D) and the MS spectral data observed for 
the compound 58 were similar to those observed in the case of the sample isolated from P. 
bussei (see Chapter II). 
 
IV.2.1.2.3. Isolation of Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61 
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After removal of the solvent to dryness under reduced pressure, fraction 2:4, yielded an 
amorphous dark white solid, which was recrystallized in MeOH to afford brown fine needles. 
The compound was identified as methyl-1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61, 
based on its physical and spectral data, and was already isolated from the roots of P. bussei as 
described in Chapter II. 
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Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61: Brown fine needles (from 
MeOH); mp 176.2-177.8 °C. The spectral data observed for the compound 61, i.e. the UV, the 
IR, the NMR (1H, 13C, 2D) and the MS, were similar to those observed for the same 
compound isolated from P. bussei (see Chapter II). 
 
IV.2.1.2.4. Isolation of 9-Methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62 
 
Fraction 2:8 (1132.2 mg, 0.25 % yield) of Table 4.3 was submitted to an isocratic MPLC 
separation on reversed phase eluting with MeOH/H2O (9:1) for 90 min under the following 
conditions: column 460 x 70 mm i.d.; precolumn, 140 x 10 mm, sample adsorbed on 12 g of 
RP18 and packed in a 230 x 36 mm i.d. sample column; flow rate, 50 ml/min at a back 
pressure < 40 bar; detection, LSD; collection 36 seconds per fraction. The separation afforded 
5 fractions, after TLC monitoring on RP18 plates and combination of the eluates (Table 4.8). 
 
Table 4.8. MPLC fractionation of fraction 2:8 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
5:1 15-20 167.6 
5:2 21-27 130.8 
5:3 28-48 253.6 
5:4 49-69 223.4 
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5:5 70-115 266.6 
 
On the one hand, fractions 5:2 and 5:3 were mixed together (384.4 mg, 0.085 % yield) and 
rechromatographed on reversed phase MPLC under an isocratic elution with MeOH/H2O 
(85:15) to afford 5 differents fractions (Table 4.9), while, on the other hand, fractions 5:4 and 
5:5 were also mixed together (490 mg, 0.11 % yield) and submitted to a MPLC under the 
same separation conditions to give rise to the 5 fractions listed in Table 4.10. MPLC 
conditions were: column, 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; sample adsorbed 
on 2.7 g and 3.5 g of RP18, respectively, and packed in a 230 x 26 mm i.d. sample column in 
each case; flow rate, 60 ml/min at a back pressure < 40 bar; detection, LSD; collection 10 
seconds per fraction. Eluates were monitored by TLC on RP18 plates eluting with 
MeOH/H2O (7:3) before combination. 
 
Table 4.9. MPLC fractionation of fractions 5:2 and 5:3 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
6:1 11-17 49.7 
6:2 18-27 88.2 
6:3 28-38 147.1 
6:4 39-62 14.9 
6:5 63-97 58.1 
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Table 4.10. MPLC fractionation of fractions 5:4 and 5:5 from the roots of  P. parvifolia 
Fraction Eluate number Weight (mg) 
7:1 17-23 74.7 
7:2 24-32 35.8 
7:3 33-46 183.9 
7:4 47-95 69.4 
7:5 96-156 104.3 
 
Fraction 6:1 and 7:1 were mixed together (124.4 mg, 0.027 % yield) and submitted to a 
reversed phase MPLC under gradient elution mode (Table 4.11). The eluates were monitored 
by TLC on RP18 plates eluted with MeOH/H2O (7:3) and combined into 3 fractions (Table 
4.12). MPLC conditions were: short column, 230 x 36 mm i.d.; precolumn, 140 x 10 mm i.d.; 
sample adsorbed on 0.9 g of RP18 and packed in a 230 x 26 mm i.d. sample column; flow 
rate, 45 ml/min at a back pressure < 40 bar; detection LSD; collection 20 seconds per fraction. 
 
Table 4.11. Programme for separation of fraction 6:1 and 7:1 from the roots of P. parvifolia 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End stepwise  
H2O/MeOH 50:50 30:70 10% 30 
 
Table 4.12. MPLC fractionation of fractions 6:1 and 7:1 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
8:1 8-16 6.2 
8:2 18-27 45.6 
8:3 28-47 14.4 
 
Evaporation of the solvent to dryness under reduced pressure from fraction 8:3 afforded an 
amorphous solid (14.4 mg, 0.0031 % yield). Based on its spectral data and physical 
properties, the compound was identified as 9-methoxy-2,2-dimethyl-2H-benzo[h]chromene-
7,10-diol 62, which was already isolated from the roots of the species P. bussei and described 
in Chapter II. 
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9-Methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62: White solid (from hexane/ 
acetone (1:1)); mp 201.8-204.0 °C. Both the UV, the IR, the NMR (1H, 13C, 2D) and the MS 
spectral data observed for the compound 62 were similar to those observed in the case of the 
sample isolated from P. bussei (see Chapter II). 
 
IV.2.1.2.5. Isolation of 9-Methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo[h]-chrome-
ne-7,10-diol 63 
 
Fractions 6:2 to 6:4 (Table 4.9) and 7:2 (Table 4.10) were mixed together (286.0 mg, 0.06 % 
yield) and rechromatographed on normal phase MPLC under a gradient mode elution (Table 
4.13) and with the following conditions: column, 460 x 10 mm i.d. sample column; flow rate, 
48 ml/min at a back pressure < 30 bar; detection LSD; collection, 15 seconds per fraction. 
The eluates were monitored by TLC on silica gel plates eluting with EtOAc/MeOH (4:1) and 
combined into 4 fractions (Table 4.14). 
 
Table 4.13. Programme for separation of fraction 6:2 to 6:4 and 7:2 from the roots 
of P. parvifolia 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End stepwise  
EtOAc/MeOH 100:0 70:30 10% 75 
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Table 4.14. MPLC fractionation of fractions 6:2 to 6:4 and 7:2 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
9:1 1-104 27.1 
9:2 105-135 37.9 
9:3 136-210 108.3 
9:4 211-232 12.2 
 
Fraction 9:3 (108.3 mg, 0.024 % yield) was additionally purified by p-TLC eluting with 
EtOAc/MeOH (4:1). A solution of the sample in EtOAc/MeOH (9:1) was prepared and 
spotted on 3 preparative TLC plates (silica gel). After development, the band with Rf 0.35 
was scraped off and the compound extracted from the adsorbent by extraction (3 x) with 
EtOAc to afford an amorphous white solid (44.4 mg, 0.01 % yield). Further purification of the 
compound by HPLC was conducted on a RP18 column. 
 
The analytical HPLC conditions were: column, a Kromasil C18, 5µm, 10 x 0.4 cm i.d., 
Teknokroma (Barcelona); elution, gradient mode with H2O/MeOH (50:50 to 0:100); flow 
rate, 1 ml/min; detection, UV 254 nm. The preparative HPLC conditions were: column, a 
Kromasil C18, 5 µm, 25 x 2 cm i.d., Teknokroma (Barcelona); elution, isocratic mode with 
H2O/MeOH (20:80); flow rate, 9 ml/min corresponding to a back pressure ≈ 179 bar; 
detection, UV 254 nm; collection 90 seconds per fraction; running time, 45 min. The sample 
was dissolved in 3 ml H2O/MeOH (1:99) and filtered through a 0.45 µm filter (Acrodisc 13 
CR PTFE, 13 mm, Gelman) before injection. The eluates in between 6.8-9.2 min (retention 
time) were mixed and dried under vacuum to give rise to a final pure compound (19.3 mg, 
0.0043 % yield). Based on its physical and spectral data, the compound was identified as 9-
methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo[f]chromene-7,10-diol 63, which was 
already isolated from the roots of the species P. bussei and described in Chapter II. 
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9-Methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo[h]chromene-7,10-diol 63: White 
solid (from hexane/(CH3)2CO (1:1)); mp 174.5-176.4 °C. The UV, IR, NMR (1H, 13C, 2D) 
and MS spectral data observed for the compound 63 were similar to those observed in the 
case of the sample isolated from P. bussei (see Chapter II). 
 
OH
OCH3
O
OCH3
HO
O
58
OH
OCH3
H3CO
H3CO
O
OCH3
OH
61 62
OH
OHO
OCH3
OH
OHO
OCH3
63
HO
H
64
 
 
Figure 4.2. Natural Products Isolated from the Hexane Extract of the  
Roots of P. parvifolia 
 
IV.2.1.3. Study of the Dichloromethane Extract of the Roots of Pentas parvifolia 
 
A sample weight of 5964.3 mg from the dichloromethane extract of the roots of P. parvifolia 
was submitted to a reversed phase MPLC separation under a gradient mode elution (Table 
4.15). The MPLC conditions were: column, 460 x 70 mm i.d.; precolumn, 140 x 10 mm i.d.; 
sample adsorbed on 42 g of RP18, divided into 3 parts chromatographed separately and each 
of which was packed in a 230 x 36 mm i.d. sample column; flow rate, 30 ml/min at a back 
pressure < 40 bar; detection, LSD; collection 80 seconds per fraction. The eluates were 
monitored by TLC on RP18 plates eluting with MeOH/H2O (4:1) and combined into 8 
fractions listed in Table 4.16. 
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Table 4.15. Programme for fractionation of the dichloromethane extract of the roots 
of P. parvifolia on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
H2O/MeOH 40:60 0:100 10% 175 
 
Table 4.16. MPLC fractionation of the dichloromethane extract of the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
10:1 1-31 233.4 
10:2 32-54 509.6 
10:3 55-59 391.6 
10:4 70-75 1199.8 
10:5 76-95 147.8 
10:6 96-104 1175.1 
10:7 105-111 266.2 
10:8 112-130 790.7 
 
 
IV.2.1.3.1. Isolation of 7-Hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromene-8-
carboxylic acid 65 
 
Fraction 10:5 (147.8 mg, 0.033 % yield) was fractionated by CPC with the sytem n-hexane/ 
EtOAc/MeOH/H2O (3:3:2:2) to afford 5 fractions (Table 4.17). The CPC conditions were: 
column 120 ml x 3; elution mode, head to tail, the upper phase as the stationary phase and the 
lower phase as the mobile phase; flow rate 1 ml/min with a pressure ~ 82 psi; revolution 
speed, 1067 rpm; equilibrium volume, 68 ml; sample loop, 14 ml; detection, UV 254 nm and 
280 nm; sample collection, 5 min per fraction; push out at 315 min with a flow rate of 6 
ml/min collected at 18 ml per tube. 
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Table 4.17. CPC fractionation of fraction 10:5 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
11:1 1-18 16.1 
11:2 19-30 9.6 
11:3 31-46 20.7 
11:4 47-66 6.3 
11:5 67-86 86.9 
 
Fraction 11:5 was dried through a removal of the solvent under reduced pressure to afford a 
yellow solid (86.9 mg, 0.019 % yield). Based on its spectral and physical data, the compound 
was identified as 7-hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromene-8-carboxylic 
acid 65, a new natural product already isolated from Pentas bussei, studied in the present 
research work, as described in Chapter II. 
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7-Hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromene-8-carboxylic acid 65: Yellow 
fine crystals (from CHCl3); mp 204.4-205.4 °C. Both the UV, the IR, the NMR (1H, 13C, 2D) 
and the MS spectral data observed for the compound 65 were similar to those observed in the 
case of the sample isolated from P. bussei (see Chapter II). 
 
In addition, from a CPC fractionation of fraction 10:3 (391.6 mg, 0.087 % yield) was isolated 
compound 61 which was already isolated from the n-hexane extracts of the roots of both P. 
parvifolia (this Chapter) and P. bussei (Chapter II). 
 
 
 
 
Pentas parvifolia                                                                                                                                   Experimental 
 198
OH
OCH3
H3CO
H3CO
O
OCH3
OH
61
O
OH O
OH
OCH3
65
 
Figure 4.3. Natural Products Isolated from the Dichloromethane Extract of the 
Roots of P. parvifolia 
 
IV.2.1.4. Study of the Ethyl Acetate Extract of the Roots of Pentas parvifolia 
 
The ethyl acetate extract of the roots of P. parvifolia (1.59 g, 0.35 % yield), was subjected to 
a reversed phase MPLC under a gradient elution mode (Table 4.18) and the following 
separation conditions: column, 460 x 49 mm i.d.; sample adsorbed on 11 g of RP18 and 
packed in a 230 x 36 mm i.d. sample column; flow rate 60 ml/min at a back pressure < 40 bar; 
detection, LSD; collection 30 seconds per fraction. All the eluates were monitored by TLC on 
RP18 plates eluting with H2O/CH3CN (3:2) and H2O/CH3CN (3:7) for more polar and less 
polar fractions, respectively. The separation gave rise to 8 different fractions (Table 4.19). 
 
Table 4.18. Programme for fractionation of the ethyl acetate extract of the roots  
of P. parvifolia on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End stepwise  
H2O/CH3CN 100:0 0:100 10% 200 
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Table 4.19. MPLC fractionation of the ethyl acetate extract of the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
12:1 38-68 164.0 
12:2 69-86 57.6 
12:3 87-161 207.1 
12:4 163-203 213.9 
12:5 205-267 236.7 
12:6 269-293 54.2 
12:7 295-325 48.3 
12:8 357-381 509.5 
 
IV.2.1.4.1. Isolation of 1,4,5-Trihydroxy-3-methoxy-6-(3,7,11,15,19-pentamethyleicosa-
2,6,10,14,18-pentaenyl)naphthalene 80 
 
Fraction 12:8 (509.2 mg, 0.11 % yield) was submitted to a normal phase MPLC separation 
under a gradient mode elution (Table 4.20) and the following separation conditions: 2 coupled 
columns, 460 x 49 mm i.d. and 230 x 36 mm i.d.; precolumn, 140 x 10 mm i.d.; sample 
adsorbed on 3.6 g of silica gel and packed in a 230 x 26 mm i.d. sample column; flow rate 48 
ml/min at a back pressure < 40 bar; detection LSD; collection 50 seconds per fraction. The 
eluates were monitored by TLC on silica gel plates, developed with EtOAc/MeOH (99:1) and 
combined into 7 fractions (Table 4.21). 
 
Table 4.20. Programme for fractionation of fraction 12:8 from the roots 
of P. parvifolia on MPLC. 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise  
n-Hexane/EtOAc/MeOH 20:80:0 0:100:0 10% 45 
n-Hexane/EtOAc/MeOH 0:90:10 0:80:20 ---- 30 
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Table 4.21. MPLC fractionation of fraction 12:8 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
13:1 1-15 25.2 
13:2 16-27 33.7 
13:3 28-39 56.4 
13:4 40-53 15.9 
13:5 54-62 60.5 
13:6 63-71 47.3 
13:7 72-112 143.8 
 
Fraction 13:7 (143.8 mg, 0.032 % yield) was subjected to a further purification on preparative 
TLC. The sample was dissolved in 6 ml of acetone/MeOH (7:3) and spotted onto 4 
preparative silica gel plates. The upper phase of the solvent mixture n-hexane/ 
EtOAc/MeOH/H2O (1:1:1:1) was used to irrigate and develop the plates. The compound 
appearing (UV, 254 nm) at Rf 0.22 was scraped off and separated from silica gel by extraction 
with acetone/MeOH (9:1). Evaporation of the solvent under reduced pressure afforded an 
amorphous compound (14.5 mg, 0.0032 % yield) which was identified as 1,4,5-trihydroxy-3-
methoxy-6-(3,7,11,15,19-pentamethyleicosa-2,6,10,14,18-pentaenyl)naphthalene 80, based 
on its spectral and physical data. The compound is a new natural product isolated for the first 
time from a plant species. 
 
80
8a
8
7
6
5 4a 4
3
2
1
OH
OH
OCH3
OH
1'
2'3'
6'
7'
10'
11'
14'
15'
18'
19'
  
  
 
 
1,4,5-Trihydroxy-3-methoxy-6-(3,7,11,15,19-pentamethyleicosa-2,6,10,14,18-pentaenyl)-
naphthalene 80: Amorphous solid; mp 185.3-186.7 °C; UV (EtOH) λmax (log ε) 264.9 (4.27), 
270.0 (4.26), 360.0 (3.76), 502.0 (2.42), 516.1 (2.33) nm; IR νmax (KBr) 3403 (OH), 2922, 
1623 (C=C), 1511, 1453, 1384, 1268, 1223, 1158, 1126, 1026, 894, 796 cm-1; 1H NMR (270 
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MHz, CDCl3) δ (ppm) 8.24 (1H, d, J = 8.7 Hz, H-7), 7.11 (1H, d, J = 8.7 Hz, H-8), 7.05 (1H, 
s, H-2), 5.32 (1H, dd, J1 = 5.4 Hz, J2 = 4.9 Hz, H-2’), 5.08 (4H, br t, J = 6.1 Hz, H-6’, H-10’, 
H-14’ and H-18’), 4.09 (2H, d, J = 4.9 Hz, H2-1’), 3.87 (3H, s, OCH3-3), 1.90-2.15 (16H, m, 
H2-4’, H2-5’, H2-8’, H2-9’, H2-12’, H2-13’, H2-16’and H2-17’), 1.87 (3H, s, CH3), 1.67 (3H, s, 
CH3), 1.58 (9H, s, 3 x CH3), 1.57 (3H, s, CH3); 13C NMR (67.5 MHz, CDCl3) δ (ppm) 156.73 
(3 x =Cq-O), 149.39 (=Cq-O), 136.60 (=Cq), 135.43 (=Cq), 134.91 (=Cq), 131.26 (=Cq), 130.78 
(=Cq), 128.82 (=Cq), 124.38 (=CH-7), 124.31 (=CH), 124.20 (2 x =CH), 123.75 (=CH), 
123.38 (=CH-7), 121.74 (=Cq), 120.43 (=Cq), 117.64 (=CH-8), 103.11 (=CH-2), 55.72 
(OCH3), 39.71 (2 x CH2), 39.66 (2 x CH2), 26.76 (2 x CH2), 26.58 (2 x CH2), 26.50 (CH2), 
25.70 (CH3), 17.68 (CH3), 16.32 (2 x CH3),  16.06 (CH3), 15.99 (CH3); ESIMS m/z (rel. int.) 
547 [M + H]+ (3), 507 (100), 247 (92), 229 (30). 
 
In addition, chromatography (MPLC) of fractions 12:3 and 12:4, together with the CPC of 
fraction 12:5 (Table 4.19) gave rise to the two benzochromenes 63 and 65, already isolated 
from, the n-hexane and the dichloromethane extracts, respectively, of the roots of P. 
parvifolia. 
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Figure 4.4. Natural Products Isolated from the Ethyl Acetate Extract of the 
Roots of P. parvifolia 
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IV.2.1.5. Study of the Methanol Extract of the Roots of Pentas parvifolia 
 
An amount of 7020.9 mg weight from the methanol extract of P. parvifolia (14.05 g, 3.11 % 
yield) was subjected to CPC using EtOAc/n-BuOH/H2O (2:1:3) as solvent system and under 
the following conditions: column 320 ml x 3; elution mode, head to tail, the upper phase as 
the stationary phase and the lower phase as mobile phase; flow rate 3 ml/min, with a pressure 
~ 70 psi; revolution speed 1064 rpm; equilibrium volume 250 ml, sample loop, 14 ml; 
detection, UV 254 nm and 280 nm; sample collection, 4 min per fraction; push out at 360 min 
with a flow rate of 8 ml/min collected at 16 ml per tube; the sample was divided into 2 parts 
partitioned separately. The eluates were monitored by TLC (on RP18 plates) and combined 
into 5 fractions (Table 4.22). 
 
Table 4.22. CPC fractionation of the methanol extract of the roots of P. parvifolia. 
Fraction Eluate number Weight (mg) 
14:1 44-50 4898.8 
14:2 51-61 446.9 
14:3 62-81 229.6 
14:4 111-131 100.2 
14:5 151-170 1135.5 
 
IV.2.1.5.1. Isolation of Damnacanthol-3-O-ß-primeveroside 57 
 
Fractions 14:2 and 14:3 were combined together (676.5 mg, 0.15 % yield) and 
chromatographed isocratically on reversed phase MPLC eluting with H2O/MeOH (7:3) to 
give rise to 3 different fractions (Table 4.23). MPLC conditions were: column 460 x 36 mm 
i.d.; sample dissolved in 12 ml of acetonitrile/water (1:9), filtered through a 0.45 µm filter (25 
mm syringe filter, PVDF, Alltech Associates, Inc.) and introduced into a 15 ml sample loop; 
flow rate 45 ml/min at a back pressure < 40 bar; detection LSD; collection 50 seconds per 
fraction. 
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Table 4.23. MPLC fractionation of the fraction 14:2-14:3 from the roots of P. parvifolia. 
Fraction Eluate number Weight (mg) 
15:1 10-14 26.5 
15:2 79-107 136.8 
15:3 112-176 183.3 
 
The solvent was removed from fraction 15:2 (136.8 mg, 0.030 % yield) by evaporation under 
reduced pressure to yield a yellow solid, identified as damnacanthol-3-O-β-primeveroside 57, 
according to its spectral and physical data, together with comparison of the latter with data 
provided in the literature (112). The compound was already isolated from the MeOH extract 
of the roots P. bussei (Chapter II). 
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Damnacanthol-3-O-ß-primeveroside 57: mp 138.4-140.6 °C, lit. mp 140-142 °C (120); 
[α]16D = -130 ° (c 0.1, H2O), lit. [α]20D = -94.8 ° (c 0.18, MeOH) (112). Both the UV, the IR, 
the NMR (1H, 13C, 2D) and the MS spectral data observed for the compound 57 were similar 
to those observed in the case of the sample isolated from P. bussei (see Chapter II). 
 
IV.2.1.5.2. Isolation of Lucidin-3-O-ß-primeveroside 56 
 
Removal of solvent from fraction 15:3 (183.3 mg, 0.041 % yield) under reduced pressure 
yielded an orange red solid which was identified as lucidin-3-O-β-primeveroside 56, based on 
the spectral and physical data of the compound, together with comparison with data of the 
literature (112). The anthraquinone glycoside was already isolated from the MeOH extract of 
the roots of P. bussei (Chapter II). 
 
 
Pentas parvifolia                                                                                                                                   Experimental 
 204
     
HO
HO
OH
O
O
O
OH
HO
HO
O
HOH2C
OH
O
O
     4'' 5''
3''
2'' 1'' 6'
5'
4'
3'
2'
1'
4a
9a
10a
8a
10
9
8
7
6
54
3
2
1
56  
 
Lucidin-3-O-ß-primeveroside 56: mp 206.5-208.3 °C, lit. mp 208-210 °C (116); [α]17D = -
140 ° (c 0.05, H2O). The UV, the IR, the NMR (1H, 13C, 2D) and the MS spectral data 
observed for the compound 56 were similar to those observed in the case of the compound 
isolated from P. bussei (see Chapter II). 
 
IV.2.1.5.3. Isolation of Rubiadin-3-O-ß-primeveroside 54 
 
Fractions 14:4 and 14:5 (Table 4.22) were mixed together (1235.7 mg, 0.27 % yield) and 
submitted to a reversed phase MPLC separation under a gradient mode (Table 4.24) to give 
rise to 3 different fractions (Table 4.25) after TLC (RP18) monitoring of all the eluates 
obtained. MPLC conditions were: column 460 x 49 mm i.d.; precolumn, 140 x 10 mm i.d.; 
sample adsorbed on 8 g of RP18 and packed in a 230 x 26 mm i.d. sample column; flow rate 
30 ml/min at a back pressure < 40 bar; detection LSD; collection, 90 seconds per fraction. 
 
Table 4:24. Programme for separation of fractions 14:4-14:5 from the roots of P. parvifolia 
 
Mobile phase 
Gradient elution  
Time (min) 
 Start End Stepwise Start 
H2O/CH3CN 100:0 0:100 10% 180 
 
Table 4.25. MPLC fractionation of the fraction 14:4-14:5 from the roots of P. parvifolia. 
Fraction Eluate number Weight (mg) 
16:1 1-24 244.4 
16:2 27-96 499.3 
16:3 97-170 175.0 
 
Fractions 16:1 and 16:2 (743.7 mg, 0.16 % yield) was rechromatographed using the previous 
conditions (Table 4.24) slightly modified (coupled columns; gradient elution running time, 
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140 min). The global MPLC conditions were: 2 coupled columns, 460 x 49 mm i.d. and 230 x 
36 mm i.d.; precolumn 140 x 10 mm i.d.; sample adsorbed on 5 g of RP-18 and packed in a 
230 x 26 mm i.d. sample column; flow rate, 48 ml/min at a back pressure < 40 bar; detection, 
LSD; collection, 40 seconds per fraction. The eluates were monitored by TLC (on RP18 
plates) and combined into 4 different fractions (Table 4.26). 
 
Table 4.26. MPLC fractionation of fractions 16:1-16:2 from the roots of P. parvifolia 
Fraction Eluate number Weight (mg) 
17:1 14-18 73.1 
17:2 31-50 410.0 
17:3 51-97 101.4 
17:4 98-211 123.7 
 
Fraction 17:2 (410.0 mg, 0.091 % yield) was submitted to a CPC with EtOAc/1-BuOH/H2O 
(2:1:3) as solvent system under the following conditions: column, 320 x 3; elution mode, head 
to tail, the upper phase as the stationary phase and the lower phase as mobile phase; flow rate 
1 ml/min with a pressure ~ 70 psi; revolution speed 1070 rpm; equilibrium volume, 188 ml; 
sample loop, 14 ml; detection, UV 254 nm and 280 nm; sample collection, 5 min per fraction; 
push out at 300 min with a flow rate of 2 ml/min; collection, 4 ml per tube. The eluates were 
monitored by TLC on RP18 plates and combined into 5 differents fractions (Table 4.27). 
 
Table 4.27. CPC fractionation of the fraction 17:2 from the roots of P. parvifolia. 
Fraction Eluate number Weight (mg) 
18:1 1-43 61.3 
18:2 44-78 32.1 
18:3 79-101 24.5 
18:4 102-116 41.7 
18:5 117-128 101.1 
 
Solvent evaporation to dryness from fraction 18:4 (41.7 mg, 0.0092 % yield) afforded a pale 
yellow solid. The compound was identified as rubiadin-3-O-β-primeveroside 54, based on the 
analysis of its spectral and physical data, together with their comparison with literature data 
(112). 
Pentas parvifolia                                                                                                                                   Experimental 
 206
     
HO
HO
OH
O
O
O
OH
HO
HO
O
H3C
OH
O
O
     4'' 5''
3''
2'' 1'' 6'
5'
4'
3'
2'
1'
4a
9a
10a
8a
10
9
8
7
6
54
3
2
1
54
 
 
Rubiadin-3-O-ß-primeveroside 54: Yellow solid; mp 251.2-253.0 °C, lit. mp 250-252 °C 
(116); [α]22D = -80 ° (c 0.1, H2O); UV (H2O) λmax (logε) 246.0 (4.03), 271.1 (4.14), 273.0 
(4.14), 327.9 (4.09), 364.0 (4.10), 412.0 (3.92), 416.9 (3.92), 456.0 (3.89) nm; IR (KBr) νmax 
3367 (broad, OH), 2934, 1673 (unchelated C=O), 1582 (chelated C=O), 1343, 1289, 1050 
(broad), 895, 775, 756, 715, 603 cm-1. 1H NMR (270 MHz, C5D5N) δ (ppm) 8.30 (2H, m, H-5 
and H-8), 8.09 (1H, s, H-4), 7.63 (2H, m, H-6 and H-7), 5.80 (1H, d, J = 6.6 Hz), H-1'), 5.10-
5.36 (OH protons), 4.91 (1H, broad d, J = 6.6 Hz, H-1''), 3.62-4.84 (the rest of sugar protons), 
2.40 (3H, s, CH3-2); 13C NMR (67.5 MHz, DMSO-d6) δ (ppm) 187.12 (C-9), 182.07 (C-10), 
161.50 (C-3), 160.90 (C-1), 134.63 (C-7), 134.49 (C-6), 133.20 (C-10a), 132.94 (C-8a), 
132.03 (C-4a), 127.10 (C-5), 126.94 (C-8), 120.56 (C-2), 111.41 (C-9a), 105.57 (C-4), 103.98 
(C-1''), 100.07 (C-1'), 76.42 (C-3''), 76.07 (C-3'), 75.66 (C-5'), 73.19 (C-2''), 73.07 (C-2'), 
69.45 (C-4''), 69.11 (C-4'), 68.02 (C-6'), 65.52 (C-5''), 8.46 (CH3-2); ESIMS m/z (rel. int.) 553 
(5), 505 (15), 390 (6), 295 (8), 253 (100). 
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Figure 4.5. Natural Products Isolated from the Methanol  
Extract of the Roots of P. parvifolia 
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IV.3. Results and Discussion 
 
No phytochemical investigation of P. parvifolia was done before. The chemistry of the plant 
was found similar to that of P. bussei (Chapter II). Four novel naphthohydroquinones of the 
benzochromene type (58, 62, 63 and 65) already isolated from P. bussei, were also reisolated 
from P. parvifolia, and are, therefore, common to the two plant species. The long-chain-
branched naphthohydroquinone 80 can be considered as a metabolic benzochromene ring 
precursor through the cyclisation of the side chain which may result in the formation of the 
pyran ring. Compound 80 was consequently attached to the class of the naphthohydroquinone 
of the benzochromene type in the following structural discussion. 
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Three additional compounds, common to the two species, are the highly oxygenated 
naphthohydroquinone 61 and the two anthraquinone glycosides lucidin-3-O-β-primeveroside 
56 and damnacanthol-3-O-β-primeveroside 57 which were also isolated from the roots of P. 
bussei. However, P. parvifolia afforded, in addition, the anthraquinone glycoside rubiadin-3-
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O-β-primeveroside 54. The ubiquitous steroid β-stigmasterol 64 was also isolated from P. 
parvifolia. 
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IV.3.1. Novel Natural Products from the Roots of P. parvifolia 
 
IV.3.1.1. Naphthohydroquinones of the Benzochromene Type 
 
IV.3.1.1.1. Common Compounds of P. bussei and P. parvifolia 
 
On the one hand, the hexane extract of the roots of P. parvifolia was partitioned between the 
lower and the upper phases of the system Hex/EtOAc/MeOH/H2O (9:1:7:1). Compounds 58, 
62 and 63 (fractions 4:2 of Table 4.7, 8:3 of Table 4.12 and 9:3 of Table 4.14, respectively) 
were isolated from the lower phase residue by the use of CPC, MPLC-RP18, MPLC-Si and p-
TLC techniques, as described on the Scheme 4.1. On the other hand, the benzochromene 
carboxylic acid 65 was isolated from the CH2Cl2 extract by the application of MPLC-RP18 
and CPC separations (Scheme 4.2). This compound came out of the fraction 11:5 (Table 4.17) 
as a yellow solid upon evaporation of the solvent. 
 
The physical and spectroscopic data of these four compounds were found identical to those of 
the respective samples isolated from P. bussei. Their full structural elucidation is discussed in 
Chapter II, Paragraph II.3. 
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Scheme 4.1: Isolation of Compounds 58, 62 and 63 from the 
Roots of P. parvifolia 
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Scheme 4.2: Isolation of Compound 65 from the 
Roots of P. parvifolia 
 
IV.3.1.1.2. 1,4,5-Trihydroxy-3-methoxy-6-(3,7,11,15,19-pentamethyleicosa-2,6,10, 14, 
                 18-pentaenyl)naphthalene 80 
 
The fractionation of the EtOAc extract of the roots of P. parvifolia by MPLC-RP18, followed 
by the application of MPLC-Si on the fraction 12:8 (Table 4.19) and the p-TLC of the fraction 
13:7 (Table 4:21) resulted in the separation of compound 80 (Scheme 4.3). 
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Scheme 4.3: Isolation of the compound 80 from the 
Roots of P. parvifolia 
 
1,4,5-Trihydroxy-3-methoxy-6-(3,7,11,15,19-pentamethyleicosa-2,6,10,14,18-penta-
enyl)naphthalene 80: Amorphous solid; mp 185.3-186.7 °C. The UV spectrum of this 
compound showed intense absorption bands at 264.9 nm (log ε 4.27), 270.0 nm (log ε 4.26) 
and 360.0 nm (log ε  3.76). The pattern observed is typical to naphthalene compounds, 
substituted with functional groups enhancing the delocalisation of electrons (121). The 
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spectrum (Figure 4.6) displayed a large absorption band at 3403 cm-1, typical to phenolic 
hydroxy groups. The absorption band at 1623 cm-1 (C=C) was unusually broadened as a result 
of the contributions of the double bonds of the side chain. 
 
The 1H NMR spectrum (in CDCl3) of the compound (Figure 4.7) showed an AB system in the 
aromatic region at δH 7.11 (1H, d, J = 8.7 Hz, H-8) and δH 8.24 (1H, d, J = 8.7 Hz, H-7). 
Another aromatic proton resonated at δH 7.05 (1H, s, H-2) as a singlet, and this is in 
agreement with its location in a trisubstituted aromatic ring. The OCH3 was observed at δH 
3.87 (3H, s, OCH3-3). The 1H NMR spectrum also showed signals ascribed to the terpenic 
side chain moiety. Two types of olefinic protons were observed in this side chain at δH 5.32 
(1H, dd, J1 = 5.4 Hz, J2 = 4.9 Hz H-2') and δH 5.08 (1H, br t, J = 6.1 Hz, H-6', H-10', H-14' 
and H-18'). A particular methylene was observed at δH 4.09 (2H, d, J = 4.9 Hz, H2-1') which 
is obviously the CH2-1' under the influence of the aromatic ring. The rest of the signals 
observed in the 1H NMR spectrum belong to methylene groups overlapping at δH 1.90-2.15 
ppm and to methyl groups. 
 
The 1H-1H COSY spectrum (Figure 4.8) showed that the sp methine groups of the side chain 
are involved in two types of coupling systems. The methylene protons H2-1' were coupled to 
the olefinic proton H-2', whereas the other overlapping olefinic protons are coupled to 
corresponding vicinal CH2 protons. The arrangement of the side chain obviously shows that 
the double bond C2'=C3' corresponds to the prenylic double bonds often involved in the pyran 
ring formation. 
 
Apart from the signals which can be attributed to the side chain, the 13C NMR spectrum 
(Figure 4.9) displayed the pattern already observed for the benzochromenes 62 and 63, 
specially concerning the =CH-2 [δH 7.05 (s)/δC 103.11], the =Cq-O region and the OCH3-3 [δ
H 3.87 (s)/δC 55.72] units. 
 
The presence of the AB system in the aromatic ring, the OCH3-3 group, the evident 
trisubstituted ring and the side chain containing a prenylic double bond which can be involved 
in the pyran ring formation, all these findings indicated that compound 80 has the same ring 
substitution pattern as that of compounds 62 and 63. 
The ESI mass spectrum of the compound displayed a pseudomolecular ion peak at at m/z 547 
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[M + H]+ (3) and which was fitting with the molecular formula C36H50O4, corresponding to an 
unsaturation index of 12. 
 
From all the above discussed spectral data, the structure of the compound was elucidated as 
1,4,5-trihydroxy-3-methoxy-6-(3,7,11,15,19-pentamethyl-eicosa-2,6,10,14,18-pentaenyl)-
naphthalene 80. This compound is a novel natural product extracted for the first time from a 
plant source. 
 
 
 
Figure 4.6. IR Spectrum of Compound 80 
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Figure 4.7. 1H NMR Spectrum of Compound 80 (270 MHz, in CDCl3) 
 
 
 
Figure 4.8. 1H-1H COSY Spectrum of Compound 80 (270 MHz, in CDCl3) 
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Figure 4.9. 13C Spectrum of Compound 80 (67.5 MHz, in CDCl3) 
 
IV.3.1.2. Highly Oxygenated Naphthohydroquinone 
 
IV.3.1.2.1. Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61 
 
The lower phase residue of the hexane extract from the roots of P. parvifolia was submitted to 
a CPC separation (Scheme 4.4) to readily afford compound 61 (fraction 2:4 of Table 4.3) 
which was already isolated from the roots of P. bussei. 
 
The compound displayed both physical and spectroscopic data identical to those obtained for 
the sample from the roots of P. bussei. The discussion about the structural elucidation of the 
compound is provided in Chapter II, Section II.3. 
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Extraction with
 hexane (Sonication)
Liquid-Liquid extraction by:
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(9:1:9:1)
Lower phase residue
("Hexane-2")
CPC:
Hex/EtOAc/MeOH/H2O
(7:7:8:2)
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Scheme 4.4: Isolation of Methyl 1,8-dihydroxy-4,6,7-trimethoxy-2- 
naphthoate 61 from the Roots of P. parvifolia 
 
IV.3.2. Anthraquinone Glycosides 
 
IV.3.2.1. Common Anthraquinone Glycosides of P. bussei and P. parvifolia 
 
The CPC fractionation of the MeOH extract of the roots of P. parvifolia, followed by the 
application of the MPLC-RP18 on the fractions 14:2 and 14:3 (Table 4.22) gave rise to the 
anthraquinone glycosides lucidin-3-O-β-primeveroside 56 and damnacanthol-3-O-β-
primeveroside 57 (Scheme 4.5), already isolated from the roots of P. bussei. The 
characterisation of their sugar moiety was done by acid hydrolysis in an HCl atmosphere on 
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TLC (140) as described in “Materials and Methods”. The two anthraquinone glycosides 
displayed physical and spectroscopic data identical to the data observed for the sample 
isolated from the roots of P. bussei. Their structural elucidation is discussed in Chapter II, 
Section II.3. 
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Scheme 4.5: Isolation of Lucidin-3-O-β-primeveroside 56 and Damnacanthol-3-O-β- 
primeveroside 57 from the Roots of P. parvifolia 
 
IV.3.2.2. Rubiadin-3-O-β-primeveroside 54 
 
The MPLC-RP18 application on the fractions 14:4 - 14:5 (Table 4.22) from the MeOH extract 
of the roots of P. parvifolia, followed by the MPLC-RP18 and CPC separations applied on the 
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deriving fractions (Scheme 4.6) led to the isolation of the anthraquinone glycoside 54. 
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Scheme 4.6: Isolation of Rubiadin-3-O-β-primeveroside 54 from 
the Roots of P. parvifolia 
 
Rubiadin-3-O-β-primeveroside 54: Yellow solid; mp 251.2-253.0 °C, lit. mp 250-252 °C 
(116). The UV spectrum of the compound displayed to pattern typical to anthraquinones with 
the absorption bands observed at 246.0 nm (log ε 4.03), 271.1 nm (log ε 4.14) and 273.0 nm 
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(log ε 4.14). The IR spectrum showed a broad band at 3367 cm-1, which was ascribed to an 
OH group, and two carbonyl bands at 1673 and 1621 cm-1, corresponding to an unchelated 
and chelated C=O, respectively. The latter hydrogen bonding was indicative of the presence 
of an OH group in the peri position. 
 
The 1H and 13C NMR spectra of compound 54 were different to those of the anthraquinone 
glycoside rubiadin-1-methyl ether-3-O-β-primeveroside 55 (isolated from P. bussei and P. 
lanceolata, this work) only by the presence of OH-1 in 54 instead of OCH3 in 55 (Chapter II, 
Section II.3). The 13C NMR spectrum of compound 54 showed the two carbonyl carbons at δC 
187.12 (C-9) and δC 182.07 (C-10) ppm, with a large ∆δC value of 5.05 ppm which is 
consistent with the presence of an OH group in 1-position. In addition, no OCH3 was 
observed in the 1H NMR spectrum. The biose nature of the sugar moiety was determined by 
partial hydrolysis in an HCl atmosphere on TLC (140) of the anthraquinone glycoside (see 
“Materials and Methods”) which readily released xylose and glucose. 
 
The ESI mass spectrum of this compound displayed the base peak at m/z 553 (4 %) which 
may correspond to the ion [M + Na – H2O]+. The molecular formula of the compound was 
deduced as being C26H28O13. 
 
On the basis of the spectroscopic data observed and their comparison (Table 4.28) with data 
available in the literature (112,116), the compound was elucidated as being the known 
anthraquinone glycoside rubiadin-3-O-β-primeveroside 54. The compound has already been 
isolated from another P. species, i. e. P. zanzibarica (112). 
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Table 4.28. Comparison of NMR data of rubiadin-3-O-β-primeveroside 54 (1H, 270 MHz, 
C5D5N; 13C, 67.5 MHz, DMSO-d6; this work) with data from the literature 
(1H/13C, 400 MHz/100 MHz, DMSO-d6; ref. 112): δ (ppm), J (Hz). 
Position This work Ref. 112 
 1H* 13C 1H* 13C 
1 - 160.90a - 161.2a 
2 - 120.56 - 120.8 
3 - 161.50a - 161.4a 
4 8.09 s 105.57 7.44 s 106.0 
4a - 132.03b - 131.5b 
5 8.30 m 127.10c 8.17 dd (2,8) 126.5c 
6 7.63 m 134.49d 7.88 dd (8, 8) 134.6d 
7 7.63 m 134.63d 7.88 dd (8, 8) 134.8d 
8 8.30 m 126.94c 8.17 dd (2, 8) 126.9c 
8a - 132.94b - 131.9b 
9 - 187.12 - 187.1 
9a - 111.41 - 110.9 
10 - 182.07 - 181.5 
10a - 133.20b - 132.9b 
CH3-2 2.40 s 8.46 2.18 s 8.4 
OH-1 - - 13.00 - 
1' 5.80 d (6.6) 100.07 5.15 d (7.5) 100.3 
2'  73.07  73.2 
3'  76.07e  76.1e 
4'  69.11f  69.2f 
5'  75.66e  75.7e 
6'  68.02  68.0 
1" 4.91 d (6.6) 103.98 4.14 d (7.5) 104.0 
2"  73.19  73.2 
3"  76.42e  76.4e 
4"  69.45f  69.5f 
5"  65.52  65.6 
a-f Assignments may be reversed in the same column 
* For the sugar moiety, only anomeric δH are shown 
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IV.3.3. Steroidal Compound: β-Stigmasterol 64 
 
The partition of the hexane extract of the roots of P. parvifolia between the two phases of the 
solvent system Hex/EtOAc/MeOH/H2O (9:1:7:1) resulted in the two residues "hexane-1" and 
"hexane-2" from the upper and lower phases, respectively. The steroid β-stigmasterol 64 was 
isolated from the "hexane-1" residue which was subjected to MPLC-Si followed by p-TLC of 
fraction 1:4 (Table 4.2) as shown on the Scheme 4.7. 
 
F3 F4 F5 F6F2F1 F7
Hexane extract    
   (4.24 g)
Pentas parvifolia
(roots, 451.49 g)
Extraction with
hexane (Sonication)
Liquid-Liquid extraction by:
Hex/EtOAc/MeOH/H2O
(9:1:9:1)
Upper phase residue
("Hexane-1")
MPLC-Si:
Hex/Acetone/MeOH,
Gradient
p-TLC:
Hex/EtOAc
 (3:2)
HO
H
64  
Scheme 4.7: Isolation of β-Stigmasterol 64 
from the Roots of P. parvifolia 
 
β-Stigmasterol 64 is an ubiquitous steroid present in several plant species. The physical and 
spectroscopic data of the isolated compound were identical to those already obtained for the 
samples extracted from P. bussei and P. lanceolata (for the structural elucidation, see Chapter 
II, Section II.3). 
Pentas parvifolia                                                                                                                   Results and Discussion 
 222
 
 
 
 
 
  223
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V. 
 
 
 
SYNTHESIS OF TWO NATURAL PRODUCTS 
ISOLATED FROM 
PENTAS LONGIFLORA Oliver (Rubiaceae) 
 
 
 
  224
 
 
 
 
 
 
Pentas longiflora                                                                                                                                    Introduction 
 225
Chapter V. SYNTHESIS OF TWO NATURAL PRODUCTS ISOLATED FROM 
PENTAS LONGIFLORA 
 
V.1. Introduction 
 
Pentas longiflora Oliver is an erect stemmed woody herb up to 3 m high. Stipules are divided 
into thread-like segments. Corolla lobs 4. Leaves are ovate, with base cuneate 2 – 3, and with 
corolla tube of 2 – 4.5 cm long and 0.5 – 1.5 mm wide. Flowers are white and located in 
terminal. The fruit is a capsule. P. longiflora originates from Oriental, Intertropical Africa 
(90a), and is reputed to possess several medicinal properties. 
 
 
Figure 5.1. Pentas longiflora Oliver 
 
In Kenya, where it is known as "Nekilango" or "Segimbe", the roots are used as a cure for 
tapeworm, for itchy rashes and for pimples. A decoction of the roots is mixed with milk and 
taken as a cure for malaria, but causes acute diarrhoea, and thus acts as a purgative (91). 
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In Rwanda, where the plant is called "Isagara", the traditional healer uses the powder of the 
roots, mixed with butter, as an ointment to treat scabies and the skin disease pityriasis 
versicolor (91,92). 
 
During a detailed phytochemical investigation of the plant (96), which was aiming at the 
identification of minor constituents and new physiologically active compounds, the two 
isomeric pyranonaphthohydroquinones, trans-3,4-dihydroxy-3,4-dihydromollugin 42 and cis-
3,4-dihydroxy-3,4-dihydromollugin 48, together with the anthraquinone 3-hydroxy-1-methyl-
9,10-anthraquinone 51 were isolated and identified. 
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Trans-3,4-dihydroxy-3,4-dihydromollugin 42 was previously isolated from another 
rubiaceous plant, Rubia cordifolia (76a), although its stereochemistry was not established. 
Cis-3,4-dihydroxy-3,4-dihydromollugin 48 was a novel natural product (104). The 
discrimination of the two stereoisomers was based on the comparison of their physical and 
spectral data. Particularly, the important observed difference between the two 1H NMR 
spectra of the two compounds was the coupling constant (J) of the two protons of the O-CH-
CH-O unit at δH 3.79 (1H, d, J = 6.4 Hz, CH-3) and 5.06 (1H, d, J = 6.4 Hz, CH-4) for the 
trans-compound (42), and at δH 3.85 (1H, d, J = 4.9 Hz, CH-3) and 5.22 (1H, d, J = 4.9 Hz, 
CH-4) for the cis-compound (48). 
 
The anthraquinone 3-hydroxy-1-methyl-9,10-anthraquinone 51 was also found as a novel 
natural product. A strong argument which could be argued against the structure assigned to 
this anthraquinone was the location of the methyl group at the 1-position which is 
contradictory to the biogenesis of anthraquinones in Rubiaceae (Scheme 5.1). From this 
biosynthetic route, it is obvious that a methyl group or an oxidised methyl group is always 
found at the 2- or 6-position which are equivalent from a biogenetic point of view (71). As 
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shown in Scheme 5.1., rings A and B of anthraquinones are derived from chorismic or 
isochorismic acid and α-ketoglutarate via O-succinylbenzoic acid through a so called 
"shikimate pathway (I and II)" (156). The origin of ring C is not yet known, either via the 
MVA or acetate/mevalonic acid pathway (III) or the MEP or 2-C-methyl-D-erythritol 4-
phosphate pathway (IV). 
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Scheme 5.1: Biosynthetic pathway leading to anthraquinones in Rubiaceae (141): 
E-4-P = erythrose 4-phosphate, P = phosphate residue, PEP = phosphoenolpyruvate, 
“TCA = tricarboxylic acid”, TPP = thiamine diphosphate 
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In order to confirm the structural assignment proposed for cis-3,4-dihydroxy-3,4-
dihydromollugin 48 and for 3-hydroxy-1-methyl-9,10-anthraquinone 51, the synthesis of the 
two compounds was undertaken. 
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V.2. Experimental 
 
Melting points measurements were carried out on a Büchi melting point apparatus. Optical 
rotations were obtained on an AA-10 automatic polarimeter. The IR spectra were recorded on 
a Perkin-Elmer 1310 infrared spectrometer. The 1H and 13C NMR spectra were recorded on a 
JEOL-JNM-Ex 270 MHz FT NMR spectrometer. The mass spectra were measured at 70 eV, 
with a Varian MAT 112 mass spectrometer, using a direct inlet system. 
 
V.2.1. Synthesis of Cis-3,4-dihydroxy-3,4-dihydromollugin 48 
 
Mollugin 38 (100 mg, 0.0003 mol) was dissolved in 50 ml of dry THF and N-
methylmorpholine N-oxide (NMO) (50 mg, 0.0004 mol) was added (solution I). A solution of 
OsO4 (0.3 mg, 10-6 mol) in 2 ml of water was prepared (solution II). Solutions I and II were 
mixed at 0 °C and kept stirring at 0 °C for 10 min. The reaction mixture was brought to room 
temperature and stirred for 24 h. Workup involved the reduction of excess of OsO4 by 
saturated NaHSO3 (the reaction mixture was poured into the NaHSO3 solution and stirred for 
30 min), and the extraction with EtOAc (157). The EtOAc solution was dried (MgSO4), and 
evaporated in vacuo to afford 67.5 mg of a crude residue which was subjected to flash 
chromatography (silica, eluent: hexane/EtOAc, 6:4) to give rise to cis-3,4-dihydroxy-3,4-
dihydromollugin 48 (50.4 mg, 50% yield). 
 
Cis-3,4-dihydroxy-3,4-dihydromollugin 48: Colourless amorphous powder; mp 106.3 – 107.7 
°C; lit. mp 107.6 – 108.0 °C (96); [α]21D –13.7 ° (c 0.42, CHCl3); IR (KBr) νmax 3565-3190 
(OH), 1665 (C=O), 1590 (C=C), 1455, 1237, 1170, 1100 cm-1; 1H NMR (270 MHz, CDCl3) δ 
(ppm) 11.15 (1H, s, OH-6), 8.11-8.31 (2H, m, H-7 and H-10), 7.46-7.60 (2H, m, H-8 and H-
10), 5.15 (1H, d, J = 4.9 Hz, H-4), 3.99 (3H, s, COOCH3), 3.78 (1H, d, J = 4.9 Hz, H-3), 1.44 
(3H, s, CH3-2), 1.43 (3H, s, CH3-2); 13C NMR (67.5 MHz, CDCl3) δ (ppm) 171.21 
(COOCH3-5), 155.63 (C-6), 140.72 (C-11), 129.43 (C-9), 128.75 (C-10a), 126.95 (C-8), 
125.53 (C-6a), 123.81 (C-10), 122.46 (C-7), 112.76 (C-4a), 104.56 (C-5), 77.70 (C-2, 
overlapping CDCl3), 72.09 (C-3), 64.31 (C-4), 52.80 (COOCH3), 24.60 (CH3-2), 22.05 (CH3-
2); EIMS m/z (rel. int.) 318 [M]+ (48), 301 (56), 288 (69), 270 (69), 216 (100), 199 (20), 187 
(20), 171 (11), 159 (40), 87 (12). 
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V.2.2. Synthesis of 3-Hydroxy-1-methyl-9,10-anthraquinone 51 
 
V.2.2.1. Synthesis of (E)-4-Methoxy-3-penten-2-one 81 
 
A dry acetone solution (350 ml) containing equimolar amounts of acetylacetone 82 and 
dimethyl sulfate (0.55 mol of each) was heated under reflux for 24 h in the presence of 
anhydrous potassium carbonate. Inorganic solids were filtered off and the filtrate and acetone 
washings were concentrated in vacuo. The crude oily mixture was distilled under reduced 
pressure (26 mm Hg). Two fractions were collected at 82-88 °C and 95-98 °C. To the fraction 
collected at 82-88 °C (12.62 g) were added 20 ml of dry ether, and 20 ml of 10 N NaOH. The 
mixture was stirred at room temperature for 1 h, and the ethereal phase was separated. The 
aqueous phase was washed three times with  dry ether. These washings were then added to 
the initial ethereal phase. Evaporation of the combined ether phases gave 14.13 g (23% yield) 
of  (E)-4-methoxy-3-penten-2-one 81 as a yellow oil (158,159). 
 
V.2.2.2. Synthesis of (E and Z)-4-Methoxy-2-trimethylsilyloxy-1,3-pentadiene 83 
 
To a suspension of anhydrous zinc chloride (77.5 mg) in triethylamine (4.37g, 0.042 mol) was 
added 1.2 equivalents of (E)-4-methoxy-3-penten-2-one 81 in 5.7 ml of benzene, followed by 
the addition of (CH3)3SiCl (4.19 g,  0.038 mole). An exothermic reaction was noted. After 30 
min, the temperature was raised to 40° C and the reaction mixture was stirred overnight. After 
cooling, it was added to 40 ml of dry ether and filtered. The filtrate and the combined ether 
washings were concentrated in vacuo to give a brown oil. Distillation through a Vigreux 
column gave 2.2 g  (39 % yield) of a mixture of the dienes (E and Z)-4-methoxy-2-
trimethylsilyloxy-1,3-pentadiene 83 (bp 63-70 °C/3 mm Hg) (158,160). 
 
V.2.2.3. Synthesis of 3-Hydroxy-1-methyl-9,10-anthraquinone 51 and Its Methyl ether 84 
 
To a solution of 2-bromo-1,4-naphthoquinone 85 (1252 mg, 0.005 mol) in 10 ml of toluene 
was added a solution of the mixture of (E and Z)-4-methoxy-2-trimethylsilyloxy-1,3-
pentadiene 83 (655 mg, 5 ml) in 10 ml of toluene. The mixture was stirred for 30 min at 0 °C. 
It was then brought to room temperature and continuously stirred overnight. SiO2 (700 mg) 
was added and the mixture was stirred for 4 h (160). The filtered and concentrated material 
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(1680 mg) was chromatographed by MPLC on silica gel. The chromatography conditions 
were: column, 460 x 49 mm i.d. ; precolumn, 140 x 10 mm i.d.; sample adsorbed on 9 g of 
silica gel and packed in a 230 x 36 mm i.d. sample column; flow 42 ml/min at a back pressure 
< 40 bars; detection, LSD ; collection 50 seconds per fraction; elution: gradient with 
hexane/EtOAc 100:0 to 0:100 (10 %, stepwise) for 135 min and with wash out by 
EtOAc/MeOH 100:0 to 95:5 for 20 min. The eluates 76 to 95 were combined together and the 
solution was dried in vacuo to afford 3-methoxy-1-methyl-9,10-anthraquinone 84 (341.2 mg, 
52 %), whereas the  combination of the eluates 149 to 171 gave rise to 3-hydroxy-1-methyl-
9,10-anthraquinone 51 (313.8 mg, 45 % yield) after evaporation of the solvent under reduced 
pressure. 
 
3-Hydroxy-1-methyl-9,10-anthraquinone 51: Yellow powder; mp 291.1-293.2 °C; mp 
reported for the “isolated natural anthraquinone” (96): 270.5 – 271.8 °C; IR (KBr) νmax 3347 
(OH), 1673 (C=O), 1649 (C=O), 1610, 1592, 1560, 1463, 1368, 1338, 1296, 1276, 1141, 993 
cm-1; 1H NMR (270 MHz, C5D5N) δ (ppm) 8.37-8.40 (1H, broad d, J = 7.0 Hz, H-8), 8.30-
8.33 (1H, broad d, J = 7.0 Hz, H-5), 8.08 (1H, d, J = 2.1 Hz, H-4), 7.61-7.71 (2H, m, H-6 and 
H-7), 7.30 (1H, d, J = 2.1 Hz, H-2), 5.47 (1H, br, OH-3), 2.89 (3H, s, CH3-1);  13C NMR 
(67.5 MHz, C5D5N) δ (ppm) 182.95 (C=O), 182.46 (C=O), 162.79 (C-3), 144.60 (C-1), 
136.89  (=Cq), 133.39 (C-6), 132.31 (=Cq), 132.26 (C-7), 130.53 (=Cq), 128.36 (=Cq), 126.34 
(C-8), 125.62 (C-5), 124.46 (C-2), 111.81 (C-4), 22.91 (CH3-1); EIMS m/z (rel. int.) 238 [M]+ 
(100%), 210 (17), 181 (18), 149 (26), 97 (11), 84 (59), 56 (33). 
 
3-Methoxy-1-methyl-9,10-anthraquinone 83: Pale white powder; mp 138.4-139.4 °C, IR 
(KBr) νmax: 1671 (C=O), 1592, 1472, 1436, 1413, 1346, 1283, 1208, 1138, 1018, 993 cm-1; 
1H NMR (270 MHz, CDCl3) δ (ppm) 8.14-8.19 (2H, m, H-5 and H-8), 7.65-7.75 (2H, m, H-6 
and H-7), 7.57 (1H, d, J = 3.0 Hz, H-4), 6.92 (1H, d, J = 3.0 Hz, H-2), 3.91 (3H, s, OCH3-3), 
2.74 (3H, s, CH3-1); 13C NMR (67.5 MHz, CDCl3) δ (ppm) 182.48 (C=O), 182.41 (C=O), 
162.79 (C-3), 144.87 (C-1), 137.02 (=Cq), 134.71 (=Cq), 134.05 (C-6), 132.97 (C-7), 132.59 
(=Cq), 127.41 (C-8), 126.47 (C-5), 124.89 (=Cq), 124.09 (C-2), 109.18 (C-4), 55.65 (OCH3-
3), 23.68 (CH3-1); EIMS m/z (rel. int.): 252 [M]+ (10), 166 (5), 150 (3), 118 (5), 83 (100), 47 
(17). 
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V.3. Results and Discussion 
 
V.3.1. Cis-3,4-dihydroxy-3,4-dihydromollugin 48 
 
The cis-dihydroxylation of mollugin 38 with osmium tetroxide and the use of N-methyl 
morpholine N-oxide (NMO) as cooxidant (Scheme 5.2) in THF in the presence of water at 
room temperature was exploited for the synthesis of cis-3,4-dihydroxy-3,4-dihydromollugin 
48. The coupling of the two oxidants has proved its effectiveness for the hydroxylation of less 
hindered olefins (161). The cis-dihydroxylation of mollugin 38 gave rise to cis-3,4-
dihydroxy-3,4-dihydromollugin 48 in 50 % yield. 
 
OH
O
O
OCH3
OH
O
O
OCH3
OH
OH
NMO (1.23 equiv.), THF (50 ml)
OsO4 (0.06 equiv.), Water (2 ml)
rt, 24 h
38 48 (50 % yield)  
Scheme 5.2: Synthesis of Cis-3,4-dihydroxy-3,4-dihydromollugin 48 
 
The IR spectrum of the synthetic diol 48 was identical to the one observed for the naturally 
occurring diol (96). The mp observed for the synthetic compound (106.3-107.7 °C) was quite 
identical to the mp of the plant-derived diol (107.6-108.3 °C). Sofar the cis-dihydroxylation 
has not been performed enantioselectively. Also at present, the absolute stereochemistry of 
the cis-3,4-dihydroxy-3,4-dihydromollugin from the plant source (P. longiflora) is not known.  
 
The comparison of the 1H and 13C NMR of the synthetic versus the natural compound (Tables 
5.1 and 5.2) showed that the two derivatives displayed the same spectroscopic data for the O-
CH-CH-O unit in 3- and 4-position. The chemical shifts observed were δH 5.15 (1H, d, J = 4.9 
Hz, H-4)[synthetic]/δH 5.22 (1H, d, J = 4.9 Hz, H-4) [natural] and δH 3.78 (1H, d, J = 4.9 Hz, 
H-3) [synthetic]/δH 3.85 (1H, d, J = 4.9 Hz, H-3) [natural]. The JH-3/H-4 = 4.9 Hz and ∆δH = δH-
4 - δH-3 = 1.37 ppm are, respectively, the same in both the two compounds. The 13C NMR 
spectra displayed also the data for the O-CH-CH-O unit at δC 72.09 (C-3) [synthetic]/δC 72.21 
(C-3) [natural] and δC 64.31 (C-4) [synthetic]/δC 64.42 (C-4) [natural]. 
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The data observed confirmed that the diol 48 isolated from the roots of Pentas longiflora (96) 
was cis-3,4-dihydroxy-3,4-dihydromollugin which is quite different from the trans-form 42 
(76a,96). The differences from the trans-form are particularly observed in the δC of the unit 
O-CH-CH-O and of the two methyl groups at the 2-position (Table 5.2). 
 
Table 5.1. Comparison of 1H NMR data of the synthetic (this work) and 
the naturally occurring (ref. 96) cis-3,4-dihydroxy-3,4-dihydromollugin 48 
(270 MHz, CDCl3) with data of the trans-3,4-dihydroxy-3,4-dihydromollugin 42 
(270 MHz, CDCl3, ref. 96; 400 MHz, CDCl3, ref. 76a) 
 
 δ (ppm) multiplicity (J in Hz) 
Proton 48 
Synthetic cis-form
(this work) 
48 
Naturally ocurring 
cis-form (ref. 96) 
42 
trans-form 
(ref. 96) 
42 
trans-form 
(ref. 76a) 
CH3-2 1.43 s 1.40 s 1.40 s 1.40 s 
CH3-2 1.44 s 1.51 s 1.58 s 1.58 s 
3 3.78 d (4.9) 3.85 d (4.9) 3.79 d (6.4) 3.80 d (6.4) 
4 5.15 d (4.9) 5.22 d (4.9) 5.06 d (6.4) 5.06 d (6.4) 
COOCH3-5 3.99 s 4.06 s 4.05 s 4.06 s 
OH-6 11.15 s 11.20 s 11.46 s 11.44 s 
7 8.11-8.31 m 8.20-8.37 m 8.19-8.36 m 8.37 d (8.0) 
8 7.46-7.60 m 7.58-7.62 m 7.57-7.62 m 7.56 t (8.0) 
9 7.46-7.60 m 7.58-7.62 m 7.57-7.62 m 7.64 t (8.0) 
10 8.11-8.31 m 8.20-8.37 m 8.19-8.36 m 8.19 d (8.0) 
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Table 5.2. Comparison of 13C NMR data of the synthetic (this work) and the naturally 
occurring (ref. 96) cis-3,4-dihydroxy-3,4-dihydromollugin 48 (67.5 MHz, CDCl3) 
with data of the trans-3,4-dihydroxy-3,4-dihydromollugin 42 
(67.5 MHz, CDCl3, ref. 96; 100 MHz, CDCl3, 76a) 
 
 δ (ppm) 
Carbon 48 
Synthetic cis-form 
(this work) 
48 
Naturally ocurring 
cis-form (ref. 96) 
42 
trans-form 
(ref. 96) 
42 
trans-form 
(ref. 76a) 
2 77.70 
(overlap with CDCl3) 
Overlap with CDCl3 overlap with 
CDCl3 
Overlap with 
CDCl3 
CH3-2 22.05 21.97 19.62 19.77 
CH3-2 24.60 24.81 25.49 25.57 
3 72.09 72.27 69.77 69.87 
4 64.31 64.42 76.06 76.18 
4a 112.76 112.90 112.84 112.96 
5 104.56 104.63 103.84 103.96 
COOCH3-5 171.21 171.21 171.30 171.35 
COOCH3-5 52.80 52.81 52.81 52.86 
6 155.63 155.79 156.43 156.52 
6a 125.53 125.67 125.60 125.27 
7 122.46 122.56 122.49 122.58 
8 126.95 127.04 126.95 127.05 
9 129.43 129.50 129.59 129.66 
10 123.81 123.91 123.95 124.04 
10a 128.75 128.92 128.96 129.09 
11 140.72 140.84 140.96 141.07 
 
V.3.2. 3-Hydroxy-1-methyl-9,10-anthraquinone 51 
 
The anthraquinone 51 was isolated as a yellow powder (mp 270.5-271.8 °C) from the 
dichloromethane extract of the roots of P. longiflora (96). To its structural assignment as a 
1,3-disubstitued anthraquinone, with the particular location of the methyl group at the 1-
position, could be opposed the fact that the methyl group should be located at the 2-position 
according to what is widely observed in the biosynthesis of anthraquinones in rubiaceous 
plants (71,141). Therefore, the regioselective synthesis of the anthraquinone 51 was 
performed in order to confirm the structural assignment of the naturally occurring 
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anthraquinone (96) through comparison of its spectral and physical data with those of the 
synthetic one. 
 
The synthesis of 3-hydroxy-1-methyl-9,10-anthraquinone 51 was performed via the 
successful use of conjugated ketene acetals in cycloaddition and through a three-step process 
(Scheme 5.3). The use of trimethylsilyloxydienes was chosen as the most promising approach 
(158). The trimethylsilyloxydiene 83 was derived from the methyl enol ether (81) of pentane-
2,4-dione 82 (159). 3-Hydroxy-1-methyl-9,10-anthraquinone 51 (45 % yield) was obtained by 
condensation (Diels-Alder reaction) of the latter diene with 2-bromo-1,4-naphthoquinone 85 
(160). 3-Methoxy-1-methyl-9,10-anthraquinone 84 (3-O-methyl ether of 51; 52 % yield) was 
also obtained as a final product of the Diels-Alder condensation. Compound 84 is a novel 
synthetic anthraquinone. 
 
3-Hydroxy-1-methyl-9,10-anthraquinone 51 was obtained as a yellow powder. The mp of 
the compound, 291.1-293.2 °C, was largely different from that (270.5-271.8 °C) of the 
anthraquinone isolated from the roots of P. longiflora (96). However, the IR spectrum of the 
synthetic anthraquinone displayed the same pattern of peaks as the naturally occurring one. 
The absorption band of the hydroxy group was observed at 3347 cm-1, whereas the carbonyl 
groups absorbed at 1673 and 1649 cm-1. The EI mass spectrum displayed a molecular ion 
peak at m/z 238 (100%) corresponding to the molecular formula of C15H10O3. 
 
The 1H NMR spectrum (in C5H5N) of the synthetic anthraquinone 51 showed an unsubstituted 
aromatic ring by displaying an AA'BB' system of four adjacent protons at δH 8.37-8.40 and 
8.30-8.33 (1H each, br d, J = 7.3 Hz, H-5 and H-8) and at δH 7.61-7.71 (2H, m, H-6 and H-7). 
A clear meta coupling system was observed in the disubstituted ring at δH 8.08 (1H, d, J = 2.3 
Hz, H-4) and 7.30 (1H, d, J = 2.3 Hz, H-2). The methyl protons resonated at δH 2.29 (3H, s, 
CH3-1), whereas the hydroxy proton resonated at δH 5.47 (1H, br s, OH-3). 
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+
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Scheme 5.3: Synthesis of 3-Hydroxy-1-methyl-9,10-anthraquinone 51 
(and its 3-O-methyl ether 84) 
 
The 13C NMR spectrum showed key signals at δC 182.95 and 182.46 (C-9 and C-10), δC 
162.79 (C-3), δC 144.60 (C-1) and δC 22.91 (CH3-1). Comparison of the 1H and 13C NMR 
data of the synthetic and the naturally occurring anthraquinone (Table 5.3) showed very 
important differences. The protons and the carbon of the methyl group were more deshielded 
(in the 1H and 13C NMR spectra, respectively) in the synthetic anthraquinone than in the 
natural one, and this was in agreement with the peri position of the CH3-1 in the case of the 
synthetic anthraquinone. Evidently, the CH3 of the anthraquinone isolated from the roots of 
Pentas longiflora (96), was not located at 1-position. The structure of this naturally occurring 
anthraquinone could also not correspond to 1-hydroxy-3-methyl-9,10-anthraquinone or 
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pachybasin 86 (108b) for two major reasons which are the lack of hydrogen bonding effect 
(chelation) in the IR spectrum of the compound, together with the lack of a deshielding effect 
of a peri hydroxy group (an OH at 1-position) on one of the carbonyl carbons in the 13C 
NMR. Besides, the melting point of the latter compound (pachybasin 86) is 179-180 °C and 
this value is very different from that of the melting point (270.5-271.8 °C) measured for the 
anthraquinone isolated from P. longiflora (96). The possibility of locating the two 
substituents, i.e. the CH3 and the OH groups, in different rings for the naturally occurring 
anthraquinone was ruled out by the presence of an AA'BB' coupling system of four aromatic 
protons (96). Finally, closer inspection of the 1H NMR spectrum of this naturally occurring 
anthraquinone did not show the clear meta coupling system for the disubstituted ring observed 
for the synthetic anthraquinone 51, but instead two sharp singlets. 
 
According to all the pertinent features discussed above, the right structure which fits with the 
data observed for the naturally occurring anthraquinone isolated from the dichloromethane 
extract of the roots of Pentas longiflora (96), and previously elucidated as 3-hydroxy-1-
methyl-9,10-anthraquinone 51 (96), is 3-hydroxy-2-methyl-9,10-anthraquinone 87. 
 
The 1H and 13C NMR data of the newly assigned anthraquinone 87 were compared (Tables 
5.4 and 5.5, respectively) to its 3-O-methyl ether (3-methoxy-2-methyl-9,10-anthraquinone) 
50 which was isolated from the EtOAc extract of the roots of P. longiflora during the same 
investigation (96) and to its isomer 7-hydroxy-2-methyl-9,10-anthraquinone 88 (109). 
 
On the one hand, Table 5.4 showed that the proton chemical shifts of the anthraquinone 87 
could be related to its 3-O-methyl ether 50. The differences observed in the disubstituted ring 
may be attributed to the substitution of the OH group in the anthraquinone 87 by a OCH3 in 
the anthraquinone 50 (96). On the other hand, both the chemical shifts and the coupling 
patterns observed in the anthraquinone 87 were different from those observed in the 
anthraquinone 88 (109). Particularly, the lack of the meta coupling systems in the 
anthraquinone 87 (whereas they were observed in 88) ruled out the possibility of locating the 
two substituents (OH and CH3) in two different rings for the anthraquinone 87. 
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In addition, the 13C NMR data of the anthraquinone 87 were found consistent (Table 5.5) with 
those of its 3-O-methyl ether (3-methoxy-2-methyl-9,10-anthraquinone) 50. The remarkable 
δC difference observed for C-4 in the two anthraquinones, 111.79 ppm for 87 and 106.84 ppm 
for 50, could be attributed to the difference of shielding effect of the OH and the OCH3 
groups in 87 and 50, respectively. The Table 5.5 also compares the  13C NMR  data of the 
newly assigned anthraquinone 87 with those of its isomer 7-hydroxy-2-methyl-9,10-
anthraquinone 88 (109). In the anthraquinone 87,   C-1 and C-4a were more deshielded by the 
OH-3, δC 130.75 ppm (C-1) and 135.78 ppm (C-4a), respectively, than in the anthraquinone 
88 for which the signals of C-1 and C-4a were displayed at δC 127.1 ppm and 131.3 ppm, 
respectively. Besides, the ortho position of the OH from the CH3 was also confirmed by the 
higher field position of the C-2 (δC 125.99) for the anthraquinone 87 than for the 
anthraquinone 88 for which the C-2 resonated at δC 145.0 ppm. All these findings reinforce 
the structural arrangement proposed for the anthraquinone 87. 
 
The data observed for the CH3-2  group of the newly assigned anthraquinone 87 were, 
somehow, comparable to those found for other 2-methyl substituted anthraquinones, such as 
the anthraquinones 36, 52 and 54 (see Chapter III), although in the latter compounds, an 
additional alkoxy substitution in ortho position to the CH3-2 exerts a significant influence in 
the chemical shifts. 
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The anthraquinone 87 was reported to occur in varous rubiaceous plants. It has been isolated 
from the root bark of Coprosma species (C. ternuicaulis and C. linariifolia) (146a), from the 
whole plant MeOH extract of Hedyotis diffusa (162), and from the benzene extract of the 
heartwood of Faramea cyanea (153c). The compound was also isolated from Ophiorrhiza 
pumila tissue and cell cultures (154). 
 
3-Hydroxy-2-methyl-9,10-anthraquinone 87 has also been successfully synthesised, both 
regiospecifically through the use of trimethylsilyloxydienes cycloaddition (Diels-Alder 
reaction)  to halonaphthoquinones (163), and non-regiospecifically by condensing benzoic 
acid with 3-methoxy-4-methylbenzoic acid in hot concentrated sulfuric acid (164). 
 
Although the anthraquinone 87 is reported in the literature as mentioned above, this is, 
however, the first time that its 1H and 13C NMR data are reported (Tables 5.4 and 5.5). 
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Table 5.3. Comparison of NMR data of the synthetic anthraquinone 51  
(this work) and the naturally occurring anthraquinone (ref. 96): 
1H and 13C, 270 MHz/67.5 MHz, C5D5N 
 
 δ (ppm) 
 Synthetic Anthraquinone 51 
(this work) 
 Naturally occurring 
anthraquinone (ref. 96) 
Proton 1H 
multiplicity 
 (J in Hz) 
13C Position 1H 
multiplicity 
 (J in Hz) 
13C 
1 - 144.60 1 8.29 s 130.75 
CH3-1 2.89 s 22.91 2 - 125.99 
2 7.30 d (2.3) 124.46 CH3-2 2.44 s 16.72 
3 - 162.79 3 - 162.79 
OH-3 5.47 s - OH-3 5.11 s - 
4 8.08 d (2.3) 111.81 4 7.97 s 111.79 
4a - 136.89 4a - 135.78a 
5 8.30-8.33 
br d (7.0) 
125.62a 5 8.28-8.31 m 126.91b 
6 7.61-7.71 m 133.31b 6 7.61-7.67 m 134.08c 
7 7.61-7.71 m 132.26b 7 7.61-7.67 m 133.57c 
8 8.37-8.40 
br d (7.0) 
126.34a 8 8.28-8.31 m 127.01b 
8a - 130.53c 8a - 132.93a 
9 - 182.95d 9 - 182.13d 
9a - 128.36c 9a - 134.24a 
10 - 182.46d 10 - 183.35d 
10a - 132.31c 10a - 134.27a 
a-d Assignments may be reversed in the same column 
 
 
Pentas longiflora                                                                                                                   Results and Discussion 
 242
Table 5.4. Comparison of the 1H NMR data of the naturally occurring anthraquinone 87  
(270 MHz, C5D5N; structural revision of anthraquinone 51 and novel data assignment  
from ref. 96) with those of its methyl ether 50 (270 MHz, CDCl3, ref. 96)  
and its isomer 88 (300 MHz, DMSO-d6, ref. 109): 
δH in ppm, multiplicity and (J in Hz). 
 
 Anthraquinone 
Proton 87 
(data of 51 according to 
ref. 96) 
50 (ref. 96) 88 ( ref.109)* 
1 8.29 s 8.06 s 7.47 d (2.4)a 
2 - - - 
CH3-2 2.44 s 2.35 s 2.50 s 
3 - - 7.23 dd (8.5, 2.4)b 
OH-3 5.11 s - - 
OCH3-3 - 4.02 s - 
4 7.97 s 7.64 s 8.06 d (8.5)c 
4a - - - 
5 8.28-8.31 m 8.25-8.29 m 8.03 d (7.8)c 
6 7.61-7.67 m 7.74-7.75 m 7.68 br d (7.8)b 
7 7.61-7.67 m 7.74-7.75 m - 
OH-7 - - 11.0 s 
8 8.28-8.31 m 8.25-8.29 m 7.92 br sa 
8a - - - 
9 - - - 
9a - - - 
10 - - - 
10a - - - 
* Protons assignment is done by us according to coupling systems and coupling 
constants given in ref. 109; 
a-c Assignments may be reversed in the same column 
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Table 5.5. Comparison of the 13C NMR data of the naturally occurring anthraquinone 87 
(67.5 MHz, C5D5N; structure revision of anthraquinone 51 and novel data assignment 
from ref. 96) with those of its methyl ether 50 (67.5 MHz, CDCl3, ref. 96) 
and its isomer 88 (75 MHz, DMSO-d6, ref. 109): δC in ppm. 
 
 Anthraquinone 
Carbon 87 
(data of 51 according to 
ref. 96) 
50 (ref. 96) 88 ( ref.109) 
1 130.75 129.77 127.1 
2 125.99 126.79 145.0 
CH3-2 16.72 16.71 21.3 
3 162.79 162.62 135.5 
OCH3-3 - 56.06 - 
4 111.79 106.84 127.1 
4a 135.78a 134.19a 131.3a 
5 126.91b 127.06b 130.1 
6 134.08c 133.97c 121.8 
7 133.57c 133.56c 163.5 
8 127.01b 127.02b 112.5 
8a 132.93a 134.19a 135.6a 
9 182.13d 182.53d 183.3b 
9a 134.24a 133.67a 133.3a 
10 183.35d 183.37d 181.5b 
10a 134.27a 133.76a 125.5 
a-d Assignments may be reversed in the same column 
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Chapter VI. SCREENING OF THE BIOLOGICAL ACTIVITY OF THE NATURAL 
PRODUCTS ISOLATED FROM PENTAS BUSSEI, PENTAS LANCEOLATA AND 
PENTAS PARVIFOLIA 
 
VI.1. Introduction 
 
All the natural products isolated from Pentas bussei, Pentas lanceolata and Pentas parvifolia 
were evaluated externally for antiviral and for their potential anticancer activity through their 
interaction with DNA. Antiviral activity was tested against two viruses: HIV (Human 
Immunodeficiency Virus) and HCV (Hepatitis C virus). 
 
HIV is the RNA-virus that causes AIDS, Acquired Immuno Deficiency Syndrome, a disease 
that was first described in the early 80’s. Since then AIDS has spread all over the world and 
more than 40 million people are infected with HIV. 
 
HCV is a flavivirus which causes a chronic infection of the liver. About 200 million patients 
worldwide are infected with the virus. Over the years, more than 20 % of the patients develop 
cirrhosis and about 10 % develop liver cancer. 
 
VI.2. Antiviral Screening 
 
VI.2.1. HIV Antiviral and Toxicity Assay 
 
The HIV antiviral activity has been determined with a cell-based replication assay. The 
antiviral assay directly measures the ongoing replication of the virus in MT4 (gene 
“membrane type-4”) cells via the specific interaction of HIV-tat with LTR (Long Terminal 
Repeat) coupled to GFP (Green Fluorescent Protein). In the toxicity assay, a reduced 
expression of the GFP reporter protein serves as a marker for cellular toxicity of a compound. 
 
Briefly, various concentrations of the test compounds are brought in a 384-well-microtiter 
plate. Subsequently, HIV (wild type) and MT4 cells are added to the plate. In order to 
determine the toxicity of the test compound, mock-infected cell cultures containing an
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identical compound concentration range, are incubated for 3 days (37 °C, 5 % CO2) in 
parallel with the HIV-infected cell cultures. Based on the calculated percent inhibitions, the 
dose response curves are plotted. The EC50 (Effective Concentration) and the CC50 (Cytotoxic 
Concentration) values are calculated. 
 
VI.2.2. HCV Cell Culture Assay 
 
The HCV cell culture system is based on the autonomous replication of subgenomic 
selectable HCV-RNAs, called replicons. In brief, the structural genes of the HCV genome 
were replaced by heterologues sequences, namely the gene encoding the neomycin 
phosphotransferase (NPT), the internal ribosome entry site (IRES) of the 
encephalomyocarditis virus and the luciferase reporter gene. The synthetic RNAs were 
introduced into the human hepatoma cell line HuH-7 (human hepatocellular carcinoma cell 
line) and after treatment with G418 (antibiotic), only cells supporting RNA replication high 
enough to confer resistance could survive and were selected. 
 
By this method, the luciferase reporter gene was correlated with the replicon status. Huh-7 
cells are exposed to various concentrations of the test compounds in 384-well plates. After 3 
days, substrate is added to the plates and the replicon status is measured by luminescence. 
Based on the calculated percent inhibitons, the dose response curves are plotted and EC50 and 
CC50 values are calculated. The compounds are tested in 384 well plates at the following 
concentrations: 32 µM - 8 µM - 2 µM - 0.5 µM - 0.125 µM - 0.031 µM - 0.0078 µM - 
0.00050 µM (4 replicates each). 
 
VI.3. Screening of the Natural Products for Potential Anticancer Activity Through 
         Interaction with DNA 
 
Genetic toxicology studies play a central role in the development and marketing of new 
chemicals for pharmaceutical, agricultural, industrial, and consumer use. During the 
discovery phase of product development, rapid screening tests that require minimal amounts 
of test materials are used to assist in the design and prioritization of new compounds (165). 
 
What kind of test(s) should be performed is greatly dependent on the destination of the 
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compound or the risk related to human exposure but as a general rule, a battery of tests is 
required in order to allow detection of different genotoxic events (gene, chromosome, genome 
mutations). 
 
The following tests were conducted to evaluate the genotoxic properties of the compounds 
isolated from P. bussei, P. lanceolata and P. parvifolia: the bacterial Ames and VITOTOX 
tests, together with the micronucleus test on human white blood cells. 
 
VI.3.1. The Bacterial Ames Test 
 
The Ames Salmonella/microsome mutagenicity assay (Salmonella Test; Ames test) is a short-
term bacterial reverse mutation assay specifically designed to detect a wide range of chemical 
substances that can produce genetic damage that leads to gene mutations. The test employs 
several histidine dependent Salmonella strains each carrying different mutations in various 
genes in the histidine operon. These mutations act as hot spots for mutagens that cause DNA 
damage via different mechanisms. The Ames test is the most widely and validated 
genotoxicity test. 
 
When the Salmonella tester strains are grown on a minimal media agar plate containing a 
trace of histidine, only those bacteria that revert to histidine independence (his+) are able to 
form colonies. The number of spontaneously induced revertant colonies per plate is relatively 
constant. However, when a mutagen (the compound) is added to the plate, the number of 
revertant colonies per plate is increased, usually in a dose-related manner (166). 
 
The sensitivity of the test is enhanced by the use of particular mutant strains preventing, e.g., 
adequate DNA repair or increasing resistance to toxic compounds. Bacteria are grown on a 
selective medium in the presence of the tested compound. After 48 h of incubation at 37 °C, 
mutant colonies are counted and compared to the number of colonies formed in unexposed 
cultures (spontaneous back mutatons). 
 
A compound is considered genotoxic when the mean number of revertants is the double of 
that found in the solvent control culture (+ dose effect relationship). Negative controls are 
normally between approximatively 5-50 revertants for TA98 and 100-150 for TA100. 
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Positive controls must show a clear increase over the solvent controls. 
 
VI.3.2. The VITOTOX Test 
 
The VITOTOX (167) test is a test which is more rapid and less expensive than the 
“classical” Ames test. The test is also at least as sensitive as the Ames test. It is based on 
bacteria that contain the lux operon of Vibrio fischeri under transcriptional control of the recN 
gene, that is part of the SOS-system (Scheme 6.1). This gene is normally not transcribed (no 
light production) but it will be “switched on” when the bacteria are exposed to a genotoxic 
compound (mutagen or “SOS-inducing” substance). Genotoxicity is thus expressed as light 
production. 
 
 
Scheme 6.1: Schematic representation of the principle of SOS-induction on 
which the VITOTOX test is based (insertion of an operon-less “lux” gene next 
to recN results in light production when the bacterial DNA is damaged) (167). 
 
Although any bacterial strain can be used, Salmonella typhimurium strains were chosen as 
these are well known for mutagenicity testing and because the same bacteria can also be used 
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for a classical Ames test. However, as all Salmonella constructs gave very comparable results, 
only the TA104 construct [called T104 (recN2-4)] is used as it was shown to be sometimes a 
little bit more sensitive than the other hybrid strains. 
 
As it was realised that some compounds act directly on the light production (e.g., aldehydes) 
or enhance the metabolism of the bacteria creating false-positive results, a constitutive light 
producing strain with a lux operon under control of the strong promoter pr1 was also 
incorporated. This is used as an internal control system, which also gives important 
information on the toxicity of the test compound. 
 
VI.3.3. The in vitro Micronucleus Test 
 
The study of DNA damage at the chromosome level is an essential part of the genetic 
toxicology because chromosomal mutation is an important event in carcinogenesis. The 
micronucleus (168) assays have emerged as one of the preferred methods for assessing 
chromosome damage because they enable both chromosome loss and chromosome breakage 
to be measured reliably. 
 
A micronucleus is formed when during cell division a chromosome or a chromosome 
fragment becomes separated from the spindle, and therefore is not incorporated into one of 
the daughter nuclei (Scheme 6.2). The test can thus detect both clastogenic (chromosome 
breaking) and aneugenic (e.g., spindle disturbances, genome mutations) events, which can be 
distinguished using either anti-kinetochore antibodies (CREST-staining), centromere banding 
(C-banding) or fluorescent in situ hybridisation (FISH). 
 
In the in vitro micronucleus test, usually human peripheral blood lymphocytes are used. To 
distinguish cells that divided just once in culture, the cultures are treated with cytochalasin-B, 
a chemical that blocks actin polymerisation and as such also cytokinesis. 
 
After one cell cycle, binucleated cells, eventually with one or more micronuclei are obtained. 
It is necessary to distinguish the cells that divided in culture, as a cell division is required 
before formation of a micronucleus and as a very small fraction of lymphocytes has 
micronuclei acquired in vivo. 
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Scheme 6.2: (a) The origin of micronuclei from lagging whole chromosomes 
and acentric chromosome fragments at anaphase. (b) Formation of a nucleoplasmic 
 bridge from a dicentric chromosome, formation of a micronucleus from the 
accompanying acentric chromosome fragment, the critical role of cytochalasin-B 
in blocking dividing cells at the binucleate stage (168a).  
 
VI.4. Results and Discussion 
 
At the moment of the finalisation of this research work on natural products, the biological 
screening of all the natural compounds isolated from the three Pentas plant species is still 
going on. Therefore, the results of the biological activity tests are not reported here. 
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VII. 1. SUMMARY 
 
Since decades, plant-based drugs have played an essential role in the primary health care of a 
large part of the world's population. Several chemotherapeutic agents have been discovered as 
a result of chemical studies directed towards the isolation of the active substances from plants 
used in traditional medicine. 
 
Several plant species from the family Rubiaceae are widely used in African Folk medicines. 
Among them, Pentas species display a broad ranges of uses. However, the phytochemistry of 
these species is only scarcely investigated. From the about 40 known species, only Pentas 
longiflora Oliver and Pentas zanzibarica (Klotsch) Vatke have been studied. Aiming at the 
search for novel naturally occurring compounds which may be used as "lead" for the synthesis 
of potentially active compounds, this work describes the isolation and structural elucidation 
of natural products from Pentas bussei K. Krause, Pentas lanceolata (Forsk.) Deflers and 
Pentas parvifolia Hiern (Chapters II, III, IV). In addition, all the isolated natural compounds 
are being subjected to a bioactivity screening for antiviral (HIV and HCV) and anticancer 
activity (Chapter VI). Chapter V has been devoted to the synthesis and structural assignment 
confirmation of two natural products isolated from P. longiflora a species already 
investigated. 
 
The fractionation, the isolation and the purification of the natural products were achieved by 
means of medium pressure liquid chromatography (MPLC), centrifugal counter current 
chromatography (CPC), high pressure liquid chromatography (HPLC), liquid-liquid 
extraction (partition) and preparative thin layer chromatography (p-TLC). The structural 
elucidation of the natural products was performed by 1H NMR and 13C NMR spectrometry 
(including 1H-1H COSY, 1H-13C COSY, DEPT, HMBC and DIFNOE techniques), mass 
spectrometry (MS), infrared (IR) and ultra violet (UV) spectrometry. 
 
Chapter II describes the phytochemical investigation of Pentas bussei. The plant is a woody 
herb or shrub, of about 0.5-4 m high, and sometimes scrambling. The plant was collected in 
Kenya where a decoction of the roots is taken as a remedy against gonorrhoea, syphilis and 
dysentery. The investigation of the hexane, the CH2Cl2, the EtOAc and the MeOH extracts of 
the roots of the plant resulted in the isolation of five naphthohydroquinones of the 
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benzochromene type, e. g. methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-methyl-3-
pentenyl)-3H-benzo[f]chromene-9-carboxylate 58, methyl 5,10-dihydroxy-7-methoxy-1,1,3a-
trimethyl-1a,2,3,3a,10c,10d-hexahydro-1H-4-oxacyclobuta[3,4]indeno[5,6-a]naphthalene-9-
carboxylate 59, 9-methoxy-2,2-dimethyl-2H-benzo[h]chromene-7,10-diol 62, 9-methoxy-2-
methyl-2-(4-methyl-3-pentenyl)-2H-benzo[h]chromene-7,10-diol 63 and 7-hydroxy-3,3-
dimethyl-10-methoxy-3H-benzo[f]chromene-8-carboxylic acid 65. All these compounds were 
new natural products. 
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In addition, two highly oxygenated naphthohydroquinones, e. g. methyl 8-hydroxy-1,4,6,7-
tetramethoxy-2-naphthoate 60 and methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61. 
These two compounds were also novel natural products. 
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Besides, four known compounds were also isolated, e. g. the anthraquinone glycosides 
rubiadin-1-methyl ether-3-O-β-primeveroside 55, lucidin-3-O-β-primeveroside 56 and 
damnacanthol-3-O-β-primeveroside 57, together with the ubiquitous β-stigmasterol 64. 
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The phytochemical investigation of natural products of Pentas lanceolata (Chapter III) 
mainly led to the isolation of five known anthraquinones, e. g. rubiadin-1-methyl ether 36, 
rubiadin 53, damnacanthol 77, 1,3-dihydroxy-2-methoxymethyl-9,10-anthraquinone (lucidin-
ω-methyl ether) 78, damnacanthol-3-O-methyl ether 79, together with the anthraquinone 
glycoside rubiadin-1-methyl ether-3-O-β-primeveroside 55 (which was already isolated from 
P. bussei). β-Stigmasterol 64 was also isolated from Pentas lanceolata. 
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Chapter IV describes the investigation of constituents of Pentas parvifolia. The chemistry of 
the plant was mainly found similar to that of P. bussei. The following four novel 
naphthohydroquinones of the benzochromene type, which were already isolated from P. 
bussei, were isolated from P. parvifolia: methyl 5,10-dihydroxy-7-methoxy-3-methyl-3-(4-
methyl-3-pentenyl)-3H-benzo[f]chromene-9-carboxylate 58, 9-methoxy-2,2-dimethyl-2H-
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benzo[h]chro-mene-7,10-diol 62, 9-methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-
benzo[h]chromene-7,10-diol 63 and 7-hydroxy-3,3-dimethyl-10-methoxy-3H-
benzo[f]chromene-8-carboxylic acid 65. The highly oxygenated naphthohydroquinone methyl 
1,8-dihydroxy-4,6,7-trimethoxy-2-naphthoate 61, the two anthraquinone glycosides lucidin-3-
O-β-primeveroside 56 and damnacanthol-3-O-β-primeveroside 57, together with the 
ubiquitous β-stigmasterol 64 were also isolated from Pentas parvifolia. 
 
In addition, the long-chain-branched naphthohydroquinone 1,4,5-trihydroxy-3-methoxy-6-
(3,7,11,15,19-pentamethyleicosa-2,6,10,14,18-pentaenyl)naphthalene 80, together with an 
additional anthraquinone glycoside, i. e. rubiadin-3-O-β-primeveroside 54, were isolated from 
Pentas parvifolia. 
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The synthesis of two natural products isolated from Pentas longiflora, i. e. cis-3,4-dihydroxy-
3,4-dihydromollugin 48 and the anthraquinone 51 allowed, on the one hand, to confirm the 
structure already assigned to the diol 48, and, on the other hand, to revise the structure 
erroneously assigned to the anthraquinone 51 from 3-hydroxy-1-methyl-9,10-anthraquinone 
(1-methyl substituted) 51 to 3-hydroxy-2-methyl-9,10-anthraquinone (2-methyl substituted) 
87. The latter structural arrangement is in agreement with the biosynthesis of anthraquinones 
in the Rubiaceae. 
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Plants continue to be the most important source of potentially useful chemical agents which 
can either be used directly or serve as "lead" compound for the synthesis of more potent 
derivatives. 
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VII. 2. SAMENVATTING 
 
Gedurende vele tientallen jaren spelen plantgebaseerde systemen een stijgende essentiële rol 
in de eerste hulpverlening bij een groot deel van de wereldbevolking. Verschillende 
chemotherapeutische stoffen werden ontdekt dankzij chemische studies over de isolatie van 
actieve bestanddelen afkomstig van traditionele medicinale planten. 
 
Verschillende plantensoorten van de familie Rubiaceae worden wijdverspreid gebruikt in de 
Afrikaanse traditionele geneeskunde. Onder deze familie ressorteren de Pentas soorten, welke 
voor verschillende doeleinden worden gebruikt. Ondanks dit gegeven is de fytochemie van 
deze soorten amper onderzocht. Van de ongeveer 40 gekende soorten werden enkel Pentas 
longiflora and Pentas zanzibarica bestudeerd. Met het doel nieuwe natuurproducten te vinden 
die kunnen gebruikt worden als leidraad voor de synthese van potentieel actieve stoffen, 
wordt in dit werk de isolatie en de structuuropheldering van natuurproducten afkomstig van 
Pentas bussei K. Krause, Pentas lanceolata (Forsk.) Deflers en Pentas parvifolia beschreven 
(hoofdstukken II, III, IV). Alle geïsoleerde natuurproducten werden onderworpen aan een 
(lopende) bioactieve screening voor antivirale (HIV and HCV) en antikanker activiteit 
(hoofdstuk VI). Hoofdstuk V is gewijd aan de synthese en bevestiging van de structuur van 
twee natuurproducten geïsoleerd uit Pentas longiflora Oliver, een reeds onderzochte 
plantensoort. 
 
De fractionering, de isolatie en de opzuivering van de natuurproducten werden uitgevoerd 
door middel van ‘medium pressure’ vloeistofchromatografie (MPLC), centrifugale 
tegenstroom chromatografie (CPC), hoge druk vloeistofchromatografie (HPLC), vloeistof-
vloeistof extractie (partitie) en preparatieve dunne laag chromatografie (p-TLC). De 
structuuropheldering van de natuurproducten werd gerealiseerd door 1H-NMR en 13C-NMR 
spectrometrie (inclusief 1H-1H COSY, 1H-13C COSY, DEPT, HMBC en DIFNOE 
technieken), massaspectrometrie (MS), infrarood (IR) en ultraviolet (UV) spectrometrie. 
 
Hoofdstuk II beschrijft het fytochemisch onderzoek van Pentas bussei. Deze plant is een 
houtachtig kruid of struik, ongeveer 0,5 tot 4 meter hoog, en soms klimmend. De planten 
werden verzameld in Kenia waar een afkooksel van de wortels gebruikt wordt als een remedie 
tegen gonorroe, syfilis en dysenterie. Onderzoek van de hexaan-, dichloormethaan-, 
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ethylacetaat- en methanolextracten van de wortels van deze plant resulteerde in de isolatie 
van vijf naftohydrochinonen van het benzochromeen-type, nl. methyl 5,10-dihydroxy-7-
methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]chromeen-9-carboxylaat 58, methyl 
5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-1a,2,3,3a,10c,10d-hexahydro-1H-4-
oxacyclobuta[3, 4]indeno[5,6-a]naftaleen-9-carboxylaat 59, 9-methoxy-2,2-dimethyl-2H-
benzo[h]chromeen-7,10-diol 62, 9-methoxy-2-methyl-2-(4-methyl-3-pentenyl)-2H-benzo-
[h]chromeen-7,10-diol 63 en 7-hydroxy-3,3-dimethyl-10-methoxy-3H-benzo[f]chromeen-8-
carbonzuur 65. Deze verbindingen zijn allemaal nieuwe natuurproducten. 
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Bovendien werden twee sterk geoxygeneerde naftohydrochinonen geïsoleerd, namelijk 
methyl 8-hydroxy-1,4,6,7-tetramethoxy-2-naftoaat 60 en methyl 1,8-dihydroxy-4,6,7-
trimethoxy-2-naftoaat 61. Deze twee verbindingen zijn eveneens nieuw ontdekte 
natuurstoffen. 
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Bovendien werden vier gekende verbindingen geïsoleerd, namelijk de antrachinon glycosiden 
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rubiadin-1-methyl ether-3-O-β-primeveroside 55, lucidin-3-O-β-primeveroside 56 en 
damnacanthol-3-O-β-primeveroside 57, samen met het veel voorkomende β-stigmasterol 64. 
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Het fytochemisch onderzoek van natuurproducten van Pentas lanceolata (Hoofdstuk III) 
leidde hoofdzakelijk tot de isolatie van vijf gekende antrachinonen, namelijk rubiadin-1-
methyl ether 36, rubiadin 53, damnacanthol 77, 1,3-dihydroxy-2-methoxymethyl-9,10-
antrachinon (lucidin-ω-methyl ether) 78, damnacanthol-3-O-methyl ether 79, samen met het 
antrachinon glycoside rubiadin-1-methyl ether-3-O-β-primeveroside 55 (dat reeds geïsoleerd 
was uit P. bussei). β-Stigmasterol 64 werd eveneens geïsoleerd uit Pentas lanceolata. 
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Hoodstuk IV beschrijft het onderzoek naar verschillende bestanddelen van Pentas parvifolia. 
De chemische opbouw van de plant was analoog met deze van P. bussei. De volgende vier 
nieuwe naftohydrochinonen van het benzochromeen type, die vroeger reeds geïsoleerd 
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werden uit P. bussei, werden afgezonderd uit P. parvifolia: methyl 5,10-dihydroxy-7-
methoxy-3-methyl-3-(4-methyl-3-pentenyl)-3H-benzo[f]chromeen-9-carboxylaat 58, 9-
methoxy-2,2-dimethyl-2H-benzo[h]chromeen-7,10-diol 62, 9-methoxy-2-methyl-2-(4-
methyl-3-pentenyl)-2H-ben-zo[h]chromeen-7,10-diol 63 en 7-hydroxy-3,3-dimethyl-10-
methoxy-3H-benzo-[f]chromeen-8-carbonzuur 65. Het meervoudig geoxygeneerde 
naftochinon methyl 1,8-dihydroxy-4,6,7-trimethoxy-2-naftoaat 61, de twee antrachinon 
glycosiden, lucidin-3-O-β-primeveroside 56 en damnacanthol-3-O-β-primeveroside 57, 
werden samen met het alomtegenwoordige β-stigmasterol 64 geïsoleerd uit Pentas parvifolia. 
 
Naast bovenvermelde verbindingen werd eveneens het naftochinon 1,4,5-trihydroxy-3-
methoxy-6-(3,7,11,15,19-pentamethyleicosa-2,6,10,14,18-pentaenyl)naftaleen 80, samen met 
een antrachinon glycoside, i.e. rubiadin-3-O-β-primeveroside 54, geïsoleerd uit Pentas 
parvifolia. 
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De synthese van twee natuurproducten geïsoleerd uit Pentas longiflora, meer bepaald cis-3,4-
dihydroxy-3,4-dihydromollugin 48 en het antrachinon 51 geven aan de ene hand de 
bevestiging van de structuur reeds toegewezen aan het diol 48 en aan de andere hand de 
herziening van de verkeerd toegewezen structuur aan het antrachinon 51 van 3-hydroxy-1-
methyl-9,10-antrachinon (1-methyl gesubstitueerd) 51 naar 3-hydroxy-2-methyl-9,10-
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antrachinon (2-methyl gesubstitueerd) 87. De laatste structuurbepaling is in overeenkomst 
met de biosynthese van antrachinonen in de Rubiaceae. 
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Planten blijven de belangrijkste bron van potentieel bruikbare chemische stoffen welke 
rechtstreeks of als leidraad voor de synthese van meer actieve derivaten kunnen gebruikt 
worden. 
 
 
 
Samenvatting 
 266
 
 
 
 
 
  267
 
 
 
 
 
 
 
 
 
 
 
 
VIII. 
 
 
 
BIBLIOGRAPHY 
 
 
  268
 
 
 
 
 
                                                                                                                                                              Bibliography 
 269
VIII. BIBLIOGRAPHY 
 
1. (a) Cragg, G. M.; Newman, D. J. and Weiss, R. B. (1997) Coral Reefs, Forests, and 
Thermals Vents: The Worldwide Exploration of Nature for Novel Antitumor Agents. 
Seminars in Oncology 24 (2): 156-163. (b) Carlson, T. J.; Cooper, R.; King S. R. and 
Rozhon, E. J. (1997) Modern Science and Traditional Healing. In: Wrigley, S.; Hayes, 
M.; Thomas, R. and Chrystal, E. (eds.) Phytochemical Diversity: A Source of New 
Industrial Products. The Royal Society of Chemistry, Cambridge, United Kingdom, p. 
84. 
2. McConnell, O.; Longley, R. E. and Koehn, F. E. (1994) The Discovery of Marine 
Natural Products with Therapeutic Potential. In: Gullo, V. P. (ed.) The Discovery of 
Natural Products with Therapeutic Potential. Boston, MA, Butterworth-Heinemann, pp. 
109-174. 
3. Cragg, G. M.; Newman, D. J. and Snader, K. M. (1997) Natural Products in Drug 
Discovery and Development. J. Nat. Prod. 60 (1): 52-60. 
4. Farnsworth, N. R.; Akerele, O.; Bingel, A. S.; Soejarto, D. D. and Guo, Z. (1985) 
Medicinal Plants in Therapy. Bull WHO 63: 965-981. 
5. Kinghorn, A. D. (1994) The Discovery of Drugs from Higher Plants. In: Gullo, V. P. 
(ed.) The Discovery of Natural Products with Therapeutic Potential. Boston, MA, 
Butterworth-Heinemann, pp. 81-108. 
6. a) Neuss, N.; Gorman, M.; Svoboda, G. H.; Maciak, G. and Beer, C. T. (1959) Vinca 
alkaloids. III. Characterization of Leurosine and Vincaleukoblastine, New Alkaloids 
from Vinca rosea. J. Am. Chem. Soc. (1959), 81: 4754-4755. b) Johnson, I. S.; Wright, 
H. F.; Svoboda, G. H. and Vlantis, J. (1960) Antitumor Principles Derived from Vinca 
rosea Linn. I. Vincaleukoblastine and Leurosine. Cancer Res. 20: 1016-1022. c) Neuss, 
N.; Gorman, M. and Cone, N. J. (1964) The Structures of the Oncolytic Alkaloids 
Vinblastine (VLB) and Vincristine (VCR) from Vinca rosea (Catharanthus roseus). 
Lloydia 27(4): 389-392. d) Neuss, N.; Gorman, M.; Hargrove, W. Cone, N. J.; Biemann, 
K.; Buechi, G. and Manning, R. E. (1964) Vinca Alkaloids XXI. Structures of the 
Oncolytic Alkaloids Vinblastine and Vincristine. J. Am. Chem. Soc. 86(7): 1440-1442. 
7. Kashman, Y.; Gustafson, K. R.; Fuller, R. W.; Cardellina, II, J. H.;  McMahon, J. B.; 
Currens, M. J., Buckheit, R. W.; Hughes, S. H.; Cragg, G. M. and Boyd, M. R. (1992) 
                                                                                                                                                              Bibliography 
 270
The Calanolides, a Novel HIV-Inhibitory Class of Coumarin Derivatives from the 
Tropical Rainforest Tree, Calophyllum lanigerum. J. Med. Chem. 35(15): 2735-2743. 
8. Shu, Y.-Z. (1998) Recent Natural Products Based Dug Development: A Pharmaceutical 
Industry Perspective. J. Nat. Prod. 61 (8): 1053-1071. 
9. Currens, M. J.; Gulakowski, R. J.; Mariner, J. M.; Moran, R. A.; Buckheit Jr., R. W.; 
Gustafson, K. R.; McMahon, J. B. and Boyd, M. R. (1996) Antiviral Activity and 
Mechanism of Action of Calanolide A Against the Human Immunodeficiency Virus 
Type-1. J. Pharmacol. Exp. Ther. 279(2): 645-651. 
10. Hizi, A.; Tal, R.; Shaharabany, M.; Currens, M. J.; Boyd, M. R.; Hughes, S. H. and 
McMahon, J. B. (1993) Specific Inhibition of the Reverse Transcriptase of Human 
Immunodeficiency Virus Type 1 and the Chimeric Enzymes of Human 
Immunodeficiency Virus Type1 and Type 2 by Nonnucleoside Inhibitors. Antimicrobial 
Agents and Chemotherapy 37 (5): 1037-1042. 
11. Buckheit, Jr., R. W.; White, E. L.; Fliakas-Boltz, V.; Russel, J.; Stup, T. L.; Kinjerski, T. 
L.; Osterling, M. C.; Weigand, A. and Bader, J. P. (1999) Unique Anti-Human 
Immunodeficiency Virus Activities of the Nonnucleoside Reverse Transcriptase 
Inhibitors Calonolide A, Costatolide, and Dihydrocostatolide. Antimicrobial Agents and 
Chemotherapy 43 (8): 1827-1834. 
12. Buckheit, R. W.; Fliakas-Boltz, V.; Decker, W. D.; Roberson, J. L.; Stup, T. L.; Pyle, C. 
A.; White, E. L.; McMahon, J. B.; Currens, M. J.; Boyd, M. R. and Bader, J. P. (1995) 
Comparative Anti-HIV Evaluation of Diverse HIV-1-specific Reverse Transcriptase 
Inhibitor-resistant Virus Isolates Demonstrates the Existence of Distinct Phenotypic 
Subgroups. Antiviral Res. 26: 117-132. 
13. McKee, T. C.; Covington, C. D.; Fuller, R. W.; Bokesch, H. R.; Young, S.; Cardellina II, 
J. H.; Kadushin, M. R.; Soejarto, D. D.; Stevens, P. F.; Cragg, G. M. and Boyd, M. R. 
(1998) Pyranocoumarins from Tropical Species of the Genus Calophyllum: A 
Chemotaxonomic Study of Extracts in the National Cancer Institute Collection. J. Nat. 
Prod. 61 (10): 1252-1256. 
14. Pengsuparp, T. (1996) Specific Inhibition of Human Immunodeficiency Virus Type 1 
Reverse Transcriptase Mediated by Soulattrolide, a Coumarin Isolated from the Latex of 
Calophyllum teysmannii. J. Nat. Prod. 59 (9): 839-842. 
15. Patil, A. D.; Freyer A. J.; Eggleston, D. S. Haltiwanger R. C.; Bean, M. F.; Taylor, P. B.; 
Caranfa, M. J.; Breen, A. L.; Bartus, H. R.; Johnson, R. K.; Hertzberg, R. P. and 
                                                                                                                                                              Bibliography 
 271
Westley, J. W. (1993) The Inophyllums, Novel Inhibitors of HIV-1 Reverse 
Transcriptase Isolated from Malaysian Tree, Calophyllum inophyllum Linn. J. Med. 
Chem. 36 (26): 4131-4138. 
16. Boyd, M. R.; Hallock, Y. F.; Cardellina II, J. H.; Manfredi, K. P., Blunt, J. W.; 
MacMahon, J. B.; Buckheit, Jr., R. W.; Bringmann, G.; Schäffer, M.; Cragg, G. M.; 
Thomas, D. W. and Jato, J. G. (1994) Anti-HIV Michellamines from Ancistrocladus 
korupensis. J. Med. Chem. 37 (12): 1740-1745. 
17. McMahon, J. B.; Currens, M. J.; Gulakowski, R. J.; Buckheit, Jr., R. W.; Lackman-
Smith, C.; Hallock, Y. F. and Boyd, M. R. (1995) Michellamine B, a Novel Plant 
Alkaloid, Inhibits Human Immunodeficiency Virus-Induced Cell Killing by at Least 
Two Distinct Mechanisms. Antimicrobial Agents and Chemotherapy 39 (2): 484-488. 
18. Vlietinck, A. J.; De Bruyne, T.; Apers, S. and Pieters, L. A. (1998) Plant-Derived 
Leading Compounds for Chemotherapy of Human Immunodeficiency Virus (HIV) 
Infection. Planta Med. 64: 97-109. 
19. Houghton, P. J.; Woldemarian, T. Z.; Khan, A. I.; Burke, A. and Mahmood, N. (1994)  
Antiviral Activity of Natural and Semi-synthetic Chromone Alkaloids. Antiviral Res. 25 
(3-4): 235-244. 
20. Pettit, G. R.; Gaddamidi, V.; Herald, D. L.; Singh, S. B.; Cragg, G. M.and Schmidt, J. M. 
(1986) Antineoplastic Agents, 120. Pancratium littorale. J. Nat. Prod. 49 (6): 995-1002. 
21. Gabrelsen, B.; Monath, T. P.; Huggins, J. W. and Kefauver, D. F. (1992). Antiviral 
(RNA) Activity of Selected Amaryllidaceae Isoquinoline Constituents and Synthesis of 
Related Substances. J. Nat. Prod. 55 (11): 1569-1581. 
22. Klayman, D. L. (1985). Qinghaosu (artemisinin): An Antiviral Drug from China. Science 
228: 1049-1055. 
23. Luo, X.-D., Shen, C.-C. (1987). The Chemistry, Pharmacology, and Clinical 
Applications of Qinghaosu (Artemisinin) and Its Derivatives. Med. Res. Rev. 7: 29-52. 
24. De Vries, P. J. and Dien, T. K. (1996). Clinical Pharmacology and Therapeutic Potential 
of Artemisinin and Its Derivatives in the Treatment of Malaria. Drugs 52 (6): 818-836. 
25. Allen, J. R. F. and Holmstedt, B. R. (1980). The Simple ß-Carboline Alkaloids. 
Phytochemistry 19: 1573-1582. 
26. Lutomski, V. J.; Malek, B. and Raybacka, L. (1975) Pharmacochemical Investigation of 
the Raw Materials from Passiflora Genus. Planta Med. 27: 112-121. 
                                                                                                                                                              Bibliography 
 272
27. Bruneton, J. (1999) Pharmacognosie: Phytochimie, Plantes Médicinales. 3è Edition, 
Editions TEC & DOC, Paris Cedex 08, pp. 409-973. 
28. Cavin, J. C.; Krasmer, S. M. and Rodriguez E. (1987). Plant-Derived Alkaloids Active 
Against Trypanosoma cruzi. J. Ethnopharmacol. 19: 89-94. 
29. (a) Proskurnina, N F. and Yakovleva, A. P. (1952) Alkaloids of Galanthus woronowi. II. 
Isolation of a New Alkaloid. Zh. Obshch. Khim. (J. Gen. Chem.) 22, 1899-1902. (Chem. 
Abstr. 47, 6959, 1953). (b) Boit, H.-G. (1954) Uber die Alkaloide der Zwiebeln von 
Galanthus nivalis (III. Mitteil. Uber Amaryllidaceen-Alkaloide). Chem. Ber. 87: 724-
725. (c) Tanahshi, T.; Poulev, A. and Zenk, M. H. (1990) Radioimmunoassay for the 
Quantitative Determination of Galanthamine. Planta Med. 56: 77-81. 
30. Paskov, D. S. (1986) Galanthamine. In: Kharkevich, D. A. (ed.) New Neuromuscular 
Blocking Agents, Vol. 79, Handbook of Experimental Pharmacology, Springer-Verlag, 
Berlin, pp. 653-672. 
31. (a) Dal-Bianco, P.; Maly, J.; Wober, C.; Lind, C.; Koch, G.; Hufgard, J.; Marshall, I.; 
Mraz, M. and Deecke, L. (1991). Galanthamine Treatment in Alzheimer’s Disease. J. 
Neural Transm. 33 (suppl.): 59-63. (b) Thomsen, T., Bickel, U., Fisher, J. P. and Kewitz, 
H. (1990a) Galanthamine Hydrobromide in a Long-term Treatment of Alzheimer’s 
Disease. Dementia 1: 46-51. (c) Harvey, A. L. (1995) The Pharmacology of 
Galanthamine and Its Analogues. Pharmac. Ther. 68(1): 113-128. 
32. Rainer, M. and Mucke, H. A. M. (1998) Long-term Cognitive Benefit from 
Galanthamine in Alzheimer’s Disease. International Journal of Geriatric 
Psychopharmacology 1(4): 197-201. 
33. (a) Liu, J. S.; Zhu, Y. L.; Yu, C. M.; Zhou, Y. Z.; Han, Y. Y.; Wu, F. W. and Qi, B. F. 
(1986) The Structures of Huperzine A and B, Two New Alkaloids Exhibiting Marked 
Anticholinesterase Activity. Can. J. Chem. 64(4): 837-839. (b) Liu, J. S.; Yu, C.; Zhou, 
Y.; Han, Y.; Wu, F.; Qi, B. and Zhu, Y. (1986) Chemistry of Huperzine A and B. 
Huaxue Xuebao 44(10): 1035-1040. (c) Zhou, B.-N.; Zhu, D.-Y.; Huang, M.-F.; Lin, L.-
J.; Lin, L.-Z.; Yue-Yi-Han and Cordell, G. A. (1993) NMR Assignments of Huperzine 
A, Serratinine and Lucidioline. Phytochemistry 34(5): 1425-1428. 
34. Wang, Y.; Yue, D. and Tang, X. (1986) Anticholinesterase Activity of Huperzine A. 
Zhongguo Yaoli Xuebao 7(2): 110-113. 
35. Prous, J. R. (1996) Drugs Future 21: 651-652. 
                                                                                                                                                              Bibliography 
 273
36. (a) Qian, L. and Ji, R. (1989) A Total Synthesis of (+/-) Huperzine A. Tetrahedron Lett. 
30(16): 2089-2090. (b) Chen, W. and Yang, F. (1995) Asymmetric Total Synthesis of 
Optically Active Huperzine A. Zhongguo Yaowu Huaxue Zazhi 5(1): 10-17. 
37. Luo, J. (1998) In: Natural Products II, New Technology to Increase Efficiency and 
Speed; Sapienza, D. M. (ed.), IBC Library Series N° 982, International Business 
Communications, Southborough, MA, pp. 119-145. 
38. (a) Bhat, S. V.; Bajwa, B. S.; Dornauer, H. and deSouza, N. J. (1977) Structures and 
Stereochemistry of New Labdane Diterpenoids from Coleus forskohlii Briq. Tetrahedron 
Lett. 19: 1669-1672. (b) Saksema, A. K.; Geen, M. J.; Shue, H. J.; Wong, J. K. and 
McPhail, A. T. (1985) Identity of Coleonol with Forskolin: Structure Revision of a Base-
catalyzed Rearrangement Product. Tetrahedron Lett. 26(5): 551-554. 
39. Ammon, H. P. T. and Müller, A. B. (1985) Forskolin: From an Ayurvedic Remedy to a 
Modern Agent. Planta Med. 51 (6): 473-477. 
40. Tatee, T.; Narita, A.; Narita, K.; Izumi, G.; Takahira, T.; Sakurai, M.; Fujita, A.; 
Hosono, M.; Yamashita, K. Enomoto, K. and Shiozawa, A. (1996). Forskolin 
Derivatives. I. Synthesis, and Cardiovascular and Adenylate Cyclase-Stimulating 
Activities of Water-Soluble Forskolins. Chem. Pharm. Bull. 44 (12): 2274-2279. 
41. (a) Dhainaut, J. F.; Tenaillon, A.; Le Tulzo, Y.; Schlemmer, B.; Solet, J. P.; Wolff, J.; 
Holzapfel, L.; Zeni, F.; Dreyfus, D. and Mira, J. P. (1994) +Platelet-activating Factor 
Receptor Antagonist BN 52021 in the Treatment of Severe Sepsis: a Randomized, 
Double-blind, Placebo-controlled, Multicenter Clinical Trial. BN 52021 Sepsis Study 
Group. Crit. Care Med. 22(11): 1720-1728. (b) Prous, J. R. (1995) Drugs Future 20: 690-
691. 
42. Prous, J. R. (1995) Drugs Future 20: 524. 
43. Hartwell, J. L. (1982). Plants Used Against Cancer. Lawrance, MA, Quaterman. 
44. Pettit, G. R.; Singh, S. B.; Boyd, M. R.; Hamel, E.; Pettit, R. K.; Schmidt, J. M. and 
Hogan, F. (1995). Antineoplastic Agents. 291. Isolation and Synthesis of 
Combretastatins A-4, A-5, and A-6 (1a) J. Med. Chem. 38(10): 1666-1672. 
45. Philipson, J. D. (1999) New Drugs from Nature - It Could be Yew. Phytother. Res. 13: 2-
8. 
46. Kingston, D. G. I. (1993) Taxol, an Exciting Anticancer Drug from Taxus brevifolia. In: 
Kinghorn, A. D. and Bahandrin, M. F (eds.) Human Medicinal Agents from Plants. 
American Chemical Society, Washington, pp. 138-148. 
                                                                                                                                                              Bibliography 
 274
47. Cragg, G. M.; Schepartz, S. A.; Suffness, and Grever M. R. (1993). The Taxol Supply 
Crisis. New NCI Policies for Handling the Large-Scale Production of Novel Natural 
Product Anticancer and Anti-HIV Agents. J. Nat. Prod. 56 (10): 1657-1668. 
48. Cortes, J. E. and Pazdur, R. (1995) Docetaxel. J. Clin. Oncol. 13(10): 2643-2655. 
49. Dev, S. and Koul, O. (1997) Insecticides of Natural Origin. Harwood Academic 
Publishers, The Nederlands. 
50. Wedge, D. E. and Camper, N. D. (2000) Connections between Agrochemicals and 
Pharmaceuticals. In: Cutler, S. J. and Cutler, H. G. (eds.) Biologically Active Natural 
Products: Pharmaceuticals. CRC Press LLC, New York, p.2. 
51. Henrick, C. A. (1995) Pyrethroids. In: Godfrey, C. R. A. (ed.) Agrochemicals from 
Natural Products. Marcel Dekker, Inc. New York, pp. 63-145. 
52. Jacobson, M. (1989) Botanical Pesticides: Past, Present, and Future. In: Arnason, J. T.; 
Philogène, B. J. R. and Morand, P. (eds.) Insecticides of Plant Origin. ACS Symposium 
Series, American Chemical Society, Washington, D.C., p.1. 
53. Casida, J. E. (ed.) (1973) Pyrethrum, The Natural Insecticide. Academic Press, New 
York. 
54. Soreng, R. J. and Cope, E. A. (1991) Baileya, 23: 145. 
55. Dev, S.; Narula, A. P. S. and Yadav, J. S. (1982) Handbook of Terpenoids: 
Monoterpenoids, Vol. II, Boca Raton: CRC Press. 
56. (a) Elliot, M. (1977) Synthetic Pyretroids. In: Elliot, M. (ed.) Synthetic Pyrethroids. 
American Chemical Society. (b) Naumann, K. (1990) Chemistry of Plant Protection, 
Vol.4. In: Bowers, W. S.; Ebing, W.; Martin, D.; Wegler, R. (eds.) Synthetic Pyrethroid 
Insecticides: Structures and Properties. Springer-Verlag, Berlin. (c) Naumann, K. (1990) 
Chemistry of Plant Protection, Vol.5. In: Bowers, W. S.; Ebing, W.; Martin, D.; Wegler, 
R. (eds.). Synthetic Pyrethroid Insecticides: Chemistry and Patents. Springer-Verlag, 
Berlin. 
57. Pruthi, H. S.; Singh, M. (1944) Stored Grain Pests and their Control. Imperial Council of 
Agr. Res., Misc. Bull. N° 57. 
58. (a) Butterworth, J. H.; Morgan, E. D. and Percy, G. R. (1972) Structure of Azadirachtin. 
Functional groups. J. Chem. Soc. Perkin Trans.1 19: 2445-2450. (b) Jone, P. S.; Ley, S. 
V.; Morgan, E. D. and Santafianos, D. (1989) Phytochemical Pesticides, Vol. 1. In: M. 
Jacobson (ed.) The Neem Tree. CRC Press, Boca Raton, FL, p.19. 
                                                                                                                                                              Bibliography 
 275
59. (a) Saxena, R. C. (1989) Insecticides from Neem. In: Arnason, J. T.; Philogène, B. J. R. 
and Morand, P. (eds.) Insecticides of Plant Origin. ACS Symposium Series, American 
Chemical Society, Washington, D. C, pp.110-135. (b) Addor, R. W. (1995) Insecticides. 
In: Godfrey, C. R. A. (ed.) Agrochemicals from Natural Products. Marcel Dekker, Inc. 
New York, pp. 1-62. 
60. Casida, J. E. (1976) Prospects for New Types of Insecticides. In: Metcalf, R. L. and 
Mckelvey, J. J. (eds.) The Future for Insecticides: Needs and Prospects. Wiley-
Interscience, New York, pp. 349-366. 
61. (a) Saxena, R. C. and Dale, D. (1989) Plant Defense Mechanisms Against Insects. In: 
Swaminathan, M. S. and Kochhar, S. L. Plants and Society. Macmillan, London, pp. 
350-366. (b) Jacobson, M. and Crosby, D. C. (eds.) (1971) Naturally Occurring 
Insecticides. Marcel Dekker, New York, p.186-224. 
62. Ujvàry, I.; Eya, B. K.; Grendell, R. L.; Toia, R. F. and Casida, J. E. (1991) Insecticidal 
Activity of Various 3-Acyl and Other Derivatives of Veracevine Relative to Veratum 
Alkaloids Veratridine and Cevadine. J. Agr. Food Chem. 39 (10): 1875-1881. 
63. Jefferies, P. R.; Toia, R. F.; Brannigan, B.; Pessah, I. and Casida, E. J. (1992) Ryania 
Insecticide: Analysis and Biological Activity of 10 Natural Ryanoids. J. Agr. Food 
Chem. (40(1): 142-146. 
64. Wang, M.; Qin H.; Kong M.; Yanzi, L. (1991) Insecticidal Sesquiterpene Polyol Ester 
from Celastrus angulatus. Phytochemistry 30(12): 3931-3933. 
65. (a) Wakabayashi, N.; Wu, W. J.; Waters, R. M.; Redfern, R. E.; Mills, G. D., Jr.; 
DeMillo, A. B.; Lusby, W. R. and Andrzejewski, D. (1988) Celangulin: a Nonalkaloidal 
Insect Antifeedant from Chinese Bittersweet Celastrus angulatus. J. Nat. Prod. 51(3): 
537-542. (b) Liu, J. K.; Jia, Z.; Wu, D.; Zuou, J. and Wang, Q. C. (1990) Insect 
Antifeeding Agents: Sesquiterpene Alkaloids from Celastrus angulatus. Phytochemistry 
29(8): 2503-2506. 
66. Marshall, G. T.; Klocke, J. A.; Lin, L. J. and Kinghorn, A. D. (1985) Effects of 
Diterpene Esters of Tigliane, Daphnane, Ingenane, and Lathyrane Types on Pink 
Bollworm, Pectinophora gossypiella Sanders (Lepidoptera: Gelechiidae). J. Chem. Ecol. 
11(2): 191-206. 
67. Klocke, J. A.; Arisawa, M.; Handa, S. S.; Kinghorn, A. D.; Cordell, G. A. and 
Farnsworth, N. R. (1985) Growth Inhibitory, Insecticidal and Antifeedant Effects of 
                                                                                                                                                              Bibliography 
 276
Some Antileukemic and Cytotoxic Quassinoids on Two Species of Agricultural Pests. 
Experientia 41: 379-382. 
68. Robbrecht, E. (1988) Tropical Woody Rubiaceae: Characteristic Features and 
Progressions, Contributions to a New Subfamilial Classification. Nationale Plantentuin 
van België, Meise, pp. 13-14. 
69. Verdcourt, B. (1976) Rubiaceae (Part 1). In: Polhill, R.M. (ed.), Flora of Tropical East 
Africa, Crown Agents For Oversea Governments and Administrations, Whitefriars Press 
Ltd, London and Tonbridge, p. 1-213. 
70. Inouye, H.; Takeda, Y.; Nishimura, H.; Kanoni, A.; Okuda, T. and Puff, C. (1988) 
Chemotaxonomic Studies of Rubiaceous Plants Containing Iridoid Glycosides. 
Phytochemistry 27(8): 2591-2598. 
71. Wijnsma, R. and Verpoorte, R. (1986) Anthraquinones in the Rubiaceae. In: Herz, W.; 
Grisebach, H.; Kirby, G. W.; and Tamm, Ch. (eds.) Progress in the Chemistry of 
Organic Natural Products. Wien, Springer-Verlag, New York, pp. 79-149. 
72. Kisakuerek, M. V.; Leeuwenberg, A. J. M. and Hesse, M. (1983). A Chemotaxonomic 
Investigation of the Plant Families of Apocyanaceae, Loganiaceae, and Rubiaceae by the 
Indole Alkaloid Content. In: Pelletier, S. W. (ed.): Alkaloids, Chemical and Biological 
Perspectives. Wiley and Sons, New York. 
73. Watt, J. M. and Breyer-Brandwijk, M. G. (1962) The Medicinal and Poisonous Plants of 
Southern and Eastern Africa. Second Edition, E. & S. Livingstone LTD. Edinburgh and 
London, pp. 900-905. 
74. Pharmacopeia of the People's Republic of China. Guangdong Science and Technology 
Press. Guangzhou, People's Republic of China, 1992, p. 179. 
75. Hocking, G. M. (1997). A Dictionary of Natural Products. Plexus Publishing. Medford, 
NJ, p.679. 
76. (a) Itokawa, H.; Ibraheim, Z. Z.; Qiao, Y.-F. and Takeya, K. (1993) Anthraquinones, 
Naphthohydroquinones and Naphthohydroquinone Dimers from Rubia cordifolia and 
their Cytotoxic Activity. Chem. Pharm. Bull. 41 (10): 1869-1872. (b) Itokawa, H.; Qiao, 
Y. and Takeya, K. (1989) Anthraquinones and Naphthoquinones from Rubia cordifolia. 
Phytochemistry 28 (12): 3465-3468. 
77. (a) Koyama, J.; Ogura, T.; Tagahara, K.; Konoshima, T. and Kozuka, M. (1992) Two 
Naphthoquinones from Rubia cordifolia. Phytochemistry 31 (8): 2907-2908. (b) Dosseh, 
                                                                                                                                                              Bibliography 
 277
C.; Tessier, A. M. and Delaveau, P. (1981) Racines de Rubia cordifolia II: Nouvelles 
Quinones. Planta Med. 43: 141-147. 
78. Chang, L. C.; Chavez, D.; Gills, J. J.; Fong, H. H. S.; Pezzuto, J. M.; Kinghorn, A. D. 
(2000) Rubiasins A-C, New Anthracene Derivatives from the Roots and Stems of Rubia 
cordifolia. Tetrahedron Lett. 41: 7157-7162. 
79. (a) Itokawa, H.; Takeya, K.; Mihara, K.; Mori, N.; Hamanaka, T.; Sonobe, T. and Iitaka, 
Y. (1983) Studies on the Antitumor Cyclic Hexapeptides Obtained from Rubiae radix. 
Chem. Pharm. Bull. 31(4): 1424-1427. (b) Itokawa, H.; Takeya, K.; Mori, N.; 
Hamanaka, T.; Sonobe, T. and Mihara, H. (1984) Isolation and Antitumor Activity of 
Cyclic Hexapeptides Isolated from Rubiae radix. Chem. Pharm. Bull. 32(1): 284-290. 
80. (a) Hitotsuyanagi, Y.; Aihara, T. and Takeya, K. (2000) RA-dimer A, a Novel Dimeric 
Antitumor Bicyclic Hexapeptide from Rubia cordifolia L. Tetrahedron Lett. 41: 6127-
6130. (b) Itokawa, H.; Morita, H.; Takeya, K.; Tomioka, N.; Itai, A. and Iitaka, Y. 
(1991) New Antitumor Bicyclic Hexapeptides, RA–VI and –VIII from Rubia cordifolia; 
Conformation Activity Relationship II. Tetrahedron 47 (34): 7007-7020. (c) Morita, H.; 
Yamaniya, T.; Takeya, K. and Itokawa, H. (1992) New Antitumor Bicyclic 
Hexapeptides, RA–XI, –XII, –XIII and –XIV from Rubia Cordifolia Chem. Pharm. Bull. 
40(5): 1352-1354. 
81. Boullard, B. (2001) Plantes Médicinales du Monde: Croyances et Réalités, Editions 
ESTEM, Paris, p. 356. 
82. Abbiw, D. (1990) Useful Plants of Ghana, Intermediate Technologies Publications Ltd., 
p.154. 
83. La Barre, J. and Wirtheimer, C. (1962) Etude Comparative des Effets Hypotenseurs des 
Extraits et Derivés du Rauwolfia vomitoria et du Morinda lucida chez le Rat Eveillé. 
Arch. Intern. Pharmacodyn. Ther. 139: 596-603. 
84. Sandberg, F. and Cronlund, A. (1982) An Ethnopharmacological Inventory of Medicinal 
and Toxic Plants from Equatorial Africa. J. Ethnopharmacol. 5: 187-204. 
85. Gbeassor, M.; Kossou, Y.; Amegbo, K.; De Souza, C.; Koumaglo, K. and Denke, 
A.(1989) Antimalarial Effects of Eight African Medicinal Plants. J. Ethnopharmacol. 25: 
115-118. 
86. Koumaglo, K.; Gbeassor, M.; Nikabu, O.; De Souza, C. and Werner, W. (1992) Effects 
of Three Compounds Extracted from Morinda lucida on Plasmodium falciparum. Planta 
Med. 58: 533-534. 
                                                                                                                                                              Bibliography 
 278
87. Sittie, A. A.; Lemmich, E.; Olsen, C. E.; Hviid, L.; Kharazmi, A.; Nkrumah, F. K., 
Christensen, S. B. (1999) Structure-Activity Studies: In vitro Antileishmanial and 
Antimalarial Activities of Anthraquinones from Morinda lucida. Planta Med. 65: 259-
261. 
88. Yff, B. T. S.; Lindsey, K. L.; Taylor, M. B.; Erasmus, D. G. and Jäger, A. K. (2002) The 
Pharmacological Screening of Pentanisia prunelloides and the Isolation of the 
Antibacterial Compound Palmitic Acid. J. Ethnopharmacol. 79: 101-107. 
89. Kaido, T. L.; Veale, D. J. H.; Havlik, I. and Rama, D. B. K. (1997) Preliminary 
Screening of Plants Used in South Africa as Traditional Herbal Remedies During 
Pregnancy and Labour. J. Ethnopharmacol. 55: 185-191. 
90. (a) Troupin, G. (Ed.) (1985) Flore du Rwanda: Spermatophytes. Vol. III. Annales-Série 
IN-8°-Sciences Economiques-n°15, Musée Royale de l’Afrique Centrale. Tervuren, 
Belgique, pp. 195-198.  (b) Dessein, S.; Scheltens, A.; Huysmans, S.; Robbrecht, E. and 
Smets, E. (2000) Pollen Morphological Survey of Pentas (Rubiaceae-Rubioideae) and 
Its Closest Allies. Review of Palaeobotany and Palynology 112: 189-205. 
91. Kokwaro, J.O. (ed.) (1976) Medicinal Plants of East Africa. East African Literature 
Bureau, Nairobi, p. 190-191. 
92. (a) Van Puyvelde, L.; Geysen, D.; Ayobangira, F.X.; Hakizamungu, E.; Nshimyimana, 
A. and Kalisa, A. (1985) Screening of Medicinal Plants of Rwanda for Acaricidal 
Activity. J. Ethnopharmacol. 13: 209-215. (b) De Kimpe, N.; Van Puyvelde, L.; 
Schripsema, J.; Erkelens, C. and Verpoorte, R. (1993) Complete Proton and Carbon-13 
NMR Spectral Assignments of Pentalongin. Magnetic Resonance in Chemistry 31(4): 
329-30. 
93. Hari, L.; De Buyck, L. F. and De Pooter, H. L. (1991) Naphthoquinoid Pigments from 
Pentas longiflora. Phytochemistry 30(5): 1726-1727. 
94. Schildknecht, H.; Straub, F. and Scheidel, V. (1976) Mollugin, ein Neuer Farbstoff aus 
Rhizomen des Wiesen-Labkrautes Galium mollugo L. Liebigs Ann. Chem., 1295-1306. 
95. Itokawa, H.; Kazuhiko, M.; Koichi, T. (1983) Studies on a Novel Anthraquinone and Its 
Glycosides Isolated from Rubia cordifolia and R. akane. Chem. Pharm. Bull. 31 (7): 
2353-2358. 
96. El-Hady, S. (1999) Dissertation (PhD): Isolation and Structural Elucidation of Natural 
Products from Pentas longiflora Oliver and Gossypioides kirkii (Mast.) J.B. Hutch., 
                                                                                                                                                              Bibliography 
 279
Faculty of Agricultural and Applied Biological Sciences, Ghent University, Ghent, 
Belgium. 
97. Harouna, H.; Faure, R.; Elias R.; Debrauwer, L.; Saadou, M.; Balansard, G. and Boudon, 
G. (1995) Harounoside, a Pentalongin Hydroquinone Diglycoside from Mitracarpus 
scaber. Phytochemistry 39(6): 1483-1484. 
98. Adjanohoun, E. J.; Ahyi, A. M. R.; Dan Dicko, L.; Daouda, H.; Delmas, M.; de Souza, 
S.; Garba, M.; Guinko, S.; Kayonga, A.; N’Golo, D.; Raynal, J. L. and Saadou, M. 
(1985) Contribution aux Etudes Ethnobotaniques et Floristiques du Niger, A. C. C. T., 
France. 
99. Naito, T.; Makita, Y.; Yazaki, S. and Kaneko, C. (1986) Cycloadditions in Synthesis. 
XXVI. 1,2-Dihydrocyclobuta[b]naphthalene-3,8-diones: Synthesis by Photochemical 
Means and Their Reactions via 2,3-Dimethylene-1,4-dioxo-1,2,3,4-
tetrahydronaphthalenes. Chem. Pharm. Bull. 34(4): 1505-1517. 
100. (a) Kesteleyn, B.; De Kimpe, N. and Van Puyvelde, L. (1999) Total Synthesis of Two 
Naphthoquinone Antibiotics, Psychorubrin and Pentalongin, and Their C(1)-Substituted 
Alkyl and Aryl Derivatives. J. Org. Chem. 64(4): 1173-1179. (b) Kesteleyn, B.; De 
Kimpe, N. and Van Puyvelde, L. (1999) Synthesis of Two Naphthoquinone Antibiotics 
Pentalongin and Psychorubrin. Synthesis 11: 1881-1883. (c) Van, T. N.; Kesteleyn, B. 
and De Kimpe, N. (2001) Synthesis of 1,3-disubstituted naphtho[2,3-c]pyran-5,10-
diones. Tetrahedron 57: 4213-4219. 
101. Hayashi, T.; Smith, F. T. and Lee, K. H. (1987) Anti-tumor Agents. 89. Psychorubrin, a 
New Cytotoxic Naphthoquinone from Psychotria rubra and Its Structure-Activity 
Relationships. J. Med. Chem. 30(11): 2005-2008. 
102. Itokawa, H.; Qiao, Y. and Takeya, K. (1991) Anthraquinones, Naphthoquinones and 
Naphthohydroquinones from Rubia onchotricha. Phytochemistry 30(2): 637-640. 
103. Heide, L. and Leistner, E. (1981) 2-Methoxycarbonyl-3-prenyl-1,4-naphthoquinone, a 
Metabolite Related to the Biosynthesis of Mollugin and Anthraquinones in Galium 
mollugo L. J. Chem. Soc., Chem. Commun. 7: 334-336. 
104. El Hady, S.; Bukuru, J.; Kesteleyn, B.; Van Puyvelde, L.; Van, T. N. and De Kimpe, N. 
(2002) New Pyranonaphthoquinone and Pyranonaphthohydroquinone from the Roots of 
Pentas longiflora. J. Nat. Prod. 65(9): 1377-1379. 
                                                                                                                                                              Bibliography 
 280
105. Van Puyvelde, L.; El Hady, S.; De Kimpe, N.; Feneau-Dupont, J. and Declercq, J.-P. 
(1998) Isagarin, a New Type of Tetracyclic Naphthohydroquinone from the Roots of 
Pentas longiflora. J. Nat. Prod. 61:1020-1021. 
106. Kesteleyn, B.; Van Puyvelde, L. and De Kimpe, N. (1999) Synthesis of Isagarin, a New 
Type of Tetracyclic Naphthoquinone from Pentas longiflora. J. Org. Chem. 64(2): 438-
440. 
107. Sartori, G.; Bigi, F.; Tao, X.; Porta, C.; Maggi, R.; Predieri, G.; Lanfranchi, M.and 
Pellinghelli, M. A.(1995) An Investigation of the Reaction Mechanism of the Bis-
acylation of Aromatics with O-Phthaloyl Dichlorides: Regioselective Synthesis of 
Anthraquinones. J. Org. Chem. 60(20): 6588-6591. 
108. (a) Cserjesi, A. J. and Smith, R. S. (1968) Anthraquinone Production by a Fungus 
Causing Black Heartwood Stain in Yellow Cedar. Mycopathol. Mycol. Appl. 35(2): 91-
96. (b) Van Eijk, G. W. and Roeijmans, H. J. (1984) Separation and Identification of 
Naturally Occurring Anthraquinones by Capillary Gas Chromatography and Gas 
Chromatography-Mass Spectrometry. J. Chromatogr. 295 (2): 497-502. 
109. Kawasaki, Y.; Goda, Y.; Yoshihira, K. and Noguchi, H. (1990) A New Anthraquinone 
from Rubia tinctorum. Shoyakugaku Zasshi 44(2): 95-97. 
110. Arisawa, M.; Kinghorn, A. D.; Cordell, G. A. and Farnsworth N. R. (1983) Plant 
Anticancer Agents. J. Nat. Prod. 46(2): 222-225. 
111. Kojima, H.; Sato, N.; Hatano, A. and Ogura, H. (1990) Sterol Glucosides from Prunella 
vulgaris. Phytochemistry 29(7): 2351-2355. 
112. Kusamba, C.; Federici, F.; De Vicente, Y. and Galeffi, C. (1993) The Anthraquinones of 
Pentas zanzibarica. Fitoterapia 64 (1): 18-22. 
113. Beentje, H.J. (ed.) (1994) Kenya Trees: Shrubs and Lianes, National Museums of Kenya, 
Nairobi, Kenya, p.531. 
114. Itokawa, H.; Takeya, K.; Mori, N.; Kidokoro, S. and Yamamoto, H. (1984) Studies on 
Antitumor Cyclic Hexapeptides RA Obtained from Rubiae Radix, Rubiaceae (IV): 
Quantitative Determination of RA–VII and RA–V in Commercial Rubiae Radix and 
Collected Plants. Planta Med. 50 (4): 313-316. 
115. Marsan, M.-P.; Warnock, W.; Muller, I.; Nakatani, Y.; Ourisson, G. and Milon, A. 
(1996) Synthesis of Deuterium-Labeled Plant Sterols and Analysis of Their Side-chain 
Mobility by Solid State Deuterium NMR. J. Org. Chem. 61(13): 4252-4257. 
                                                                                                                                                              Bibliography 
 281
116. Lu, Y.; Xu, P.-J.; Chen, Z.-N. and Liu, G.-M. (1998) Anthraquinones Glycosides from 
Rhynchotechum vestum. Phytochemistry 49(4): 1135-1137. 
117. Bennet, G. T.; Harrisson, L. J.; Lim, M.-S.; Sim, K.-Y.; Tan, E.-C. and Connolly, J. D. 
(1991) Geranyl Anthraquinones from the Bark of Ploiarium alternifolium. 
Phytochemistry 30 (9): 3141-3143. 
118. Huang, L.; Fullas, F.; Mc Givney R. J.; Brown, D. M.; Wani, M. C.; Wall, M. E.; Tuker, 
J. C.; Beecher, C. W. W.; Pezzuto, J. M. and Kinghorn, A. D. (1996) A New Prenylated 
Flavonol from the Root of Petalostemon purpureus. J. Nat. Prod. 59 (3), 290-292. 
119. Tsopmo, A.; Tene, M.; Kamnaing, P.; Ngnokam, D.; Ayafor, J. F. and Sterner, O. (1998) 
Geranylated Flavonoids from Dorstenia poinsettifolia.  Phytochemistry 48 (2): 345-348. 
120. Decosterd, L. A.; Parsons, I. C.; Gustafson, K. R.; Cardellina II, J. H.; McMahon, J. B.; 
Cragg, G. M.; Murata, M.; Pannell, L. K.; Steiner, J. R.; Clardy, J. and Boyd, M. R. 
(1993) Structure, Absolute Stereochemistry, and Synthesis of Conocurvone, a Potent, 
Novel HIV-Inhibitory Naphthoquinone Trimer from a Conospermum sp. J. Am. Chem. 
Soc. 115 (15): 6673-6679. 
121. (a) Williams, D. H. and Fleming, I. (1995) Spectroscopic Methods in Organic Chemistry, 
Fifth Edition, McGraw-Hill Publishing Company, Maidenhead, Berkshire, England, pp. 
17-25. (b) Silverstein, R. M.; Basler, G. C. and Morill, T. C. (1998) Identification 
Spectrométrique des Composés Organiques, 5ème Edition, De Boeck & Larcier s.a., Paris, 
Bruxelles, pp. 27-311. 
122. Bukuru, J. F.; Tuyen, N. V.; Puyvelde, L. V.; Mathenge, S. G.; Mudida, F. P. and De 
Kimpe, N. (2002) A Benzochromene from the Roots of Pentas bussei.  J. Nat. Prod. 65 
(5): 783-785. 
123. (a) Crombie, L.; Redshaw, S. D.; Slack, D. A. and Whiting, D. A. (1979) Synthesis and 
Structure of Eriobrucinol and Isomeric “Cyclol” Meroterpenes. J. Chem. Soc., Chem. 
Commun.: 628-630. (b) Rashid, M. A.; Armstrong, J. A.; Gray, A. I. and Waterman, P. 
G. (1992) Tetra- and Pentacyclic 6-C-Monoterpenyl-5,7-dioxycoumarins from 
Eriostemon brucei and E. brucei Subspecies cinereus. Phytochemistry 31 (10): 3583-
3588. (c) Crombie, L. and Ponsford, R. (1971) Synthesis of Cannabinoids by Pyridine-
catalysed Citral-Olivetol Condensation: Synthesis and Structure of Cannabicyclol, 
Cannabichromen, (Haschish Extractives), Cytrilidene-cannabis, and Related compounds. 
J. Chem. Soc. (C): 796-804. 
                                                                                                                                                              Bibliography 
 282
124. (a) Montero, J. L.and Winternitz, F. (1973) Structure de la Rubranine Chalcone Isolée du 
Bois de Rose Aniba Rosaeodora Ducke-II: Synthèse d’Analogues Cannabinoides 
Derivant de la Phloroacétophénone. Tetrahedron 29: 1243-1252. (b) Nakagawa, N.; 
Saito, S.; Suzuki, A. and Itoh, M. (1967) Magnetic Anisotropy of the Cyclobutane 
System with a Puckered Structure. Tetrahedron Lett. (11): 1003-1007. 
125. (a) Bandaranayake, W. M.; Begley, M. J.; Brown, B. O.; Clarke, D. G.; Crombie, L. and 
Whiting, D. A. (1974) Synthesis of Acridone and Carbazole Alkaloids involving 
Pyridine-catalysed Chromen Formation: Crystal and Molecular Structure of 
Dibromocannabicyclol and its Bearing on the Structures of the “Cyclol” Alkaloids. J. 
Chem. Soc. Perkin Trans. I.: 998-1007. (b) Jefferies, P. R. and Worth, G. K. (1973) The 
Chemistry of the Western Australian Rutaceae – VI: Two Novel Coumarins from 
Eriostemon brucei. Tetrahedron 29: 903-908. (c) Gray, A. I; Rashid, M. A.and 
Waterman, P. G. (1992) NMR Assignments for the Pentacyclic Coumarins Bruceol and 
Deoxybruceol. J. Nat. Prod. 55(5): 681-684. 
126. Crombie, L.; Redshaw, S. D.; Slack, D. A. and Whiting, D. A. (1983) Synthesis of (±)-
Eriobrucinol and Regioisomeric Monoterpenoid Coumarins, Using Intramolecular 
Cycloadditions. J. Chem. Soc. Perkin Trans. I.: 1411-1416. 
127. (a) Crombie, L.; Ponsford, R.; Shani, A.; Yagnitinsky, B. and Mechoulan, R. (1968) 
Hashish Components: Photochemical Production of Cannabicyclol from 
Cannabichromene. Tetrahedron Lett. (55): 5771-5772. (b) Crombie, L. and Ponsford, R. 
(1971) Pyridine-Catalysed Condensation of Citral with Phloroglucinols, a Novel 
Reaction Leading to Tetracyclic Bis-ethers and Chromens: Two-step Synthesis of (±)-
Deoxybruceol. J. Chem. Soc. (C): 788-795. 
128. Begley, M. J.; Crombie, L.; King, R. W.; Slack, D. A. and Whiting, D. A. (1977)  
Chromens and Citrans Derived from Phloroacetophenone and Phloroglucinaldehyde by 
Citral Condensation: Regioselectivity, Mechanism, and X-Ray Crystal Structures. J. 
Chem. Soc., Chem. Commun.: 2393-2402. 
129. (a) Kureel, S. P.; Kapil, R. S. and Popli, S. P. (1969) Terpenoid Alkaloids from Murraya 
koenigii Spreng.–II: The Constitution of Cyclomahanimbine, Bicyclomahanimbine, and 
Mahanimbidine. Tetrahedron Lett.: 3857-3862. (b) Begley, M. J.; Clarke, D. G.; 
Crombie, L. and Whiting, D. A. (1970) The X-Ray Structure of Dibromocannabicyclol: 
Structure of Bicyclomahanimbine. J. Chem. Soc., Chem. Commun.: 1547-1548. 
                                                                                                                                                              Bibliography 
 283
130. Ghisalberti, E. L.; Jefferies, P. R.; Raston, C. L.; Skelton, B. W.; White, A. H. and 
Worth, G. K. (1981) Structural Studies of Some Hydroxyeriobrucinol Derivatives. J. 
Chem. Soc. Perkin Trans. II.: 576-582. 
131. (a) Morrison, R. T. and Boyd, R. N. (1987) Organic Chemistry, Fifth Edition, Allyn and 
Bacon, Inc, Boston, pp. 1092-1093. (b) Vollhardt, C. and Schore, N. E. (1995) Traité de 
Chimie Organique (Traduit de l'anglais par Paul Depovere), 2ème Edition, De Boeck-
Wesmael S.A., Bruxelles, pp. 869-870, 885-892. 
132. (a) Pozharskii, A. F.; Soldatenkov, A. T. and Katritzky, A. R. (eds). (1997) Heterocycles 
in Life and Society, John Wiley & Sons, Chichester, New York, pp. 63-69. (b) Kesteleyn, 
B. (1999) Dissertation (Ph.D): Synthesis of Pyranonaphthoquinones and Related 
Naturally Occuring Heteroanthraquinones, Ghent University, Belgium, pp. 23-24. (c) 
Fukuyama, Y.; Kiriyama, Y. and Kodama, M. (1998) Naturally Occurring 5-
Lipoxygenase Inhibitors. VII. Practical Synthesis of Ardisiaquinones D, E, and F. Chem. 
Pharm. Bull. 46(11): 1770-1775. 
133. Iwaki, H.; Fukuyama, Y. and Matsui, K. (1985) 1,4-Benzoquinone Derivatives and 
Benzene Derivatives. Eur. Pat. Appl. (EP 0 151 995 B1), 241 pp. (Chem. Abstr., 1986, 
104: 33861). 
134. Haraguchi, H.; Ohmi, I. and Kubo, I. (1996) Inhibition of Aldose Reductase by 
Maesanin and Related p-Benzoquinone Derivatives and Effects on Other Enzymes. 
Bioorg. Med. Chem. 4(1): 49-53. 
135. El-Gamal, A. A.; Takeya, K.; Itokawa, H.; Halim, A. F.; Amer, M. M.; Saad, H.-E. A. 
and Awad, S. A. (1996) Anthraquinones from the Polar Fractions of Galium sinaicum. 
Phytochemistry 42(4): 1149-1155. 
136. Tori, K.; Hirata, T.; Koshitani, O. and Suga, T. (1976) Carbon-13 NMR Spectral Studies 
of Aloein and its Derivatives. Carbon-13 Signal Assignment Problem of 4-Methoxy-2-
pyrones. Tetrahedron Lett. (16): 1311-1314. 
137. Kasai, R.; Suzuo, M.; Asakawa, J.-I. and Tanaka, O.  (1977) Carbon-13 Chemical Shifts 
of Isoprenoid-β-D-Glucopyranosides and -β-D-Mannopyranosides. Stereochemical 
Influences of Aglycone Alcohols. Tetrahedron Lett. (2): 175-178. 
138. (a) El-Emary, N. A. and Backheet, E. Y. (1998) Three Hydroxymethylanthraquinone 
Glycosides from Rubia tinctorum. Phytochemistry 49 (1): 277-279. (b) Perlin, A. S.; 
Casu, B. and Koch, H. J. (1970) Configurational and Conformational Influences on the 
Carbon-13 Chemical Shifts of some Carbohydrates. Can. J. Chem. 48: 2596-2606. 
                                                                                                                                                              Bibliography 
 284
139. Coskun, M.; Tanker, N.; Sakushima, A.; Kitagawa, S. and Nishibe, S. (1984) An 
Anthraquinone Glycoside from Rhamnus pallasii. Phytochemistry 23(7): 1485-1487. 
140. Uniyal, G. C.; Agrawal, P. K.; Thakur, R. S. and Sati O. P. (1990) Steroidal Glycosides 
from Agave cantala. Phytochemistry 29(3): 937-940. 
141. Han, Y.-S.; Van der Heijden, R.; Lefeber, A. W. M.; Erkelens, C. and Verpoorte, R. 
(2002) Biosynthesis of Anthraquinones in Cell Cultures of Cinchona "Robusta" Proceeds 
via the Methylerythritol 4-phosphate Pathway. Phytochemistry 59(1): 45-55. 
142. (a) Demagos, G. P.; Baltus, W. and Höfle, G. (1981) New Anthraquinones and 
Anthraquinone Glycosides from Morinda lucida. Z. Naturforsch. 36b: 1180-1184. (b) 
Kawasaki, Y.; Goda, Y. and Yoshihira, K. (1992) The Mutagenic Constituents of Rubia 
tinctorum. Chem. Pharm. Bull. 40 (6): 1504-1509. 
143. (a) Jagodzinska, B. M.; Trimmer, J. S.; Fenical, W. and Djerassi, C. (1985) Sterols in 
Marine Invertebrates: 49. Isolation and Structure Elucidation of Eight New 
Polyhydroxylated Sterols from the Soft Coral Sinuralia dissecta. J. Org. Chem. 50(9): 
1435-1439. (b) Eggersdorfer, M. L.; Kokke, W. C. M. C.; Crandell, C. W.; Hochlowski; 
J. E.; Djerassi, C. (1982) Sterols in Marine Invertebrates: 32. Isolation of 3β-
(Hydroxymethyl)-A-nor-5α-cholest-15-ene, the First Naturally Occurring Sterol with a 
15-16 Double Bond. J. Org. Chem. 47(27): 5304-5309. (c) Eggert, H.; VanAntwerp, C. 
L.; Bhacca, N. S. and Djerassi, C. (1976) Carbon-13 Nuclear Magnetic Resonance 
Spectra of Hydroxy Steroids. J. Org. Chem. 41(1): 71-78. 
144. Agnew, A. D. Q. (1974) Upland Kenya Wild Flowers: A flora of the Ferns & 
Herbaceous Flowering Plants of Upland Kenya, Oxford University Press, London, pp. 
403-404. 
145. Zhao, H. and Biehl, E. (1995) Preparation of Naturally Occurring Anthraquinones Using 
the Aryne Reaction. J. Nat. Prod. 58(12): 1970-1974. 
146. (a) Briggs, L. H.; Beachen, J. F.; Cambie, R. C.; Dudman, N. P. B.; Steggles, A. W. and 
Rutledge, P. S. (1976) Chemistry of the Coprosma Genus. Part XIV. Constituents of 
Five New Zealand Species. J. Chem. Soc., Perkin I: 1789-1792. (b) Brew, E. J. C. and 
Thomson, R. H. (1971) Naturally Occurring Quinones. Part XIX. Anthraquinones in 
Hymenodictyon excelsum and Damnacanthus major. J. Chem. Soc. (C): 2001-2007. (c) 
Adesida, G. A. and Adesogan, E K. (1972) Oruwal, a Novel Dihydroanthraquinone 
Pigment from Morinda lucida Benth. J. Chem. Soc., Chem. Comm.: 405-406. 
                                                                                                                                                              Bibliography 
 285
147. Dosseh, C.; Tessier, A. M. and Delaveau, P. (1981) Nouvelles Quinones des Racines de 
Rubia cordifolia L. III. Planta Med. 43: 360-366. 
148. Chang, P. and Lee, K.-H. (1984) Cytotoxic Antileukemic Anthraquinones from Morinda 
parvifolia. Phytochemistry 23(8): 1733-1736. 
149. Castonguay, A. and Brassard, P. (1977) C-Alkylation of 1,3-Dihydroxyanthraquinones. 
Total Synthesis of (±)-Averufin and (±)-Bipolarin. Can. J. Chem. 55: 1324-1332. 
150. Koyama, J.; Okatani, T.; Tagahara, K.; Kouno, I. and Irie, H. (1992) Anthraquinones of 
Damnacanthus indicus. Phytochemistry 31(2): 709-710. 
151. Kuiper, J. and Labadie, R. P. (1981) Polyploid Complexes Within the Genus Galium. 
Part I: Anthraquinones of Galium album. Planta Med. 42: 390-399. 
152. Banthorpe, D. and White, J. J. (1995) Novel Anthraquinones from Undifferentiated Cell 
Cultures of Galium verum. Phytochemistry 38(1): 107-111. 
153. (a) Koyama, J.; Ogura, T. and Tagahara, K. (1993) Anthraquinones of Galium spurium. 
Phytochemistry 33(6): 1540-1542. (b) Ismail, N. H.; Ali A. M.; Aimi, N.; Kitajima, M.; 
Takayama, H. and Lajis, N. H. (1997) Anthraquinones from Morinda ellipta. 
Phytochemistry 45(8): 1723-1725. (c) Ferrari, F.; Monache, G. D. and Alves de Lima, R. 
(1985) Two Naphthopyran Derivatives from Faramea cyanea. Phytochemistry 24(11): 
2753-2755. 
154. Kitajima, M.; Fischer, U.; Nakamura, M.; Ohsawa, M.; Ueno, M. Takayama, H.; Unger, 
M.; Stöckigt, J. and Aimi, N. (1998) Anthraquinones from Ophiorrhiza pumila Tissue 
and Cell Cultures. Phytochemistry 48(1): 107-111. 
155. Thomson, R. H. (1987) Naturally Occurring Quinones III, Recent Advances. Chapman 
and Hall, London. 
156. (a) Leistner, E. (1981) Biosynthesis of Plant Quinones. In: Conn, E. E. (ed.) The 
Biochemistry of plants, Vol. 7, Academic, London, pp. 403-423. (b) Leistner, E. (1985) 
Biosynthesis of Chorismate-derived Quinones in Plant Cells Cultures. In: Neumann, K. 
H.; Barz, W. and Reinhard, E. (eds.) Primary and Secondary Metabolism of Plant Cell 
Cultures. Springer, Berlin, pp. 215-224. 
157. (a) Larsen, S. D. and Monti, S. A. (1977) Total Synthesis of Racemic α-trans- and α-cis-
Bergamotene and α-Pinene. J. Am. Chem. Soc. 99(4): 8015-8020. (b) Ray, R. and 
Matteson, S. (1980) Osmium Tetroxide Catalysed Hydroxylation of Hindered Olefins. 
Tetrahedron Lett. 21: 449-450. 
                                                                                                                                                              Bibliography 
 286
158. Roberge G. and Brassard, P. (1978) Total Synthesis of the Methyl Ether Ester 
Derivatives of the Coccid Anthraquinones Laccaic Acid D and Kersemic Acid. J. Chem. 
Soc. Perkin I 9: 1041-1046. 
159. Chong, R. and Clezy, P. S. (1966) O-Methylation of β-Dicarbonyl Compounds. 
Tetrahedron Lett. 7: 741-742. 
160. Danishefsky, S and Kitahara, T. (1974) A Useful Diene for the Diels-Alder reaction. J. 
Am. Chem. Soc. 96: 7807-7808. 
161. VanRheenen, V.; Kelly, R. C. and Cha, D. Y. (1976) An Improved Catalytic OsO4 
Oxidation of Olefins to cis-1,2-Glycols Using Tertiary Amine Oxides as the Oxidant. 
Tetrahedron Lett. 23: 1973-1976. 
162. Tai, D.-F.; Lin, Y.-M. and Chen, F.-C. (1979) Components of Hedyotis diffusa Willd. 
Huaxue 3: 60-61. (Chem. Abstr. 94, 1996g, 1981). 
163. Brisson, C. and Brassard, P. (1981) Regiospecific Reactions of Some Vinylogous Ketene 
Acetals with Haloquinones and Their Regioselective Formation by Dienolization. J. Org. 
Chem. 46(9): 1810-1814. 
164. Hirose, Y.; Kuroiwa, M.; Yamashita, H.; Tanaka, T. and Megumi, T. (1973) Chemical 
Studies on the Natural Anthraquinones. I. Synthesis of Munjistin, Emodin, and 3-
Hydroxy-2-methylanthraquinone. Chem. Pharm. Bull. 21(12): 2790-2793. 
165. Gollapudi, B. B. and Krishna, G. (2000) Practical Aspects of Mutagenicity Testing 
Strategy: an Industrial Perspective. Mutation Res. 455: 21-28. 
166. Mortelmans, K. and Zeiger, E. (2000) The Ames Salmonella/Microsome Mutagenicity 
Assay. Mutation Res. 455: 29-60. 
167. (a) Verschaeve, L.; Van Gompel, J.; Regniers, L.; Van Parijs, Ph. and Van der Lelie D. 
(1999) VITOTOX Genotoxicity and Toxicity Test for the Rapid Screening of 
Chemicals. Environ. Molec. Mutagen. 33: 240-248. (b) Van der Lelie, D.; Regniers, L.; 
Borremans, B.; Provoost, A. and Verschaeve, L. (1997) The VITOTOX Test, a SOS-
bioluminescence Salmonella typhimurium Test to Measure Genotoxicity Kinetics. 
Mutation Res. 389: 279-290. 
168. (a) Fenech, M. (2000) The in vitro Micronucleus Technique. Mutation Res. 455: 81-95. 
(b) Krishna, G. and Hayashi, M. (2000) In vivo Rodent Micronucleus Assay: Protocol, 
Conduct and Data Interpretation. Mutation Res. 455: 155-166. 
 
  
                                                                                                                                                              Bibliography 
 287
 
                                                                                                                                                              Bibliography 
 288
 
 
 
 
 
  289
 
 
 
 
 
 
 
 
 
 
 
 
IX. 
 
 
 
CURRICULUM VITAE 
 
 
  290
 
 
 
 
 
                                                                                                                                                        Curriculum vitae 
 291
IX. CURRICULUM VITAE 
 
JACQUES BUKURU was born on July 6th 1965, at Kirundo-Minyago, Republic of Burundi. 
He obtained his “Licenciate” degree in Chemical Sciences at the Faculty of Sciences of the 
University of Burundi, on November 19th 1991. From July 1992 to February 1996, he worked 
as a research assistant at the “Centre de Recherche Universitaire sur la Pharmacopée et la 
Médecine Traditionnelle (CRUPHAMET)” of the University of Burundi (Faculty of 
Sciences). He obtained his “DEA” (Diplôme d’Etudes Approfondies) in Pharmaceutical 
Sciences (Chemistry) at the Catholic University of Louvain (Belgium) in September 1998. In 
October 1998, he was admitted to the Department of Organic Chemistry, Faculty of 
Agricultural and Applied Biological Sciences, Ghent University, as a PhD student in natural 
products research under the guidance of Prof. Dr. ir. N. De Kimpe. 
 
 
Scientific Publications 
 
1.  Bukuru, J. F.; Van T. N.; Van Puyvelde, L.; Mathenge, S. G.; Mudida, F. P. and De 
Kimpe, N. (2002) A Benzochromene from the Roots of Pentas bussei. Journal of Natural 
Products 65(5): 783-785. 
2.  El-Hady, S.; Bukuru, J.; Kestelyen, B.; Van Puyvelde, L.; Van, T. N. and De Kimpe, N. 
(2002) New Pyranonaphthoquinone and Pyranonaphthohydroquinone from the Roots of 
Pentas longiflora. Journal of Natural Products 65(9): 1377-1379. 
3.  Poupaert, J. H.; Bukuru, J. and Gozzo, A. (1999) Clay (Montmorillonite K10) Catalysis of 
the Michael Addition of α,β-Unsaturated Carbonyl Compounds to Indoles: The Beneficial 
Role of Alcohols. Monatshefte für Chemie 130: 929-932. 
4.  Hari, L.; Bukuru, J.; De Pooter, H. L.; Demyttenaere, J. R. and Fierens, H. (1996) Essential 
Oil of Plectranthus defoliatus Hochst. Ex Benth. Journal of Essential Oil Research 8: 87-
89. 
5.  Hari, L.; Bukuru, J. and De Pooter, H. L. (1994) The Volatile Fraction of Aframomum 
sanguinum (K. Schum) K Schum from Burundi. Journal of Essential Oil Research 6: 395-
398. 
 
Papers Submitted for Publication 
                                                                                                                                                        Curriculum vitae 
 292
 
1.  Bukuru, J.; Van, N. T.; Puyvelde, L. V.; He, W. and De Kimpe, N. (2003) A New 
Pentacyclic Cyclol-type Naphthohydroquinone from the Roots of Pentas bussei. 
Tetrahedron (accepted). 
2.  Li, W.-L.; Zheng, H.-C.; Bukuru, J. and De Kimpe, N. (2003) Natural Medecines Used in 
the Traditional Chinese Medical System for Therapy of Diabetes Mellitus. Journal of 
Ethnopharmacology (submitted). 
 
 
Posters Presented at Conferences 
 
1.  Bukuru, J. F.; Nguyen Van, T.; Van Puyvelde, L.; Mathenge, S. G.; Mudida, F. P. and De 
Kimpe, N. (2001) A New Benzochromene Isolated from the Roots of Pentas bussei. 53rd 
International Symposium On Crop Protection. May 8th, 2001, Ghent University, Belgium. 
2.  Bukuru, J. F.; He, W.; Van Puyvelde, L.; Mathenge, S. G. and De Kimpe, N. (2001) 
Screening of Potential Biologically Active Compounds from the Genus Pentas: Highly 
Oxygenated New Naphthohydroquinones from P. bussei and P. parvifolia. One Day 
Symposium on “Drug Discovery Strategies: From Leads to Drugs” by the “Société Royale 
De Chimie”, Medicinal Chemistry Division. November 16th, 2001, Louvain-la-Neuve, 
Belgium. 
 
 
Participation at International Conferences 
 
1. “51st International Symposium On Crop Protection”. Symposium Organised by the 
Faculty of Agricultural and Applied Biological Sciences, Ghent University. May 4th, 
1999, Ghent, Belgium. 
2. “Flash Chromatography in Combinatorial Chemistry”. Seminary Organised by the 
Company Beun De Ronde SERLABO (Belgium). February 24th, 2000, Ghent, Belgium. 
3. “The Screening of Plant Species for Potential Medicinal Use”, Workshop Organised as a 
Part of the “Bilateral International Scientific and Technological Cooperation” Project 
Between Flanders (Belgium) and South Africa by the “Vlaamse Instelling Voor 
Technologisch Onderzoek (VITO)” and the University of Ghent. October 19th, 2001, Mol, 
                                                                                                                                                        Curriculum vitae 
 293
Belgium. 
4. “5th SIGMA-ALDRICH Organic Synthesis Meeting”.  December 6th − 7th, 2001, Spa, 
Belgium. 
5. “From Medicinal Plant to Phytomedicine: Microbial and Parasitic Infections”. LOF-
Symposium Organsed by the “Landelijk Overleg Farmacognosie (LOF)”.  February 28th, 
2003, University of Antwerp (UIA), Antwerp, Belgium. 
 
